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Could Aeromonas spp. be considered a vector of resistance genes from the 
environment to human intestinal flora? 
 
 
 
Antibiotic resistant bacteria and antibiotic resistance genes cause increasing problems in 
clinical setting and are considered emerging environmental contaminants. In the environment, 
antibiotic resistant bacteria may be inactivated but their resistance determinants may become 
part of the environmental gene pool and may move back to human and animal intestinal flora 
via food and drinking water. 
In order to assess the role of Aeromonas spp. in the flow of resistant determinants, we 
analyzed by resistance profiles, plasmidic and integrons content and characterization, 231 
Aeromonas spp. and 250 Fecal Coliforms isolated from different aquatic environments. 
Resistance patterns could be related to both the presence of multiple plasmids and to the 
origin of the strains. The 31.7% of the plasmids carried by the Aeromonas strains were 
mobilizable as assess by dot-blot of MOB-subfamily covering the BHR (Broad Host Range) 
incompatibility groups. The majority (75%) of the Class 1 integrons were chromosomally 
locate and were found in the 27.7% of the Aeromonas spp. tested. 
 The number and type of resistance genes identified so far on Aeromonas spp. support 
the hypothesis of considering these bacteria as a "reservoir" of resistance genes.  
The capability of some Aeromonas strains to transfer their resistance to Fecal Coliform 
has been demonstrated, thus allowing to assert its role as a “vector” of resistance genes to 
members of the human intestinal flora. 
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1 INTRODUCTION 
 
1.1 Aquatic Environments – antibiotics and reservoirs of resistance 
determinants  
 
Freshwater environment includes groundwater and surface freshwater. Groundwater holds 
low amount of nutrients but is rich in mineral content due to rocks erosion, while surface 
water covering lakes, rivers and canal water, carries a diverse range of flora and fauna and 
manifold physical and chemical conditions (Holmes et al., 1996). In Europe the fresh waters 
are subject of a framework for the protection and the improvement of the ecological status by 
the European Water Framework Directive 2000/60/CE. The directive focuses on the 
evaluation of the ecological effects, biological communities and multiple anthropogenic 
stressors (European Community, 2000). 
Aquatic ecosystems are exposed to a broad range of natural stressor elements, such as 
temperature and oxygen depletion acting on individuals, populations and communities, as 
well as to a wide spectrum of different product categories (micro-pollutants) released in the 
environment. The micro-pollutants could include plant protection products, biocides, drugs 
and components of consumers goods (e.g. body creams, detergents) (UFAM, 2009) 
originating from municipal and industrial wastewater as well as from urban and agricultural 
areas (Connon et al., 2012). 
In recent years, the pharmacological treatment of human infections caused by pathogenic 
bacteria has become difficult due to their increasing resistance, giving rise to a further 
increase in the use of antibiotics and in the bacterial resistance. Nowadays, among the micro-
pollutants of the aquatic environment there are also antibiotics used in human and veterinary 
medicine and multiresistant pathogenic bacteria. The contamination by human and veterinary 
antibiotics was found in studies conducted either on wastewater treatment plants than on 
watersheds; generally the concentration was less than 1µg/L. Veterinary antibiotics are 
introduced in the environment because they are used as fertilizer or for veterinary purpose. 
Antibiotics are found in soils and can reach basins and rivers by the rainfalls (Kim et al., 
2010; Campagnolo et al., 2002). 
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The antibiotic concentrations tend to increase along the rivers due to the polluted incoming 
water. Even when antibiotic concentrations are sub-therapeutic, there is a high probability of 
resistant bacteria development. (Zuccato et al., 2010). 
The presence of pollutants, antimicrobial resistant bacteria and resistant determinants in the 
aquatic systems enables and facilitates the horizontal gene transfer (HGT) between bacteria. 
The interactions among non-pathogenic environmental and pathogenic human/animal bacteria 
can lead to the establishment of resistance in clinical relevant isolates (Figure 1.1.1) (Taylor 
et al., 2011). 
 
    
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1.1: Contact flow between antimicrobial-resistant bacteria and resistant genes through terrestrial 
environment, aquatic system and humans. (From Taylor et al., 2011) 
 
 
Bacteria have different methods to adapt to stressful conditions in their environments, either 
in nature or in human beings. The mechanisms allowing a survival increasing are molecular 
adaptations and acquisition of exogenous DNA by horizontal gene transfer, thus leading to the 
bacterial evolution (Moura et al., 2010).  
Bacteria have spontaneously developed five methods to bypass the impact of small bio-
molecules or bioactive compounds (Figure 1.1.2): (i) exclusion by the membrane; (ii) 
intracellular modification/deactivation of the antimicrobial compound; (iii) extrusion; (iv) 
reduction of the target sensitivity; and (v) intracellular sequestration. These survival 
mechanisms can be acquired by different pattern: (a) transduction via the action of viruses; (b) 
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transformation by the uptake of foreign DNA; (c) conjugation by the interaction of two 
bacteria (Taylor et al., 2011). 
 
Figure 1.1.2: Horizontal Gene Transfer (HGT) and Antimicrobial Resistance in bacteria (AMR): (i) 
exclusion by the membrane; (ii) intracellular modification and/or deactivation of the antimicrobial; (iii) 
extrusion; (iv) reduction in sensitivity of the cellular target; and (v) intracellular sequestration. Exogenous DNA 
can be obtain by (a) viruses –Transduction-, (b) environment –Transformation-, (c) other bacteria –Conjugation-. 
Antibiotics: Amp, ampicillin; CMA, coumermycin; Rif, rifampicin; Tet, tetracycline; Van, vancomycin. (From 
Taylor et al., 2011) 
 
The dissemination of antimicrobial resistance genes is supported by many bacteria which 
encode resistant and other accessory genes on broad-host range (BHR) plasmids. Plasmids 
holding clinical relevant resistant genes were isolated from effluents of wastewater treatment 
plants, thus promoting the environmental spread of resistant determinants (Rahube et al., 
2010). The process of conjugation is believed to be the main pathway for the horizontal gene 
transfer among bacteria as conjugative plasmids can be transferred between different genera 
or domains. In addition to the resistance plasmids, there are other genetic structures involved 
in the acquisition and/or expression of resistant genes such as the integrons, which can be 
mobilized, and the transposons (Moura et al., 2012 –a–). 
The resistance gene flow between the natural environment and the human microbial flora, has 
to be considered bidirectional. Therefore, any selective pressure acting in the environment can 
increase the danger to the human health through the enhancement of the resistant determinant 
transfer among bacteria (Cabello et al., 2013). 
Two environmental bacteria groups with mobile genetic elements are aeromonads and 
enterobacteria, respectively found in aquatic environment and common residents of polluted 
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water (Moura et al., 2012 –b–). Aeromonads and enterobacteria can carry plasmids harboring 
multiple antibiotic resistant determinants of clinical and environmental concern. 
 
1.2 Aeromonas spp. 
 
1.2.1 Identification and taxonomy 
Aeromonas belong to the bacteria domain, proteobacteria kingdom, phylum gamma-
proteobacteria, class Aeromonadales, and genus Aeromonas. Aeromonads are gram-negative 
bacilli, oxidase-positive, facultative anaerobic, glucose fermenting bacteria, autochthonous of 
the aquatic environments.  
Aeromonads are natural inhabitants of water environments and have been isolated from 
brackish, fresh, estuarine, marine, chlorinated and un-chlorinated water worldwide; their 
density is higher in the warmer months. Strains were isolated also from cold and warm-blood 
animals, in which they can cause diseases. The first isolate from a human date from the early 
1950s. The pathologies caused by aeromonads affect both compromised and 
immunocompromised human hosts. Aeromonads can be classified in two major groups based 
on their growth characteristics and biochemical features: the mesophilic group, including 
Aeromonas species able to grow well at 35 to 37°C, motile, which can be associated to human 
pathologies, and the psychrophilic, composed by strains showing an optimal growth 
temperatures of 22 to 25°C, non-motile and associated to fish diseases (Carnahan et al., 
1996).  
Studies based on DNA-DNA hybridization reveled that in each group are present multiple 
hybridization groups (HGs) (Janda et al., 2010) that are hardly distinguishable with 
biochemical methods (Abbott et al., 2003). Many molecular methods have been applied to 
Aeromonas to unravel their classification: the 16S rRNA gene sequencing, the rpoB (β-
subunit of the multi-subunit enzyme DNA-dependent RNA polymerase), the gyrB (B-subunit 
of DNA gyrase), the rpoD, and the MLSA (Multilocus Sequence Analysis) sequencing 
methods. This last method, which combines the information derived from the sequences of 
seven housekeeping genes (gyrB, rpoD, recA, dnaJ, gyrA, dnaX, and atpD) has been recently 
proposed during the 10th International Symposium on Aeromonas and Plesiomonas, whereas a 
MLSA based on gyrB, groL, gltA, metG, ppsA, and recA can be used to identify 
unequivocally all the species of the genus (http://pubmlst.org/aeromonas) (Küpfer et al., 
2006; Beaz-Hidalgo et al., 2012). 
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The number of validated Aeromonas species had increase rapidly in the last 20 years; 
currently the genus comprises the following species: A. hydrophila (subspecies: hydrophila 
and ranae), A. bestiarum, A. salmonicida (subspecies: salmonicida, masoucida, smithia, 
achromogenes and pectinolytica), A. caviae, A. media, A. eucrenophila, A. sobria, A. veronii 
(subspecies veronii and sobria), A. encheleia, A. jandaei, A. schubertii, A. trota, A. 
allosaccharophila, A. popoffii, A. simiae, A. molluscorum, A. bivalvium, A. tecta, A. 
aquariorum, A. piscicola, A. fluvialis, A. taiwanensis, A. sanarellii, A. diversa and A. rivuli 
(Beaz-Hidalgo et al., 2012).  
 
1.2.2 Aeromonas and environment 
As ubiquitous bacteria in the biosphere, aeromonads can be virtually isolated from every 
bacterial ecosystem such as aquatic environments, fishes, domestic pets, farm animals, birds, 
invertebrate species, insects, foods and natural soils. Their constant presence lead to the 
continuous exposure and interaction between Aeromonas and human beings. Table 1.2.2.1 
resumes the distribution of Aeromonas spp. in diverse niches (Janda et al., 2010). 
 
 Table 1.2.2.1: Distribution of Aeromonas spp. a 0, not reported; ±, rare; +, uncommon; ++ common; +++, 
predominant species. Data were selected in different previous study: population, identification, method of 
analysis and other factor. b Includes bivalves and snail; c Insects and arachnids; d Includes leeches; e Estuaries; f 
Excludes fish shellfish and crustaceans (From Janda et al., 2010). 
 
Members of the genus Aeromonas are a proper example of bacteria able to colonize the 
aquatic environments in the urban water cycle (Figure 1.2.2.1), which is composed by 
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drinking water, household tap water, municipal wastewater and river; these environments are 
also potential spots for antimicrobial resistance dissemination (Figueira et al., 2011). 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2.2.1: Schematic representation of urban aquatic cycle. 1, raw surface water; 2, ground water; 3, 
filtration; 4, ozonation; 5, coagulation/flocculation; 6, flotation and filtration; 7, chlorination; 8, treated water 
reservoir; 9, drinking water; 10, row waste water; 11, treated waste water. A-U, drinking and waste water 
treatment plant and water treatment stages. CFUmL-1, culturable count of Aeromonas. (From Figueira et al., 
2011) 
 
 
Invertebrates and insects such as leeches and mosquitoes can be carriers of Aeromonas 
strains. In the leeches, Aeromonas act as symbionts, helping to digest the blood. A. culicicola 
was isolated from the midgut of Culex quinquefasciatus and Aedes aegypty, where the normal 
bacterial flora inhibit the development of pathogens within the mosquitoes (Pidiyar et al., 
2002).   
 
1.2.3 Human pathologies 
There is a strong correlation between Aeromonas and aquatic environment, in fact many 
microbiologists consider the word “Aeromonas” to be a synonymous for “water”. However, 
the association between human infection/colonization and aeromonads is not always 
obviously connected to the water. Indeed, the pathway of the human infection/colonization by 
aeromonads (Figure 1.2.3.1) may include: ingestion of contaminated drinking water or food 
(e.g. meat and dairy products contaminated during the “farm-to-table” operations or bivalves 
as mussels and oysters directly in contact with these bacteria by filtering the water), direct 
contamination of major or unapparent traumas during boating, fishing or diving activities, and 
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zoonotic origin such as the reptile and vertebrate bites or contact with pets and other animals 
(Janda et al., 2010).    
 
 
 
 
 
 
 
 
 
Figure 1.2.3.1: Possible environmental routes to 
infection or contamination of human beings with 
Aeromonas. The black arrows indicated the 
interaction between the environments and humans. 
(From Janda et al., 2010) 
 
 
Among the recognized twenty-five Aeromonas spp., three species (A. hydrophila, A. caviae, 
and A. veronii bv. sobria) are responsible for the majority (over 85%) of human infections. 
Other species, for example A. aquariorum, A. tecta, A. schubertii, can occasionally be 
identified in intestinal and extra-intestinal infections (septicemia, peritonitis, osteomyelitis 
and soft-tissue infections) (Puah et al., 2013; Puthucheary et al., 2012; Janda et al., 2010). 
The pathologies related to Aeromonas infections affect different tissues and apparatus. These 
bacteria have been recognized as the etiological agent in: (i) gastroenteritis; (ii) blood-borne 
infections; (iii) skin and soft tissue infections (SSTIs); (iv) intra-abdominal infections; (v) 
respiratory tract infections; (vi) urological tract infections and (vii) eye infections (Janda et 
al., 2010). Aeromonas strains causing enteritis are not limited to a single genomospecies or a 
peculiar biotype/genotype (Albert et al., 2000). The illness seems closely correlate with water 
and seafood as well as fishes consumption. The symptoms includes fever, diarrhea and 
vomiting, and may occur in five clinical forms: mild enteritis, severe form accompanied by 
bloody stools, sub-acute or chronic intestinal syndrome, rare cholera-like disease and episodic 
traveler’s diarrhea. A. veronii biotype sobria and A. caviae are the most prevalent species 
identified in traveler’s diarrhea from Asia, Africa and Latin America (Demarta et al., 2000; 
Vila et al., 2003). Some cases of Aeromonas colitis may evolve in long term in a chronic 
condition such as ulcerative colitis or pan-colitis. The severe gastroenteritis with bloody 
stools can lead to the death of the patients (Janda et al., 2010). The main species involved in 
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the blood-borne infections are A. hydrophila, A. caviae and A. veronii bv. sobria. Sepsis can 
be caused, although less frequently, also by A. jandaei, A. veronii bv. veronii and A. 
schubertii. Skin and soft tissue infections can appear as a mild external problem such as 
pustule lesions until to serious or deadly infections. Intra-abdominal infections caused by 
Aeromonas include pancreatitis, acute cholangitis and peritonitis. A. hydrophila is the most 
common species implicated in peritonitis in Southeast Asia, although A. veronii bv. sobria 
may also be the causative agent (Janda et al., 2010). Respiratory tract infections include 
asymptomatic colonizations, but also pneumonia that may be caused by a near-drowning 
event (Bossi-Küpfer et al., 2007) or non obvious event that lead to a respiratory sufferance 
with fever, productive cough, vomiting and/or respiratory failure (Rodriguez et al., 2005). A. 
hydrophila and A. veronii bv sobria have caused spontaneous bacterial empyema in males 
with cirrhosis in Southeast Asia (Chen et al., 2006; Wang et al., 2000). Aeromonas 
occasionally cause infection of the urological tract; cases involving A. veronii bv sobria, A. 
popoffii and A. caviae were reported (Hua et al., 2004). A. caviae may be involved in dysuria, 
hematuria and cystitis (Al-Benwan et al., 2007). Finally, Aeromonas can cause ocular 
diseases ranging from endophtalmitis to keratitis and corneal ulcerations that are not related to 
a previous ocular trauma or environmental contamination. Pinna et al., (2004) described a 
case of A. caviae keratitis associated with contact lens wear.  
 
1.2.4 Fish diseases 
The mesophilic and psychrophilic species of aeromonads, such as A. hydrophila, A. veronii 
and A. salmonicida, are implicated in fish diseases. 
The role of aeromonads as etiological agent of fish diseases has been known for several years. 
The mesophilic Aeromonas hydrophila and A. veronii, can cause septicemias (hemorrhagic 
septicemias) in many species of fishes including carps, tilapias, perches, catfishes and 
salmons. The red sore and ulcerative infections in basses, carps, catfishes, cods, gobies are 
other diseases related to Aeromonas. A. hydrophila is considered the major cause of fish death 
around the Earth (Janda et al., 2010).  
The furunculosis (Figure 1.2.4.1), caused by the psychrophilic species A. salmonicida, is one 
of the main diseases affecting fish industry with a high rate of mortality and economic losses 
in the european salmonid aquacultures. Although vaccination programs are established, the 
aquacultures are regularly exposed to furunculosis outbreaks requiring antibiotic treatments 
(Holten-Andersen et al., 2012). The capacity of A. salmonicida to cause infection is due to 
its intrinsic virulence, as for the strain 01-B526 (Charette et al., 2012), and its ability to 
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evade the host immune system (Kilpi et al., 2013). The furunculosis presents a wide range of 
serious manifestations such as acute septicemia with hemorrhages at the fin base, inappetence, 
and melanosis, but it can also assume a subacute or even chronic form in older fish which 
manifest lethargy, slight exophthalmia and bleeding in muscle and internal organs (Janda et 
al., 2010). The risk of mortality increases after the tenth day of infection (Holten-Andersen 
et al., 2012).  
 
 
 
Figure 1.2.4.1: Furunculosis in Atlantic salmon. From 
AGDAFF (2008) Aquatic Animal Diseases Significant to 
Australia: Identification Field Guide. Australian Government 
Department of Agriculture, Fisheries and Forestry, 2008. 
Canberra. Diseases — Furunculosis (infection with Aeromonas 
salmonicida subsp. salmonicida).  
 
1.3 Fecal Coliforms 
The term of fecal coliforms is referred to bacteria that are gram-negative non-sporulating 
bacilli, aerobic or facultative anaerobic, oxidase-negative, able to growth in presence of bile 
salts, and able to ferment lactose with acid and gas production at 44±0.5°C in 48 hours (Doyle 
et al., 2006). This non taxonomic group includes genera of bacteria that originate in feces 
(e.g. Escherichia) as well as genera not of fecal origin (e.g. Enterobacter, Klebsiella, 
Citrobacter). E. coli is therefore the most specific indicator of fecal contamination, not only in 
water but also in foods (shellfishes, oysters, fresh vegetables and beverages or tap water). 
The fecal contamination of water is detected by evaluating the presence of the total coliforms, 
fecal coliforms and Escherichia coli. This analysis is carried out to prevent human exposure 
to microbial pathogens (Girones et al., 2010; Kishinhi et al., 2013, Ballestè et al., 2010). 
 
1.3.1 Aquatic environment 
Water is the major resource for all form of life, it is required to sustain health, for sanitation 
needs, as solvent and for industrial applications. Inadequate treatments of this resource have 
implications on the public health as it can contain pathogens (Akturk et al., 2012); in fact, 
the World Health Organization (WHO) estimates that 3.4 million persons, in large part 
children, die every year from water-related diseases. 
The fecal contamination is an important way of spreading pathogenic bacteria, virus and 
protozoa  in public water supplies. The potential sources of the fecal contamination in aquatic 
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environments are the domestic, the wild animals and the birds defecations, septic tanks or 
wastewater treatment plant malfunctions, agriculture run-off, and municipal and industrial 
effluents (Kishinhi et al., 2013). 
Although the sewage treatment plants remove most of the microbial pathogens, many of these 
are discharged through the effluent water and enter in the environment as a point source of 
contamination (Girones et al., 2010). 
Usually, the risk for humans to contract a pathogen from domestic or agricultural animal feces 
is lower than from human feces, in part because of the high microorganisms host specificity. 
This is not true for skin infections, which are more frequent in beaches with contaminated 
water from animal wastes. Moreover, the fecal contamination by wild animals seems to have 
increased the number of infections due to waterborne zoonotic pathogens (Field et al., 2007). 
Infections by fecal pathogens may be acquired by direct contact with a skin lesion, air 
(aerosol) through the respiratory system, or by ingestion of contaminated water. As a matter 
of fact, during a swimming session of about eighty minutes a child, a woman and a man can 
absorbs 0.63 mL/min, 0.34 mL/min and 0.50 mL/min, respectively (Thorolfsdottir et al., 
2013). 
 
1.3.2 Escherichia coli 
Escherichia coli is a common member of the intestinal flora in humans and animals. E. coli is 
a gram-negative bacteria, facultative anaerobic whose cells are typically rod-shaped. This 
enteric species comprises both commensally and pathogenic strains. E. coli is also used as 
indicator organism of fecal contamination, because E. coli cells are always present in the 
feces of warm-blooded animals (Janezic et al., 2013). 
In the environment, E. coli is able to survive for extended periods of time in various habitats 
such as soil, sediments, sand of the beaches and aquatic vegetation. The ability of these 
intestinal bacteria to survive in soil or in surface waters seems to be related to a high 
concentration in nutrients which may originate from runoff of residential areas, from animal 
feeding operations and  from other urban sources (Goto et al., 2011Ibekwe et al., 2011). 
Beside the presence of nutrients, other environmental factors affect the survival of these 
bacteria such as UV light, temperature and predation.  
The Escherichia coli populations are genetically diverse, and organized in distinct clones 
(Topp et al., 2003; Ibekwe et al., 2011). The genetic diversity is also accompanied by the 
gain/loss of genes that are useful only in the current/preferred habitat. However, there are 
some highly conserved genes maintained in all E. coli strains , such as stress-associate genes 
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(i.e. oxidative, acidic, osmotic condition, heat/cold shock, toxic compound, DNA 
protection/repair, etc.), whereas others, such as evgAS, umuDC, nhaR and betBT  probably 
conferring an advantage for the colonization of the human gastrointestinal tract, those 
implicate in adherence (hemolysin E, hlyE; fimbrial-like adhesin, sfmH) and nutrient uptake, 
can be lost by environmental strains (Oh et al., 2012). 
The extreme plasticity of the E. coli strains assumes an important role in the emergence of 
new virulent strains that are of concern to public health (Middleton et al., 2013). The 
environments contaminated by these E. coli strains can serve as reservoirs for the 
dissemination of the existing and/or the new variant strains. The issues for the public health 
may arise from their metabolic richness, virulence factors and antibiotic resistances (Janezic 
et al., 2013). 
The genome plasticity and the evolutionary behavior of the E. coli strains are due to the 
horizontal gene transfer. During an outbreak reported in Germany in 2011, the genomes of 
two Escherichia coli O104:H4 were sequenced. This demonstrated that the strains in charge 
of the outbreak had acquired several mobile elements (plasmids, transposons, and 
pathogenicity islands) encoding for tellurite and mercury resistance, type IV pilus system, 
colicin, hemolysin E, and F fimbriae (involved in high frequency of recombination) as well as 
mobilization and transfer genes (Brzuszkiewicz et al., 2011).  
 
1.4 Plasmids 
Plasmids are circular double-stranded deoxyribonucleic acid molecules. The main feature of 
these accessory DNA molecules are genes allowing it to replicate autonomously in the host 
cell (initiation and control of replication). Some plasmids have genes that ensure their stable 
inheritance, such as equipartitioning during bacterial division or conjugal transfer, and many 
contain useful genes to themselves and to the bacterial hosts. The length can vary from few to 
several hundred kilobase (kb) pairs (Couturier et al., 1988). 
Historically, bacterial plasmids are divided in two main groups: the R (resistance) plasmids  
and the F (fertility) plasmids. The R plasmids possess two central characteristics, namely the 
ability to render the bacteria resistant to antibiotics and eventually enable them to transmit 
resistances to other bacteria. Plasmids named F (for fertility factor or “sex factor”) are those 
able to be transmitted and/or to promote integration into the chromosome (Meynell et al., 
1968). 
When released in the environment, after bacterial lysis, the plasmids can be found in three 
different topological conformation (Figure 1.4.1): (i) supercoiled or covalently close circular, 
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(ii) relaxed circular or (iii) linear (Demanèche et al., 2002). In the first topological 
conformation the DNA is uncut and presents an integral twist, which confers a compact form. 
The second topoform shows a fully intact DNA enzymatically relaxed, while the third is a 
linearized plasmid due to cutting of the DNA. In addition, it is possible to find a fourth 
topological form of plasmids in which the DNA has only one strand cut, the nicked open-
circular. 
 
 
Figure 1.4.1: Topological conformations of plasmids. (Modified images from Google) 
 
Plasmids do not harbor functional genes needed for the bacterial growth and/or multiplication, 
but they may have other sets of genes conferring advantages to survive particular 
environmental situations, such as polluted aquatic environments or in the presence of 
antibiotics. In fact, these accessory genetic materials may carry a variety of genes including 
antibiotic resistance determinants and/or genes conferring resistance to toxic heavy metals 
such as mercury (Hg), cadmium (Cd), silver (Ag), genes that code for enzymes that increase 
bacterial nutritional versatility, virulence determinants for invasion and survival in animal 
hosts, and genes which enhance the DNA repair (Bennett, 2008). These genes are generally 
inserted in transposons (mobile genetic elements) allowing the formation of highly variable 
and flexible plasmids (Couturier et al., 1988). 
The complexity of a plasmid depends on the number and type of genes contained. The coding 
sequences (CDSs) can be categorized as follows: replication (Rep genes), stable inheritance 
and portioning (Par genes), mobilization (Mob genes), transposition and recombination 
(transposons), resistance, restriction and modification, and unknown function (Figure 1.4.2).  
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Figure 1.4.2: Example of the 
genetic complexity within a 
plasmid. 
A: Genetic map of a Ralstonia 
eutropha resistance plasmid. 
Arrows indicated the 
orientation of the coding region. 
The modular structures is 
shown in the median circle: 
plasmid replicons, Rep1 e Rep2 
(green); mobilization region, 
Mob (light blue); first resistance 
region includes macrolide and 
truncated aminoglycoside- 
phosphotransferase (purple); 
integron contain Tn402-like 
element(red); 
modification/restriction region 
(gray); unknown functions 
(white); insertion sequence, IS, 
and transposon, Tn (blue); 
genes within integron gene 
cassettes (yellow); putative 
genes (white arrows). OriV, 
origin of vegetative and OriT, 
origin of transfer replication 
(black dots). 
B: General features of the 
plasmid. 
(From Schülter, 2007) 
 
 
The mobilization modules may belong to different MOB families (e.g. MOBp) or subfamilies 
that include different mobilization genes such as mobA, mobB, mobC, mobD and mobE. Their 
product recognizes and binds to the origin of transfer (ori genes). Therefore, the presence of 
those particular genes increases and optimizes the replication and the dissemination of 
plasmids in different host bacteria. The resistance genes can be included in integrons (as gene 
cassettes), in transposons or spread along the plasmid (e.g. mel gene, for the ABC-type efflux 
pump) (Schülter et al., 2007).  
 
 
 
 
 
A
B
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1.5 Antibiotics and resistance genes 
 
 The discovery of antibiotics in the first half of 1900 has reduced the mortality of humans and 
increased life expectancy. In the 1928, Sir Alexander Fleming (born: 6 August 1881, 
Lochfield, Scotland; died: 11 March 1955, London, United 
Kingdom), during an experiment with staphylococci, noticed that 
a plate was contaminated by a fungus that repressed bacterial 
growth in the surrounding area. This fungal contamination 
(Penicillium rubens) was able to produce a substance inhibiting 
numbers of pathogenic bacteria. The substance found by Fleming 
was named penicillin,  the first antimicrobial compound (β-
lactam antibiotic) discovered. Nowadays the number of used 
antibiotics is grown, but, on the other hand, bacteria have 
acquired the ability to resist to these compounds. 
Antibiotic resistance may be due to different mechanisms that are: permeability changes, 
active efflux pumps, enzymatic modifications and/or degradations of the antibiotics, 
acquisition of alternative metabolic pathways, modification of the targets, and overproduction 
of the targets (van Hoek et al., 2011).  
 
1.5.1 Aminoglycosides 
Aminoglycosides act as inhibitors of the protein synthesis through the ribosome binding. The 
resistance to these antimicrobial agents (Figure 1.5.1.1) consists in the production of modified 
enzymes (that catalyze the covalent modification of specific amino or hydroxyl functions of 
the drugs) reducing the binding of the antibiotics to the ribosomes. On the other hand, the 
inactivation of the antibiotics are caused by three enzymes: (i) phosphotransferases (e.g. 
resistance to gentamicin); 
(ii) nucleotidyl-transferases 
or adenyl-transferases; (iii) 
acetyl-transferases (e.g. 
resistance to kanamycin) 
enzymes (Taylor et al., 
2004). 
 
Figure 1.5.1.1: Examples of aminoglycosides antibiotics  
Sir Alexander Fleming
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1.5.2 β-lactams 
The β-lactams are a wide family of antibiotics which includes penicillins and the derivatives, 
cephalosporins, carbapenemes, monobactams. The starting point to design these compounds 
is the core of the penicillin (6-APA, 6-aminopenicillinic acid) (Figure 1.5.2.1).  
 
 
Figure 1.5.2.1: 
Penicillin: core and 
derivatives. The 6-APA 
is the base structure for 
the drug design of 
derivatives of the 
penicillin compound. In 
the Table are indicate the 
possible lateral chains 
(R) of the basic structure 
of the Ampicillin. 
 
The mechanism of action of this family of antibiotics is the inhibition of the cell wall 
synthesis starting by the binding of the compound to the penicillin-binding proteins (PBPs) in 
bacteria, hence interfering with the cross-linking of the peptidoglycan (van Hoek et al., 
2011). Resistance to the β-lactams is due often to the production of β-lactamases enzymes, 
which are able to hydrolyze of β-lactam ring therefore inhibiting the activity of the drugs 
(Taylor et al., 2004).  
The β-lactamases families were clustered either based on their functionality (Bush-Jacoby-
Medeiros groups) or on their molecular characteristic (Amber classes). The Bush 
classification, is based on biochemical parameters (i.e. enzymatic activity). This classification 
form four major groups: groups 1, 2 and 4 are serine-β-lactamases, while the group 3 includes 
the metallo-β-lactamases. The Amber classes take into consideration the molecular 
characteristics of the molecules (i.e. amino acid homology) but is lacking of the enzymatic 
activity information. Here too, the Amber classification allows to separate the enzymes in four 
classes: A,C and D include the serine-β-lactamases, while the class C includes the metallo-β-
lactamases that require Zinc for their activity (van Hoek et al., 2011). 
Extended spectrum β-lactamases (ESBLs) are enzymes that hydrolyze extended-spectrum 
cephalosporins such as cefotaxime, ceftriaxone, and ceftazidime, as well as aztreonam (Figure 
1.5.2.2). The ESBLs are frequently plasmid encoded and arise from amino acid substitutions 
in the sequence of TEM-1, TEM-2 (TEM, from Temoniera patient’s name) and SHV-1 (SHV, 
from Sulfhydryl reagent Variable) enzymes (Shaheen et al., 2011; van Hoek et al., 2011). 
Carbapenems are the treatment of choice for serious infections due to ESBL-producing 
6-APA
Penicillin
R
Penicillin G
Penicillin X
Di-hydro-Penicillin
Penicillin F
Flavicin
Name
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organisms, yet carbapenem-resistant isolates have recently been reported (Nordmann et al., 
2011). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5.2.2: Example of 
cephalosporins from the first 
to the fourth generation. The 
ESBLs genes are able to confer 
the resistances to the first three 
generations of antibiotics (bold 
font).  
 
The mutations in the blaTEM gene allow the enzyme to hydrolyze the cephalosporins. The first 
variant of this gene is the enzyme TEM-2, where the lysine in 39-position is replaced by a 
glutamine. Other mutations in the blaTEM gene led to the formation of more than ninety TEM 
derivatives ESBLs enzymes with specific resistance patterns for a wide range of  β-lactam 
compounds. Mutations of the blaSHV-1 gene has in parallel expanded the ability to resist to the 
extended-spectrum cephalosporins and monobactams (Rupp et al., 2003). 
Within the clinical setting, the variants ESBL TEM-3 and SHV-12 are the most frequent 
encountered in enterobacteria (Poirel et al., 2012 -a-). 
ESBLs are not only composed by the TEM-1 and TEM-2 derivative variants, they also 
include the OXA-type and the CTX-M-type β-lactamases, commonly found within the 
Enterobacteriaceae and Pseudomonas aeruginosa (Rupp et al., 2003).  
 
 
 
 
 
IInd Generation
Cefazolin
Cefuroxime
Ist Generation
IIIrd Generation
Cefotaxime
IVth Generation
Cefepime
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1.5.3 Chloramphenicol 
The genes named cat (chloramphenicol acetyltransferase) catalyze the transfer of an acetate 
group from the Acetyl-coA (acetyl-coenzyme A) to the 
carbon-3 of the chloramphenicol (Figure 1.5.3.1). These 
genes are present in strains of gram-positive and gram-
negative bacteria and are associated with plasmids. In 
the bi-acetylated form, the antibiotic is inactive, 
because unable to bind to the prokaryotic ribosomes 
(Taylor et al., 2004) 
 
 
1.5.4 Glycopeptides 
The antimicrobial activity of the first glycopeptide isolated (vancomycin, Figure 1.5.4.1) was 
found in a fermentation product from Streptomyces 
orientalis. The glycopeptides bind to the target, the D-
alanyl-D-alanine (D-Ala-D-Ala), thereby blocking the 
transglycosylase, interfering with the polymerization of the 
peptidoglycan. The resistance to vancomycin is due to the 
modification of the peptidoglycan precursor causing a low 
binding affinity for the glycopeptide. The vanA and vanB 
genes are plasmid and/or chromosomal located, while 
vanC1, vanC2/3, vanD, vanE, and vanG have exclusively 
been found in the chromosome (van Hoek et al., 2011). 
 
1.5.5 Quinolones 
The quinolones were discovered by chance in 1962, when nalidixic acid was discovered as 
by-product of the chloroquine production, an antimalarial compound. Since the frequence of 
resistance to the quinolones increased just after their introduction as clinical treatments, the 
fluoroquinolones were developed. These antibiotics (ciprofloxacin (Figure 1.5.5.1), 
norfloxacin, perfloxacin) originate through the substitution of a fluorine in 6-position (Kim et 
al., 2011). 
 
Chloramphenicol
Figure 1.5.3.1: Molecular structure 
of chloramphenicol. 
Vancomycin
Figure 1.5.4.1: Molecular 
structure of the vancomycin. 
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A B
 
Figure 1.5.5.1: Examples of quinolones compounds. A, proto-type of quinolone; B, fluoroquinolone: fluorine 
modified quinolone in 6-position. 
 
Quinolones are broad-spectrum antibiotics used in both human and animal treatments, so they 
are easily found in the environment at low concentrations. The resistance to quinolones (Qnr) 
depends on DNA gyrase A and topoisomerase IV chromosomal mutations, or on the 
overexpression of efflux pumps (Qep). Resistance can be also plasmid-mediated, therefore 
transferable (PMQR, plasmid-mediate transferable quinolone resistance); in this case, 
resistance is conferred by: (i) the Qnr-type pentapeptide proteins (QnrA, QnrB, QnrC and 
QnrS) that are able to protect the target gene, DNA gyrase; (ii) the AAC(6’)-Ib-cr, modified 
aminoglycoside acetyltransferase in two specific amino acid that acetylates both ciprofloxacin 
and norfloxacin; (iii) and QepA proteins, an efflux pump. Findings suggest that the qnrS and 
the aac(6’)-ib-cr may spread silently among bacteria, without expressing the phenotypic 
resistance (Picão et al., 2008). The mutations causing resistance are in the N-terminus of the 
GyrA protein, named “quinolone resistance determinant region” (QRDR), between the amino 
acids Ala67 and Gln106. A double mutation, near the active site of the enzyme, the amino 
acids Ser83→Ile and Asp87→Asn, increase the resistances to the fluoroquinolones (Goñi-
Urriza et al., 2002; Poirel et al., 2012 -b-). The QnrA inhibits the activity of quinolones 
protecting the DNA gyrase and the topoisomerase IV, increasing the resistance to the 
fluoroquinolones from four- to eightfold. The efflux pump coded by the qepA gene confers 
resistance to the hydrophilic quinolones such as ciprofloxacin, norfloxacin, and enrofloxacin 
(Crémet et al., 2011).  
  
1.5.6 Tetracyclines 
Tetracyclines were characterized in 1948 from Streptomyces aureofaciens. These antibiotics 
are largest used throughout the world. They can be separated in two groups (Figure 1.5.6.1): 
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Trimethoprim
Figure 1.5.7.1: Molecular structure 
of trimethoprim 
typical (i.e. chlortetracycline, doxycycline, etc.) and atypical (e.g. anhydrotetracycline and 6-
thiatetracycline) tetracyclines. The mechanisms of resistance can be divided into three 
categories: energy-efflux pumps, ribosomal protection proteins (RPPs), and enzymatic 
inactivation. Genes involved in tetracycline resistances are tet and tcr (tetracycline resistance), 
and otr (oxytetracycline resistance). Of these genes, 25 tet, 2 otr and 1 tcr code for efflux 
pumps, 10 tet and 1 otr code for RPPs, while the tet (U) gene code for an unknown 
mechanism. tet (M) had the broadest host range of all tetracycline resistance gene. Three other 
tet genes confer resistance through an enzymatic inactivation. In gram negative bacteria the 
most common gene conferring resistance to tetracyclines is tet (B) (van Hoek, 2011). 
 
 
Chlortetracycline
A B
6-thiatetracycline
 
Figure 1.5.6.1: Examples of the structure of tetracyclines. The two molecules are part of the tetracycline 
typical (A) and atypical (B) groups. 
  
1.5.7 Trimethoprim 
Trimethoprim (Figure 1.5.7.1) is completely synthetic and belong to the diaminopyrimidine 
group of molecules (van Hoek et al., 2011). The activity of this synthetic antibiotic is the 
competition with the dihydrofolate reductase (DHFR), 
inhibiting the synthesis of the folic acid necessary to 
the replication of the genetic material. The resistance to 
trimethoprim is due to the specific genes dfr and is 
achieved by a bypass mechanism in which a non-allelic 
and drug-insusceptible variant of a chromosomal 
DHFR is produced. These acquired DHFRs genes are 
divided in distinct groups: the dfrA (474 nucleotides) 
family is composed of more than 30 genes, in the dfrB 
(237 nucleotides) family there are at least 8 different 
genes while the dfrK family includes only few genes (van Hoek et al., 2011). The dfr1 seems 
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to be the most common trimethoprim resistance gene in gram-negative bacteria: it is usually 
carried on the plasmid-located transposons Tn7 (Taylor et al., 2004).  
 
1.6 Integrons  
Integrons are mobile elements able to capture gene cassettes by site-specific recombination 
mechanisms. They are a mean to spread genes, particularly in gram-negative bacteria. Given 
the high divergence of the genes that encode their integrase, eight classes of integrons were 
discovered and characterized (Rowe-Magnus and Mazel, 2001; Zhao and Hu, 2011). 
The class 1 integrons are the most important in the acquisition, expression and spread of 
antibiotic resistance determinants, though little is known about the flux of genes in this class 
within and between bacterial communities (Nardelli et al., 2012). 
The structure of a class 1 integron (Figure 1.6.1) is based on three regions: a 5’ and a 3’ 
conserved segments (5’CS and 3’CS) separated by a variable region. The 5’CS region of the 
class 1 integron includes: the integrase-encoding gene (intI1), the insertion site for the gene 
cassette (attI) and a promoter region (Pc) for the transcription of the gene cassettes. The 3’CS 
includes a partial deleted qac gene (qacE∆1) fused to a sul1 gene, that confer resistance to the 
quaternary ammonium compounds (antiseptics) and to sulphonamides (Zhao and Hu, 2011). 
 
 
 
 
 
 
Figure 1.6.1: Class 1 integron and 
acquisition of gene cassettes. 
A, basic structure of the class 1 
integrons. The 5’CS region includes the 
intI1, the attI and the promoter region 
(Pc), while the 3’CS includes the  
qacE∆1 (quaternary ammonium 
resistance) and the sul1 (sulphonamide 
resistance) genes. 
B-C, A class 1 integron after insertion 
of resistance gene cassettes (R1 and 
R2). The gene cassettes carry the 
resistance genes (R1 and R2) and the 
recognition site for the integrase (attC, 
also called 59 base element). 
(From Zhao and Hu, 2011) 
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The cassettes are mobile genetic elements holding a gene (in class 1 integrons commonly an 
antibiotic resistance gene) encoding a protein able to increase bacterial adaptation to 
environmental stressful conditions, and the attC (or 59 base element, 59be), an integrase-
specific recombination site (Rowe-Magnus and Mazel, 2001; Hall and Collis, 1995). 
Most of the attC sites are unique and their lengths and sequences can vary significantly (57-
141bp) apart at the ends, which correspond to the inverse core site (ICS) and to the core site 
(CS), whose sequences are RYYAAC and GTTRRRY (R, purine; Y, pyrimidine) respectively 
(Rowe-Magnus and Mazel, 2001). 
The gene cassettes are always inserted into the integron with the same orientation to allow 
gene expression; the insertion is however reversible and the cassettes may also be lost (Hall 
and Collis, 1998). Their transcription is not uniform along the variable zone of the integron: 
expression of distal genes may be reduced due to an early termination of the transcripts at or 
near the end of the preceding cassette (Hall and Collis, 1995). 
The frequency of integron-carrying bacterial strains is influenced by the surrounding 
environment and the lack of gene cassettes in integrons does not seem to be related with the 
absence of antibiotic contaminations. In most cases, the same strain can carry both an empty 
integron and one carrying resistance genes (Mokracka et al., 2012). 
The high number of studies and information on these mobile genetic elements have permitted 
to create a database called Integrall (http://integrall.bio.ua.pt) that collect, organize and search 
the integrons and gene cassettes. The current version (1.2) of this database includes: (i) 
background information on integrons; (ii) list tool; (iii) search tool and BLAST interface; (iv) 
guideline for nomenclature of the gene cassettes; (v) glossary of integron-associated genes; 
(vi) forum discussion on mobile genetic elements (Moura et al., 2009). To now, the database 
includes 6575 entries, 1507 integrase genes, 8549 gene cassettes, 116 genera, and 242 
bacterial species.  
Class 1 integrons can be found in more complex structures, such as the Tn 21 transposons 
(Fig. 19). In gram-negative bacteria, and in particular in the Enterobacteriaceae, the 
transposons that encode multiple antibiotic resistances belong to the Tn 21 class, subgroup of 
the Tn3 family. The integrons within the transposons are potentially independent mobile 
DNA fragments. In fact, the integrons possess a site-specific integration system, encoded by 
RecA-indipendent, for gene cassettes acquisition, while the Tn21 transposon carries genes for 
the transposition (tnp) and a mercury resistance (mer) operon (Liebert et al., 1999).  
Transposons Tn21 may be associated to many resistant gene cassettes in the class 1 integrons, 
such as dfrA1, dfrA12, dfrA17 and dfrA7. On the other hand, class 1 integrons can be found in 
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other transposons such as Tn5086 and Tn5090, and includes other gene cassettes such as 
dfrIIc (Tn5086) and dfrVII (Tn5090) (Kiiru et al., 2013; Radström et al., 1994).  
 
A
D
C
B
 
Figure 1.6.2: Structure and characteristic of the Tn21 transposon. A, structure of the Tn21 transposon: the 
genes for the transposition (tnpA, tnpR) and the mercury resistance operon (merD, merA, merC, merP, merT and 
merR) are shown. The transposon includes the In2, the class 1 integron (intI1, attI1, qacE∆1, sul1, orf5), and the 
tni module (tniB∆1 and tniA). The aadA1 gene cassette and the insertion sequence IS1326 followed by the 
IS1353, are located inside and outside the class 1 integron, respectively. Both the transposon, integron and 
insertion sequences are flanked by inverted repeat sequences (IR). B, coordinates and size of the Tn21 and the 
included mobile elements. C, sequenced regions and GeneBank accession numbers. D, features of the 
transposition region of the Tn21 transposon. (From Liebert et al., 1999) 
 
1.7 Mobilization and incompatibility groups 
Plasmids are characterized by a backbone of core genes, highly conserved during a long 
evolutionary time, and by genetic material which is integrated or lost in the plasmid structure 
but that does not change its characteristics. Therefore, the identification and characterization 
of a plasmid allow to obtain information on its physiology and mode of transmission. The 
relaxase gene is the most informative unit of the plasmid backbone (Garcillàn-Barcia et al., 
2011). The catalytic domain of the relaxases is located at the N-terminus of the protein (300 
amino acids), and its sequence has permitted the classification of plasmids in different 
families.  
The main super-families of small mobilizable plasmids are: the MOBQ, the ColE1, the 
pMV158, and the CloDF3. The MOBQ and a part of the ColE1 overlapping with the MOBP 
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family, are the only families that are mobilizable and transferable, while plasmids of the other 
families require a second plasmid for their transfer (Francia et al., 2004). The same method 
of classification was applied to the large conjugative plasmids. The conjugative plasmids are 
for the most part included in the MOBF, the MOBH, the MOBC, the MOBV and in two 
families which grouped also the small mobilizable plasmids, MOBQ and MOBP (Garcillàn-
Barcia et al., 2009).  
During the mobilization and conjugation processes ( Figure 1.7.1), the relaxase is the key 
enzyme that recognizes the origin of transfer (oriT), catalyzes the initial and the final steps in 
the conjugation cleaving the oriT in the donor and catalyzes also the re-ligation of the plasmid 
transferred in the recipient bacterium.  
The mobilization/transfer process require the presence of two other enzymatic complex: the 
type IV coupling protein (T4CP) and the type IV secretion system (T4SS). Mobilizable 
plasmids may carry the T4CP, while transferable plasmids require both enzymatic complexes 
(Smillie et al., 2010).    
 
 
Figure 1.7.1: Schematic view of mobilizable 
and transmissible plasmids. A, necessary genes 
in the mobilizable or conjugative plasmids. B, 
schematic interaction among the relaxase and the 
secretion complex. oriT, origin of transfer 
(violet); R, relaxase (red); T4CP, type IV 
coupling protein (green); T4SS, type IV secretion 
system (blue); MPF, mating pair formation. 
(From Smillie et al., 2010). 
 
The analysis of the relaxases and the replicons has highlighted a high correlation between the 
MOB families and the incompatibility groups (Inc groups): in a single MOB subfamily can be 
grouped different Inc plasmids (Figure 1.7.2) (Alvarado et al., 2012). 
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Figure 1.7.2: Relation between MOB and incompatibility groups. A: distribution of the inc/rep groups in the 
MOB families (From Garcillàn-Barcia, 2009). B: representation of the abundance of the MOB subfamilies, 
rendered by the width and depth of the colored triangles, and relative distribution of the incompatibility groups 
(color boxes) (From Alvarado et al., 2012). 
 
The incompatibility was defined as the inability of two coresident plasmids to be permanently 
inherited in absence of external selection. More generally, the introduction of a second 
plasmid destabilize the inheritance of the first (Novick, 1987).  
The autonomous replication of a plasmid is under the control of genes that maintain the 
average number of copy per cell in a given bacterium and growth condition. The replicons 
consist in: the origin of replication (cop), the control region of initiation of the replication 
(inc) and the replication and its control (rep) region. Based on these plasmidic regions, it was 
possible to formulate a schema for the classification of the incompatibility groups of 
plasmids. The incompatibility groups include: FIA, FIB, FIC, HI1, HI2, I1-Iγ, L/M, N, P,W, 
T, A/C, K, B/O, X, Y, F, and FIIA replicons (Couturier et al., 1988). Among these 
incompatibility groups, the most important are represented by the broad-host range (BHR) 
groups that confer the ability to the plasmids to be spread and maintained in a wide range of 
bacteria. The BHR plasmids belong to the incompatibility groups IncN, IncP, IncW, Inc L/M, 
IncK and IncX (Götz et al., 1996), IncA/C (McIntosh et al., 2008), and IncU (Cattoir et al., 
2008). The incompatibility group Q (IncQ) is considered a BHR due to the high degree of 
mobilization and not to its ability to transfer (Loftie-Eaton and Rawling, 2012).  
Recent studies have shown that mobilizable plasmids are generally of small size: they present 
an average size around 5 kb though some can reach 50 to 300 kb. The (self-transmissible) 
conjugative plasmids are generally larger with an average size of 100 kb. The majority of the 
plasmids are non transmissible and have variable sizes but can be grouped in sizes around 5, 
35 and 400 kb (Smillie et al., 2010; Garcillàn-Barcia et al., 2011). The distribution of the 
mobilizable, conjugative, and non-transmissible plasmids is reported in Figure 1.7.3. 
 - 29 - 
A B
 
Figure 1.7.3: Comparison of the size of plasmids. Distribution of plasmids according to the size of the 
mobilizable plasmids (green curves), conjugative plasmids (yellow curve) and non-transferable plasmids (violet 
curve).  The bars indicate the number of plasmids with the same size. A: Size and distribution of 1730 plasmids 
(From Smillie et al., 2010). B: Update of the database used from Smillie et al. (2010) (From Garcillàn-Barcia 
et al., 2011). 
 
 
1.8 Plasmid Curing 
The “plasmid curing” is a method resulting in the chemical elimination of the accessory DNA 
plasmids from bacteria. The lost of plasmids can be spontaneous or forced by different 
chemical compounds. Historically, the chemical compounds used to eliminate resistance (R) 
or sex (F) factors carried by plasmids were cobalt, nickel ions and acridine dyes. The effect of 
these treatments can vary depending on bacteria species; as example, the acridine dyes have a 
lower efficacy in E. coli than in Shigella where the effect can reach the 100%. The treatment 
with sodium dodecyl sulfate 10% (SDS), a reagent routinely used in laboratory for the 
bacterial lysis, permitted to increase the number of cured bacteria following the incubation 
time (Tomoeda et al., 1968). SDS treatment provide a slow partial lysis of the bacteria that 
have reach the stationary growth phase, thus facilitating the loss of the plasmids. Bacterial 
cultures remain viable up to 72 hours after the treatment (Inuzuka et al., 1969). 
Plasmid curing can also be obtained through the repetitive culture transfer of the bacteria at 
sub-optimal temperature in absence of chemical compounds. In any case, curing methods 
have to be adapted to both the plasmids and the bacteria (Ghosh et al., 2000).  
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1.9 Horizontal gene transfer 
 
The genetic material can be moved within a bacterium (intracellular mobility) or between 
bacteria (intercellular mobility). The sequences of DNA, that encode enzymes or other 
proteins, which may be mobilized, are defined mobile genetic elements (MGEs). The 
intercellular exchange of these MGEs can take place in three ways: conjugation, 
transformation, and transduction (Frost et al., 2005). 
 
1.9.1 Conjugation 
 The conjugative transfer of MGEs needs the cell-to-cell junction and a pore formation 
allowing the DNA to be transferred from a donor to a recipient bacteria, as well as a type IV 
secretion apparatus (Type IV Secretion System, T4SS) to produce a pilus. The interaction 
between the donor and the recipient bacteria is due to the combination of the mating-pair 
apparatus with the lipopolysaccharides and outer-membrane proteins of the recipient cell 
surface (Thomas and Nielsen, 2005). The conjugative transfer is commonly associated with 
plasmids which are transferred to recipient bacteria (Thomas and Nielsen, 2005). The high 
horizontal transfer frequency of plasmids may allow them to be maintained as molecular 
parasites, whilst other mobile elements are transmitted vertically (Madsen et al., 2012). 
Different kind of plasmids provide the cell to form flexible or rigid pili. Strains harboring 
IncIα, IncI2, and IncK plasmids show thin and flexible pili able to conjugate in aquatic 
environments, while strains containing IncM, IncN, IncP, IncW plasmids, produce rigid pili 
able to conjugate prevalently on a solid substrate (Bradley et al., 1980).  
The conjugation is an important way to spread resistance genes, heavy metal, and virulence 
factor between pathogenic resistant strains to other bacteria belonging to the endogenous 
human flora (Anjum et al., 2011; van den Bogaard and Stobberingh, 2000). 
 
1.9.2 Transformation 
In the environment, the natural transformation of bacteria is the mechanism of acquisition of 
foreign DNA. This DNA can be integrated in the genome and can supply the bacterium with 
new functions. To allow the transformation mechanism, bacteria need to be in a peculiar 
physiological state that involves approximately 20 to 50 regulatory proteins: this state is 
defined competence. In most of the cases the competence state is time-limited, and it is 
activated in response to particular condition such as altered growth conditions or nutrient 
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accessibility, cell density or starvation, that can vary among bacterial species or even strains. 
In the environment only 1% of bacteria is considered naturally competent while in clinical 
settings, different human pathogenic bacteria are naturally transformable: Campylobacter, 
Haemophilus, Helicobacter, Neisseria, Pseudomonas, Staphylococcus, and Streptococcus. 
The mechanisms favoring the DNA uptake varies among bacteria, in general, the foreign 
double-stranded DNA is converted to a single-strand during the translocation across the 
membrane. The majority of competent bacteria are able to translocate, both plasmids and 
chromosomal DNA (Thomas and Nielsen, 2005). 
 
1.9.3  Transduction 
Transduction is the mechanism of horizontal gene transfer that exploit viruses, in particular 
bacteriophages, carrying bacterial genes in their own genome. Transduction can be 
generalized, when any bacterial gene can be transferred, or specialized, when a restricted set 
of bacterial genes can be transferred. Since bacteriophages are one of the most abundant 
biological particles in the world, it seems likely that they can play a significant role in the 
horizontal gene transfer between bacteria (Muniesa et al., 2013). 
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2 PURPOSE 
 
The aim of the study is to evaluate the role of Aeromonas spp. in the environmental spread of 
genes conferring resistance to antibiotics. Since Aeromonas are natural inhabitants of water 
environments and some species are pathogenic for both humans and animals, it can be 
assumed that they play a crucial role in the dissemination of resistant genetic determinants. 
Through the observation of the biodiversity of Aeromonas strains regarding their resistance 
against antibiotics, we wanted to verify if these bacteria are reservoirs of resistance genes or 
can be considered as vectors of the same. 
In the last decades, bacterial resistance to antibiotics has assumed an increasing importance 
with regard to its impact on public health, making difficult the treatment of some life-
threatening infections. However antibiotic resistance is not only found in pathogenic bacteria 
but also in environmental organisms inhabiting terrestrial and aquatic habitats. In fact, the 
extraordinary capacity of bacteria to adapt to their environments soon allows these organisms 
to develop mechanisms of resistance enabling them to overcome the toxic effects of 
antibiotics (Stalder et al., 2012). 
In the environment, the higher numbers of resistant bacteria is found in polluted habitats, 
indicating that humans contribute substantially to their increase proportion. Possible 
mechanisms by which humans enhance the spread of antibiotic resistance among 
environmental bacteria include the discharge of antibiotics and of resistant bacteria into the 
sewage. The environmental contamination with antibiotics, resistant bacteria and resistance 
genes affects the biodiversity of natural ecosystems by the suppression of susceptible 
organisms and the selection of the resistant ones. Moreover, in these environments, bacteria 
can play a role as reservoir and/or vector for the spread of antibiotic resistance genes. The 
main risk for public health is that resistance genes pass from environmental bacteria to human 
pathogens by genetic transfer such as conjugation, transformation and transduction. Humans 
can become contaminated by the contact with or by ingestion of contaminated surface or 
drinking water (Baquero et al., 2008). 
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3 MATERIAL AND METHODS 
3.1 Water Sampling 
Water sampling were taken from: the Ticino river (before and after the wastewater treatment 
plant), the Bellinzona hospital wastewater, the active sludge of the Giubiasco wastewater 
treatment plant and from the alpine lake Cadagno (Figure 3.1.1). 
 
 
Figure 3.1.1: Map of sampling locations in Canton Ticino. Lake Cadagno (in light blue) and Bellinzona (in 
red) with the four sampling locations: Ticino river before wastewater treatment plant (blue), Bellinzona hospital 
(dark green), wastewater treatment plant (brown) and Ticino river after wastewater treatment plant (orange). In 
light green area is indicated the Laboratory of  Applied Microbiology in Bellinzona. 
 
The wastewater treatment plant serves nine municipalities of the Bellinzona district and it is 
dimensioned to treat 66000 equivalent inhabitant/24 h. Table 1 resumes sample collection 
temperature, dates and hour.  
 
 
Table 3.1.1: Temperatures and time of sample collection 
Areas Abbreviations Temperature Data Hour
Ticino River before Wastewater 
Treatment Plant TR-b-WWTP 3 °C 18.01.2011 9.30 am
Bellinzona Hospital wastewater HWW 16°C 26.04.2011 8.45 am
Giubiasco Wastewater Treatment 
Plant WWTP 17°C 08.08.2011 8.00 am
Ticino River after Wastewater 
Treatment Plant TR-a-WWTP 13°C 08.08.2011 12.00 am
Cadagno Lake CL 10°C 13.09.2011 10.00 am
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At each sampling site, 3 liters of water were collected in sterile/autoclaved glass bottles. 
Samples were then transported in a refrigerate bag at 4°C and processed within 2 hours of 
collection. 
 
3.2 Bacterial isolation 
Logarithmic dilutions (from 102ml to 10-2ml) of the water samples were prepared in 0.1% 
peptone (enzymatic digest of animal proteins) water and filtered through 0.45 µm-pore size 
sterile filter (Millipore) of 47 mm diameter. Filters were placed on m-Aeromonas selective 
agar base (Biolife) supplemented with Ampicillin and on C-EC Mug agar to isolate 
Aeromonas spp. and Fecal Coliforms, respectively. Aeromonas spp. selective plates were 
incubated at 30°C for 24h, while fecal coliforms C-EC Mug agar plates were incubated at 
44°C for 24 hours. Fifty colonies of Aeromonas spp. (yellow colonies) and fecal coliforms 
(blue colonies) were randomly selected and plated onto COL-S 5% SB agar (Columbia agar 
5% Sheep Blood, BD BBLTM StackerTM Plates). After 24 hours of incubation at 30°C or 
37°C, the strains were inoculated into Skim-Milk (Difco, BD) and frozen at -20°C for 2 hour. 
These cultures were then stored at -80°C. 
 
3.3 Identification of the bacterial species 
Identification of Aeromonas spp. and Fecal Coliforms to the species level was achieved using 
MALDI-TOF MS (Matrix Assisted Laser Desorption Ionization – Time Of Flight, Mass 
Spectrometry). Pure cultures were preliminarily screened by the oxidase test revealing the 
presence of the Cytochrome C enzyme in aerobic and facultative anaerobic bacteria: 
Aeromonas spp. are always positive whereas Fecal Coliforms lack this enzyme.  
Biomarkers (the majority represented by ribosomal proteins) with a specific mass signal (2 - 
20kDa) can be detected by MALDI-TOF MS. Mass spectra are generated as positive lines by 
scanning the samples with a laser beam (Figure 3.3.1). After the signal acquisition, the spectra 
are automatically processed removing the baseline. The useful picks identified are compared 
with each reference spectra present in the database (SARAMIS – Spectral Archive And 
Microbial Identification System) for the identification of microorganisms and the results are 
expressed in percentage of confidence relating to the reference spectra (Benagli et al., 2012).  
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Figure 3.3.1: Schematic representation of the identification process by MALDI-TOF MS. From poster: 
Development and validation of a MALDI-TOF MS microbial database for rapid identification of public-, 
animal-, and plant-health relevant environmental bacteria. Tonolla M., Vogel G., Duffy B., Rezzonico F. KTI 
Medtech Event 2010. 
 
A bacterial colony was spotted twice on the wells of the MALDI plate; after the addition of 1 
µL of α-cyano matrix (composition and volumes are listed in Table 3.18.1), the colony is 
processed by the MALDI-TOF. Bacteria are shown as a list of proteins mass spectra and the 
presence of specific picks allows genus and species identification. 
 
3.4 Antibiotic susceptibility test 
Antibiotic susceptibility was determined by the disc diffusion method (Kirby-Bauer) on 
Mueller Hinton agar (composition and volumes are listed in Table 3.18.1), according to the 
EUCAST (European Committee on Antimicrobial Susceptibility Testing, 2011) guidelines. 
Three colonies of an overnight culture were inoculated in 2 mL of TSB (Trypticase Soy 
Broth, Oxoid) for 3-5 hours. The bacterial suspension was diluted to a 0.5 McFarland 
turbidity, corresponding approximately to 1.8·108 CFU/mL, in 5 mL of saline solution (NaCl 
0.9%) and inoculated on the Mueller Hinton Petri dish using a cotton swab. The antibiotics 
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(listed in Table 3.4.1) were chosen among different antibiotic groups covering different 
resistance mechanisms. They were applied on the plate within 15 minutes after inoculation of 
the bacterial strain.  After 24 hours of incubation at 30°C or 37°C, for Aeromonas spp. and for 
Fecal Coliforms respectively, the strains were classified as resistant, intermediate or sensitive, 
accordingly to the EUCAST guidelines. 
 
Table 3.4.1: Antibiotics used to determine the phenotypic profiles of resistance in bacteria. The resistance 
phenotypes were determined by comparing the diameters of inhibition. Bacteria were considered resistant or 
sensitive when the diameters were less than equal or equal than higher of those indicated. 
Antibiotics Abbreviation Concentration (µg) Resistant Intermediate Sensitive
Cefazolin CZ 30 19 20-22 23
Cefuroxime CXM 30 18 --- 18
Ceftriaxone CRO 30 20 21-22 23
Cefoxitin FOX 30 19 --- 19
Gentamicin GM 10 14 15-16 17
Bactrim SXT 23.75/1.25 13 14-15 16
Ciprofloxacin CIP 5 19 20-21 22
Meropenem MEM 10 16 17-21 22
Polymyxin PB 300 unit 11 --- 12
Chloramphenicol C 30 17 --- 17
Nalidixic Acid NA 30 13 14-18 19
Amikacin AN 30 13 14-15 16
Ampicillin AM 10 14 --- 14
Tetracycline Te 30 11 12-14 15
Streptomicyn S 10 11 12-14 15
Trimetoprim TMP 5 15 16-17 18
Sulfamethoxazole RL 100 18 19-21 22
Aztreonam ATM 30 24 25-26 27
Tobramicyn NN 10 13 14-15 16
Kanamicyn K 1000 10 --- 10
Netilmicin NET 10 12 13-14 15
Diameters  (mm)
 
 
3.5 Detection of Extended Spectrum β-Lactamases (ESBLs) 
The presence of ESBLs was tested by the disk diffusion method described above (Table 3.5.1) 
only for those strains showing resistances to the first, second and third generation of 
cephalosporins but susceptibility to Cefoxitin. ESBL strains show a synergy between 
Ceftriaxone/Augmentin and Cefotaxine/Augmentin (Figure 3.5.1) causing an increase of the 
inhibition diameter due to the inhibitory effect of the clavulanic acid, contained in Augmentin 
(Amoxicillin and Clavulanic Acid 2:1) on the ESBL enzymes. In absence of synergy but with 
the resistance profiles described above, the  ESBL phenotype was confirmed by E-Test®  
(Biomèrieux) with CT/CTL (Cefotaxime/ Cefotaxime-Clavulanic Acid) (Figure 3.5.2) 
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Figure 3.5.1: Example of synergy between 
CTX/AMC. The synergy of Cefotaxine (CTX) 
and Augmentin (AMC) is characterized by the 
presence of an increasing inhibition zone 
between the two antibiotics (black arrow). 
Modified image from Calvo J. et al 2011.  
 
 
 
 
 
Table 3.5.1: Antibiotics used to determine the phenotypic ESBL profile in bacteria. The concentration 
20/10 µg of Augmentin is referred to Amoxicillin and Clavulanic Acid. 
Antibiotics Abbreviation Concentration (µg) Resistant Intermediate Sensitive
Ceftriaxone CRO 30 20 21-22 23
Cefoxitin FOX 30 19 --- 19
Ampicillin AM 10 14 --- 14
Cefuroxime CX 30 19 --- 19
Cefpodoxime CPD 10 21 --- 21
Augmentin AMC 20/10 17 --- 17
Aztreonam ATM 30 24 25-26 27
Cefepime FEP 30 21 22-23 24
Cefotaxine CTX 5 18 19-20 21
Diameters  (mm)
 
 
  
. 
 
 
 
 
 
 
 
 
Figure 3.5.2: E-Test® CT/CTL on a E.coli strain. The presence of 
the Clavulanic Acid in the CTL reduce the resistance to the 
Cefotaxime content in the upper part of the strip visible as a 
“rounded” phantom inhibition zone (black arrow). 
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3.6 Plasmid extractions 
Plasmid extractions were carried out by a modified alkaline/SDS lysis procedure (buffer, 
composition and volumes are listed in Table 3.6.1). In order to have a large amount of total 
plasmid extracts, plasmid extraction was performed following a “midi-prep” procedure 
(Plasmid DNA Purification, NucleoBond® PC100, Machery-Nagel). When little amounts 
were needed, plasmid extractions were executed following a “mini-prep” protocol (Plasmid 
DNA Purification NucleoBond® PC20, Machery-Nagel) (Table 3.6.2). Both protocols were 
suitable for the extraction of a wide range of plasmids, cosmids and large construct (BACs, 
PACs), ranging from 3 to 300 Kbp of size. An overnight bacterial culture, obtained 
inoculating an appropriate volume of LB medium (depending to the employed procedure), 
was centrifuged at 4°C, 6000 x g for 15 minutes, the supernatant was discharged and the 
pellet subsequently resuspended in Buffer S1+RNase A. The bacterial alkaline lysis was 
performed adding Buffer S2, mixing by inverting 6-8 times and incubating for 2-3 minutes at 
room temperature, to denature the total DNA (chromosomal and plasmidic DNA). The 
addition of Buffer S3 (Potassium acetate buffer) and the subsequent ice incubation for 5 
minutes caused the formation of a precipitate containing the chromosomal DNA and other 
cellular compound (debris). The potassium acetate buffer neutralized the lysate and revert the 
plasmidic DNA to its negative supercoiled structure that remained in solution. The anion-
exchange resins of the NucleoBond® Column were equilibrated with buffer N2. To remove 
the “debris”, the lysates were centrifuge at 12000 x g for 10 minutes at 4°C (for “mini-prep”) 
or filtered by NucleoBond® Folded filter (for “midi-prep”). The cleared lysates were loaded 
on the NucleoBond® Columns where plasmidic DNA bound to the resin; after the washing 
step with Buffer N3, the plasmids could be eluted with Buffer N5. Plasmidic DNA was 
afterwards purified by alcoholic precipitation adding 750 µL or 3.5 mL of 2-propanol and 
centrifuging at 15800 x g for 30 minutes at 4°C. Pellets were washed with 500 µL or 2 mL of 
ethanol 70% and centrifuged at 16100 x g for 10 minutes at room temperature, and dried for 
10-20 minutes at room temperature. Finally, plasmid extracts were resuspended in TE buffer 
or PCR grade water. 
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Table 3.6.1: Kit contents, buffer composition and reaction volumes. 
Activity Buffer Composition Mini Midi
Resuspension S1 50 mM Tris-HCl 0.4 4
10 mM EDTA
100 µg/mL RNase A
pH 8.0
Lysis S2 200 mM NaOH 0.4 4
1% SDS
Neutralization S3 2.8 M Kac 0.4 4
pH 5.1
Column Equilibration N2 100 mM Tris 1 2.5
15% ethanol
900 mM KCl
0.15% Triton X-100
pH 6.3 (adjusted by H3PO4)
Wash N3 100 mM Tris 1 (3x) 10
15% ethanol
1.15 M KCl
pH 6.3 (adjusted by H3PO4)
Elution N5 100 mM Tris 1 5
15% ethanol
1 M KCl
pH 8.5 (adjusted by H3PO4)
Volumes (mL)
 
 
 
 
Table 3.6.2: Correlation between bacterial culture volume to expected plasmid yield.  
Copy plasmids LB culture volume NucleoBond® Column Average yield
High copy 1 - 5 mL PC20 (mini) 3 - 20 µg
5 - 30 mL PC100 (midi) 20 - 100 µg
Low copy 3 - 10 mL PC20 (mini) 3 - 20 µg
10 - 100 mL PC100 (midi) 20 - 100 µg
 
 
3.7 PCR detection of BHR Incompatibility Groups 
Plasmids of Aeromonas spp. and Fecal Coliforms were screened in order to detect the Broad 
Host Range (BHR) incompatibility groups by PCR, using the primers and the PCR conditions 
listed in Table 6. The PCR mix consisted in 2.5 U/reaction of Hot Start Taq (Qiagen), 2.5 µL 
Buffer 10X (Tris-HCl, KCl, (NH4)2SO4, 15 mM MgCl2; pH 8.7), 0.5 µL dNTPs 10 mM, 0.5 
µL of each primer Forward and Reverse 10 µM, MgCl2 (see Table 3.7.1), 1-5 µL of sample 
and water to a final volume of 25 µL. 
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Table 3.7.1: List of primers and PCR condition for BHR incompatibility groups. The initial denaturation 
and the final elongation were set at 95°C for 15 minutes and 72°C for 10 minutes for all PCR programs. 
Primer Name Primer Sequence (5'-3') Final MgCl2 
concentration (mM) PCR condition
Amplicon size 
(bp) Reference
Inc A/C For GAGAACCAAAGACAAAGACCTGGA 1.5 465 Carattoli A. 2005
Inc A/C Rev ACGACAAACCTGAATTGCCTCCTT
Inc P For CTATGGCCCTGCAAACGCGCCAGAAA 1.5 534 Carattoli A. 2005
Inc P Rev TCACGCGCCAGGGCGCAGCC
Inc W For CCTAAGAACAACAAAGCCCCCG 1.5 242 Carattoli A. 2005
Inc W Rev GGTGCGCGGCATAGAACCGT
Inc N For GTCTAACGAGCTTACCGAAG 1.5 559 Carattoli A. 2005
Inc N Rev GTTTCAACTCTGCCAAGTTC
Inc U-For CTGGCTGAAATGCTGTTGCC 3.75 590 Cattoir V. 2008
Inc U-Rev GCTTCATAGGCTTCACGCTC
Inc Q repB1 TCGTGGTCGCGTTCAAGGTACG 3.75 1160 Götz A. 1996
Inc Q repB2 CTGTAAGTCGATGATCTGGGCGTT
Inc Q oriT 1 TTCGCGCTCGTTGTTCTTCGAGC 4.75 191 Götz A. 1996
Inc Q oriT 2 GCCGTTAGGCCAGTTTCTCG
35 cy1cles, 94°C for 1', 62°C 
for 1', 72°C for 1'
35 cy1cles, 94°C for 1', 57°C 
for 1', 72°C for 1'
30 cycles, 94°C for 30'', 60°C 
for 1.5', 72°C for 1.5'
30 cycles, 94°C for 30'', 60°C 
for 1', 72°C for 1'
30 cycles, 94°C for 30'', 60°C 
for 1.5', 72°C for 1.5'
30 cycles, 94°C for 30'', 60°C 
for 1.5', 72°C for 1.5'
35 cy1cles, 94°C for 1', 57°C 
for 1', 72°C for 1'
 
 
3.8 Bacterial conjugations 
Bacterial conjugations were performed using Aeromonas spp. as donor and fecal coliforms or 
Aeromonas spp. as recipient. The choice of bacterial strains was made considering the 
presence of plasmids (at least one plasmid for the donors and no plasmids for the recipients) 
and the resistance phenotype of the strains. The concentration of antibiotics used for the 
selection of transconjugants was established according to the minimum inhibitory 
concentration (MIC) reported in the EUCAST and CLSI (Clinical and Laboratory Standard 
Institute) tables. Solid and liquid conjugations were performed in three steps: I, donors and 
recipients were grown in 2 mL of TSB for 3 hours at 30°C (Aeromonas spp.) and 37°C (Fecal 
coliforms) and spread on single, double selective and non-selective LB agar plate to check the 
sensitivity to the selections; II, donor and recipient were inoculated for 3 hours in 2 mL of 
TSB at the optimal temperature condition; after having reached a 0.5 McFarland 
concentration in 5 mL saline solution, they were spread on the non selective plate in ratio of 
1:2 (100 µL and 200 µL) and 1:4 (100 µL and 400 µL) and incubated for 24 hours at 30°C. 
The liquid conjugations were performed inoculating the same ratio volumes in 5 mL of LB 
broth; III, after conjugation on solid media, the colonies were collected in 5 mL of saline 
solution up to a concentration of 3 McFarland from which 100 µL were spread on selective, 
double selective or non-selective LB agar plate subsequently incubated at 37°C or 30°C, if the 
recipient are Fecal Coliforms or Aeromonas spp. respectively, for 24 hours. The same amount 
of the liquid conjugation was spread on the selective or non selective agar plates.  
Transconjugated bacteria (Fecal Coliforms or Aeromonas) were plated for other 24 hours at 
 - 41 - 
37°C or 30°C on a double selective LB agar. Antibiograms and plasmidic extractions were 
carried out to confirm the transfer of plasmids from the donors to the recipients. 
 
3.9 Total DNA extraction 
Total DNA was extracted from Aeromonas spp. and Fecal Coliforms by a boiling method in 
presence of matrix beads (InstaGene Matrix, Biorad). Briefly, one bacterial colony was 
resuspended in 200 µL of InstaGene matrix, incubated at 56°C for 30 minutes, vortexed at 
high speed for 10 seconds then placed in a 100°C heated block for 8 minutes and vortexed at 
high speed for 10 seconds. The bacterial lysates were spun at 12000 rpm for 3 minutes. Total 
DNA is contained in the supernatant, while the debris are bound to the matrix in the pellet. 
 
3.10 Chemically competent bacteria (CaCl2) and bacterial transformation 
To increase the ability of bacteria to acquire exogenous DNA by transformation, strains were 
treated with CaCl2. Two E.coli strains (DH5α, BL21) were inoculated in 3 mL of LB broth at 
37°C for 24 hours. This suspension was diluted in 300 mL of LB broth and grown up to an 
absorbance of 0.6 (OD600) for 3-5 hours at 37°C prior to incubate on ice for 10 minutes. 
Portions of 50 mL were centrifuged for 10 minutes at 3000 rpm at 4°C and supernatants were 
removed. The pellets were resuspended in 0.5 mL of LB broth to which were added 20 mL of 
100 mM CaCl2 and then incubated again on ice for 20 minutes. Once more, the bacterial 
suspensions were centrifuged for 10 minutes at 3000 rpm at 4°C and the supernatants were 
discarded. Pellets were resuspended in 0.5 mL, 4 mL of 100 mM CaCl2 were added and 
incubated at room temperature (RT) for 20 minutes. The bacterial suspensions were 
centrifuged for 10 minutes at 3000 rpm at RT and supernatants were removed. Finally, 
bacteria were resuspended one last time in 0.5 mL of 100 mM CaCl2 and 0.12 mL of glycerol 
50%. Portions of 50 µL were frozen in liquid Nitrogen for 10 minutes and stored at -80°C. 
For transformations, the competent bacteria were exposed to plasmids of environmental 
strains. The portions of 50 µL of chemically competent bacteria were thawed on ice. 1 to 5 µL 
of plasmid DNA (1 µg) was added and mixed gently. As positive control, 1µL of the plasmid 
pUC19 (1 µg/µL) was added to a separate vial. Vials were heated at 42°C for 30 seconds, and 
incubated for 2 minutes on ice. The bacteria were placed at 37°C for 1 hour after addition of 
250 µL of LB broth to increase the number of transformed cells. 100 µL of the bacteria and 
1:10, 1:100 dilutions were spread on a selective LB agar plate containing antibiotics and 
incubated for 24 hours at 37°C. 
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The transformation efficiencies (expressed as Transformants/µg DNA) were calculated by 
the following formula: 
 
n° colonies/pg DNA · 106pg/µg · 300 µL/ X µL plated · dilution factor 
 
3.11 PCR amplification of Gyrase A (GyrA) gene 
The Gyrase A gene (GyrA) was amplified by PCR using the total DNA extract from 
Aeromonas spp. and Fecal Coliforms. PCR were carried out using 2.5 U/reaction of Hot Start 
Taq (Qiagen), 2.5 µL Buffer 10X (Tris-HCl, KCl, (NH4)2SO4, 15 mM MgCl2; pH 8.7), 0.5 µL 
dNTPs 10 mM, 0.5 µL of each primer Forward and Reverse 10 µM, MgCl2 (Table 3.11.1), 1-
5 µL of DNA extract and water to a final volume of 25 µL. Primer sequences and PCR 
conditions are listed in Table 3.11.1. 
 
Table 3.11.1: List of primers and condition of the PCR Gyrase A gene. The initial denaturation and the final 
elongation were of 95°C for 15 minutes and 72°C for 10 minutes for all PCR programs. 
Primer Name Primer Sequence (5'-3') Final MgCl2 
concentration (mM) PCR condition
Amplicon 
size (bp) Reference
GyrA For TTCTATCTTGATTACGCCATG 3 482 Goni-Urizza, 2002
GyrA Rev CATGCCCACCGCRATACC
GyrA Fw entero TCCTATCTGGAYTATGCGATG 3 482 This study
GyrA Rv entero CWTMCCKACSGCGATACC
35 cycles, 95°C for 1', 
55°C for 1', 72°C for 1'
35 cycles, 95°C for 1', 
55°C for 1', 72°C for 1'
 
 
3.12 PCR amplification of Integrase I gene (Int I), 5’-3’ CS and Pant-
QacE∆1 
The Integrase I gene (Int I), the 5’-3’ CS and the Pant-QacE∆1 regions were amplified by 
PCR in the total plasmidic extracts from Aeromonas spp. and Fecal Coliforms. Primer 
sequences and PCR conditions are listed in Table 3.12.1. The PCR mix consisted in a 12.5 µL 
Taq PCR Master Mix (2.5 U/reaction Taq DNA polymerase, Tris-HCl, KCl, (NH4)2SO4, 15 
mM MgCl2, pH 8.7; 200 µM of each dNTPs. Qiagen), 0.75 µL of each primer, 1-5 µL of 
samples and water to a final volume of 25 µL. 
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Table 3.12.1: Primers and PCR conditions to amplify Integrase I gene, variable region (5’-3’CS) and gene 
cassettes (PantF-qacE∆1). 
Primer Name Primer Sequence (5'-3') Final MgCl2 
concentration (mM) PCR condition
Amplicon size 
(bp) Reference
Int I-L CTGCGTTCGGTCAAGGTTCT 1.5 882 Lanz, 2003
Int I-R GGAATGGCCGAGCAGATCCT
5'CS-R GATGCCCGAGGCATAGACT 1.5 Variable This study
3'CS-L TGCTCACAGCCAAACTATCA
Pant F GTCGAAACGGATTAAGGCACG 1.5 Variable Sandvang, 1999
qacE∆1 CAAGTCTTTGCCCATGAAGC
94°C for 3'; 35 cycles, 94°C for 1', 68°C 
for 1', 72°C for 1'; 72°C for 7'
95°C for 15'; 30 cycles, 95°C for 1', 55°C 
for 30'', 72°C for 1.5'; 72°C for 7'
94°C for 3'; 31 cycles, 95°C for 45'', 60°C 
for 45'', 72°C for 6'; 72°C for 7'
 
 
3.13 PCR amplification of ESBL genes 
Total plasmidic extracts were amplified with specific primers to identify ESBL genes. The 
conditions and the primer sequences are listed in Table 3.13.1. The Hot Start Taq (Qiagen) 
and the Taq PCR Master Mix (Qiagen) were used to amplify the following genes: blaSHV, 
blaCTX-M, blaTEM and blaOXA.  
 
Table 3.13.1: Primers and PCR conditions for OXA, SHV, TEM and CTX-M genes. 
Primer Name Primer Sequence (5'-3') Final MgCl2 
concentration (mM) PCR condition
Amplicon size 
(bp) Reference
OXA-F ATATCTCTACTGTTGCATCTCC 1.5 619
OXA-R AAACCCTTCAAACCATCC
SHV-A ATGCGTTATWTTCGCCTGTGT 1.5 821
SHV-B TTAGCGTTGCCAGTGCTCG
PRE-TEM-1 GTATCCGCTCATGAGACAATA 1.5 1000
PRE-TEM-2 TCTAAAGTATATATGAGTAAACTTGGTCTG
CTX-M A1 SCSATGTGCAGYACCAGTAA 1.5 504
CTX-M A2 CCGCRATATGRTTGGTGGTG
95°C for 5'; 32 cycles, 94°C for 30'', 54°C 
for 30'', 72°C for 1'; 72°C for 10'
95°C for 3'; 30 cycles, 95°C for 30'', 55°C 
for 30'', 72°C for 1'; 72°C for 10'
95°C for 3'; 30 cycles, 95°C for 30'', 55°C 
for 30'', 72°C for 1'; 72°C for 10'
95°C for 3'; 30 cycles, 95°C for 30'', 55°C 
for 30'', 72°C for 1'; 72°C for 10'
Mammeri, 
2005 
Colom, 2003
Mammeri, 
2005 
Lartigue, 
2007
 
 
3.14 PCR clean-up and gel extraction  
Amplicons were purified before sequencing using the PCR Clean-up (Macherey-Nagel) kit, 
while DNA was extracted from gels with the NucleoSpin® Gel (Macherey-Nagel) following 
the manufacturer’s instructions. The PCR products were purified as reported in the user 
manual. Due the excessive size of the plasmids, the extracts were purified increasing the 
amount of samples loaded in the column.  
200 µL of buffer NT1 were added to 100 µL of PCR product or 100 mg of agarose gel. For 
the gel extraction the samples were incubate for 10 minutes at 50°C. Samples are then loaded 
into the NucleoSpin® columns and centrifuged for 30 seconds at 11000 x g. The flow-through 
is discarded. The silica membranes are washed twice with 700 µL of buffer NT3, centrifuged 
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Template Quantity
100–200 bp 1–3 ng
200–500 bp 3–10 ng
500–1000 bp 5–20 ng
1000–2000 bp 10–40 ng
>2000 bp 20–50 ng
for 30 seconds at 11000 x g, discharging the flow-through, and dried for 1 minute at 11000 x 
g to remove the buffer. The DNA was eluted by addition of 15-30 µL of buffer NE (5 mM 
Tris/HCl, pH 8.5), followed by an incubation at room temperature for 1 minute (70° for large 
fragments) and centrifuge for 1 minute at 11000 x g. 
 
3.14.1 Sequencing 
Sequencing was carried out using BigDye Terminator® v3.1 (Applied Biosystems). The 
reactions were carried out with 1µL of BigDye Terminator®, 1.5 µL of 5X BigDye Buffer, 
DNA as listed in Table 3.14.1.1, 2 µL of primer forward or reverse 1 µM and water to a final 
volume of 10 µL. The thermal cycling was set with a 
denaturation step at 96°C for 1 minute followed by 25 
cycles of 96°C for 10 seconds, 50°C for 5 seconds and 
60°C for 4 minutes. 
Products were purified by IllustraTM SephadexTM G50 
Fine DNA Grade (GE Healthcare) and were sequenced 
with the addition of 5 µL HiDiTM Formamide (Applied 
Biosystems) on a genetic Analyzer ABI/Hitachi 3500 
(Applied Biosystems) (figure 3.14.1.1).   
 
 
 
 
 
 
 
 
Figure 3.14.1.1: Analyzer ABI/Hitachi 3500. Image from 
http://www.chikyu.ac.jp/laboratories/public_E/instruments_E/
DNAseq_E.html. 
 
 
Data were analyzed by the 3500 Data Collection Software v.1.00 (Applied Biosystems) and 
multiple alignments were performed using MEGA version 4 (Molecular Evolutionary 
Genetics Analysis) (Tamura et al., 2007).    
Table 3.14.1.1: Amount of PCR 
product to use in a sequencing 
reaction based on the size of the 
amplicon. 
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3.15 Plasmid curing 
Plasmid curing was performed on Aeromonas spp. following five methods: plate curing, 10% 
SDS curing, Minimal medium curing, water curing and acridine orange curing. The first 
method consisted in plating repeatedly and growing at 30°C on COL-S 5% SB agar a single 
bacterial colony. This treatment was repeated every 48 hours for eight weeks. The second 
method was performed incubating a single bacterial colony in 5 mL of MH broth with 10% 
SDS (modified method of Molina-Aja et al., 2002) for 24 hours at 30°C and plating 100 µL 
of this suspension on COL-S 5% SB agar for other 24 hours at 30°C. The third method was 
carried out growing the bacteria in 5 mL of minimal medium (Table 15) for one week at 
15°C. The fourth method consisted in the inoculation of one colony in filtered 0.45µm 
(0.45µm-pore size filter, Millipore) water lake and grown for one week at 15°C. The last 
method (modified from Molina-Aja et al., 2002) was executed by inoculation of the bacteria 
in LB broth containing different concentration of acridine orange (50, 75, 100 and 125 
µg/mL) and growing for 24 hours at 30°C. After each treatment, bacteria were submitted to an 
antibiotic susceptibility test, and in case of resistance variations, the plasmids were extracted 
and visualized through electrophoresis in agarose gel at 0.7%.  
 
3.16 PCR amplification of Mobilizable Groups (MOBs) 
Total plasmid extracts were amplified using the specific MOB subfamily primers and the 
conditions  listed in Table 3.16.1. The polymerase chain reactions were carried out using  Taq 
PCR Master Mix (Qiagen) in a final volume of 25 µL. 
 
Table 3.16.1: Primer sequences and MOB PCR condition. All the primers shown degenerate bases in 3’ 
terminal region to include most subfamily members. 
Primer Name Primer Sequence (5'-3') PCR condition Amplicon 
size (bp) Reference
H121-f GCCAGCTTCCGAATCACAYCAYCAYCG 313
H121-r GTCGCTTGTCGCGCCACCGDATRAARTA
F12-f AGCGACGGCAATTATTACACCGACAAGGAYAAYTAYTA 234
F1-r ACTTTTGGGCGCGGARAABTGSAGRTC
P12-f GCACACTATGCAAAAGATGATACTGAYCCYGTTTT 189
P1-r ACGGATGTGGATGTGAAGGTTRTCNGTRTC
P131-f AACCCACGCTGCAARGAYCCVGT 180
P1-r ACGGATGTGGATGTGAAGGTTRTCNGTRTC
P14-f CGCAGCAAGGACACCATCAAYCAYTAYRT 174
P1-r ACGGATGTGGATGTGAAGGTTRTCNGTRTC
H11-f CCGGCGTCGGAGAAYCAYCAYCA 207
H11-r AAGGTCGTATACCTTYCCKGCRTCRTG
F11-f GCAGCGTATTACTTCTCTGCTGCCGAYGAYTAYTA 234
F1-r ACTTTTGGGCGCGGARAABTGSAGRTC
94°C for 4'; 25 cycles, 94°C for 30'', 50°C for 30'', 72°C 
for 30''; 72°C for 10'
94°C for 4'; 25 cycles, 94°C for 30'', 53°C for 30'', 72°C 
for 30''; 72°C for 10'
94°C for 4'; 11 cycles, 94°C for 30'', start at 65°C ∆Ta=-
1 for 30'', 72°C for 30''; 15 cycles, 94°C for 30'', 55°C 
for 30'', 72°C for 30''; 72°C for 10'
94°C for 4'; 25 cycles, 94°C for 30'', 59°C for 30'', 72°C 
for 30''; 72°C for 10'
94°C for 4'; 25 cycles, 94°C for 30'', 55°C for 30'', 72°C 
for 30''; 72°C for 10'
94°C for 4'; 30 cycles, 94°C for 30'', 53.8°C for 30'', 
72°C for 30''; 72°C for 10'
94°C for 4'; 30 cycles, 94°C for 30'', 59°C for 30'', 72°C 
for 15''; 72°C for 10'
Alvarado, 2012
Alvarado, 2012
Alvarado, 2012
Alvarado, 2012
Alvarado, 2012
Alvarado, 2012
Alvarado, 2012
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3.17 Dot blotting 
Dot-Blot experiments were performed using the DIG High Prime DNA Labeling and 
Detection Starter Kit I and DIG Wash and Block Buffer Set (Roche Applied Science). Buffers 
and contents are listed in Table 3.17.1. Purified DNA probes were labeled with Digoxigenin 
and used to identify by hybridization the target genes either on plasmids and on chromosomal 
DNA, which were spotted on a nylon membrane. 
 
      Table 3.17.1: Kit contents and buffers composition. 
Reagents/Buffers Composition
DIG-High Prime (5x) Random primers
Nucleotides
DIG-dUTP (alkali-labile)
DIG-labeled Control DNA pBR328 (linearized with BamHI) 5 µg/mL
DNA dilution buffer Fish sperm DNA 50 µg/mL
Tris-HCl 10 mM
EDTA 1 mM
pH 8.0
Anti-Digoxigenin-AP conjugate Fab-fragment (sheep)
750 U/mL
NBT/BCIP (50x) nitroblue tetrazolium chloride 18.75 mg/mL
5-bromo-4-chloro-3-indolyl-phosphate 9.4 mg/mL
DMSO 67% (v/v)
DIG Easy Hyb granules not specified
Washing buffer Maleic Acid 0.1 M
NaCl 0.15 M
pH 7.5
Tween-20 0.3% (v/v)
Maleic Acid buffer Maleic Acid 0.1 M
NaCl 0.15 M
pH 7.5 (adjusted with NaOH solid)
Detection buffer Tris-HCl 0.1 M
NaCl 0.1 M
pH 9.5
 
 
3.17.1 Digoxigenin-DNA labeling 
DNA was labeled with Digoxigenin-11-dUTP by DIG-High Prime. From 10 ng to 3 µg of 
amplicon was added to double distilled water to a final volume of 16 µL. The DNA was 
denatured by heating in a boiling bath for 10 minutes and quickly chilled on ice/water bath. 4 
µL of DIG-High Prime were added to the samples and incubated for 20 hours at 37°C in a 
thermocycler (Verity, Applied Biosystems). Reactions were blocked adding 2 µL of EDTA 
0.2 M (pH 8.00) and incubated for 10 minutes at 65°C. The theoretical amount of probes was 
extrapolated by means of the graphic 3.17.1.1. 
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Graphic 3.17.1.1: Theoretical correlation between the amount of template DNA and synthesized labeled 
probe. The two curves represent the theoretical increase of  the amount (in ng) of probe from 1 hour (dots) to 20 
hours (triangles) of synthesis.         
 
3.17.2 Determination of labeling efficiency 
The determination of the labeling efficiency is an important step to perform reproducible 
results. A too high or too low probe concentrations could cause respectively background or 
weak signals. Labeled probes and positive control (pBR328 linearized with BamHI) were 
diluted up to 1 ng/µL, according to the theoretical probes concentration, and used as start 
samples for the subsequent dilutions (Table 3.17.2.1). 
 
Table 3.17.2.1: Volumes and final concentrations of labeled probes and positive control dilutions. 
Tube DNA (µL) From Tube DNA Dilution Buffer (µL) Dilution
Final 
Concentration
1 Diluited original - - 1 ng/uL
2 2 1 198 1:100 10 pg/uL
3 15 2 35 1:333 3 pg/uL
4 5 2 45 1:1000 1 pg/uL
5 5 3 45 1:3333 0.3 pg/uL
6 5 4 45 1:10000 0.1 pg/uL
7 5 5 45 1:33333 0.03 pg/uL
8 5 6 45 1:100000 0.01 pg/uL
9 - - 50 - 0
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One micro-liter (1 µL) of dilutions 2 to 9 (see Table 3.17.2.1) of the labeled probes and of the 
positive control were applied to the nylon membrane (Roche). Nucleic acids were fixed for 1 
hour at 100°C in an air incubator. Then, the membrane was transferred in a plastic container 
with 20 mL of Maleic Acid buffer, incubated under shaking for 2 minutes at room 
temperature and subsequently treated with 10 mL of Blocking buffer for 30 minutes. The 
immunological detection was carried out adding 10 mL of Antibody solution (1:5000) for 30 
minutes. The membrane was washed twice with 10 mL of Washing buffer for 10 minutes. To 
visualize the spot, the membrane was treated with 2 mL of Color substrate solution freshly 
prepared. The reaction was stopped after 2 or 2.5 hours with 50 mL of PCR grade water. If 
0.1 pg dilution spots of the probe and the positive control were visible, then the labeled probes 
had the same concentration as this calculated theoretically. 
 
3.17.3 DNA transfer, fixation and hybridization 
Total plasmid extracts or chromosomal DNAs were boiled for 10 minutes, chilled in ice/water 
bath, and spotted (1 or 2 µL respectively) on a nylon membrane placed on a soaked 3MM 
paper with 10x SSC. After the fixation of the samples in an air incubator for 1 hour at 100°C, 
the membrane was washed briefly in water and dried at room temperature. The appropriate 
hybridization temperatures (Table 3.17.3.1) were calculated according to the CG content and 
the homology of the probes to their target according to the following equations: 
 
 Tm = 49.82 + 0.41 (% C + G) – (600/l) 
 Topt = Tm – 20 to 25°C 
 
where Tm is the melting temperature of the probe, l is the length of the hybrid in base pair and 
Topt is the optimum temperature used for the hybridization (high or low stringency). 
 
Table 3.17.3.1: Probes and optimal temperatures to hybridize. The stringency used in the hybridization 
experiments is indicated.  
Probes %G+C length (bp) Tm (°C) Topt (°C) Stringency
MOB H121 57 326 71 51 High
MOB F12 59 234 71 49 Middle
MOB P12 48 189 66 44 Middle
MOB P13 47 180 66 43 Middle
MOB P14 55 174 69 46 Middle
MOB H11 45 207 65 43 Middle
IncU 57 590 72 50 Middle
Integrase I 61 882 74 49 Low
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The DIG Easy Hyb buffer was pre-heat to the appropriate hybridization temperature 
(10mL/100cm2 filter) and used to prehybridize the nylon membrane for 30 minutes with 
gentle agitation. The DIG-labeled probes were boiled for 5 minutes at 100°C in a water bath 
and rapidly cooled in ice/water. Denatured probes were added to the pre-heated DIG Easy 
Hyb buffer (3.5 mL/100 cm2 filter) to a final concentration of 25 ng/mL. The prehybridization 
solution was poured off and replaced by the probe/hybridization mixture. Hybridization was 
carried out overnight with gentle agitation. 
 
3.17.4 Immunological detection 
The hybridized membrane was washed twice with 25 mL of 2x SSC, 0.1% SDS at room 
temperature for 5 minutes to remove the unbound probes, then twice with high stringency 
washing made of 25 mL 0.5x SSC, 0.1% SDS at 68°C for 15 minutes to remove the weakly 
bound probes. The incubation steps for the immunological detection took place at room 
temperature with agitation. After the high stringency washings, the membranes were rinsed in 
Washing buffer for 5 minutes and subsequently incubated with 100 mL of Blocking solution 
for 30 minutes. Afterwards membranes were incubated with 20 mL of Antibody solution for 
30 minutes and washed twice with 100 mL of Washing buffer for 15 minutes.  
The detection of positive samples were performed incubating the membranes in 10 mL of 
freshly prepared Color substrate solution in the dark, and the reactions were stopped after 2.5 
hours washing the membranes for 5 minutes in 50 mL of PCR grade water. Results were 
recorded in a tif format picture. 
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3.18 Culture media and solution. 
 
Table 3.18.1: Solution, medium and broth.  
Solution/Medium/Broth Reagents Amount Sterilization Cooling
m-Aeromonas selective agar base Tryptose 5 g
Yeast Extract 2 g
Dextrin 11.4 g
Sodium Chloride 3 g
Potassium Chloride 2 g
Magnesium Sulphate 0.1 g
Ferric Chloride 0.06 g
Sodium Desoxycholate 0.1 g
Bromothymol Blue 0.08 g
Agar 13 g
H2O up to 1L
--- 121°C for 15' 40-45°C
Ampicillin 10 µg/mL
C-EC MUG Agar Peptone 5 g 121°C for 15' 40-45°C
Tryptophan 1 g
Tryptose 10 g
Yeast Extract 3 g
Bile Salts n.3 1.5 g
Sodium Chloride 5 g
IPTG 0.1 g
X-GAL 0.08 g
MUG 0.05 g
Agar 13 g
H2O up to 1L
pH 7.4 ± 0.1 (25°C)
Peptone water 0.1% Bacteriological Peptone 1 g 121°C for 15'
Distilled water up to 1L
Skim-Milk Skim-Milk 10 g
H2O 70 mL
--- 121°C for 15'
Calf serum 10 mL
Glycerin 20 mL
TSB Trypticase Soy Broth 30 g 121°C for 15'
H2O up to 1L
Saline solution NaCl 9 g 121°C for 15'
H2O up to 1L
 
          Continued… 
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Solution/Medium/Broth Reagents Amount Sterilization Cooling
Mueller Hinton agar Mueller Hinton Agar 38 g 121°C for 15'
H2O up to 1L
Mueller Hinton broth-10% SDS Mueller Hinton pounder 38 g
H2O up to 1L
--- 121°C for 15' 20°C
SDS 100 g
α-cyano α-cyano-4-hydroxy-
cinnamic acid, 97% 40 mg
acetonitrile 330 µL
Ethanol 330 µL
H2O 330 µL
Trifluoroacetic Acid 30 µL
Minimal medium TSB 100 mL
NaCl solution 900 mL
EDTA 0.2 M EDTA 37.224 g 121°C for 15'
H2O 500 mL
pH 8.00
TE Tris HCl 1 M 10 mL 121°C for 15'
EDTA 0.5 M 2 mL
H2O up to 1 L
20x SSC Sodium Citrate 88.2 g 121°C for 15'
NaCl 175.3 g
H2O up to 1 L
pH 7.00
2x SSC, 0.1% SDS 20x SSC 5 mL
SDS 50 mg
H2O 45 mL
0.5x SSC, 0.1% SDS 20x SSC 1.25 mL
SDS 50 mg
H2O 48.75 mL
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4 RESULTS 
 
4.1 Sampling 
The result of the quantification of Aeromonas and Fecal Coliforms, expressed in CFU/100 
mL, in the various samples is summarized in Table 4.1.1. 
The Aeromonas strains were recovered from the five sampling areas with concentration 
ranging from 2·103 (Ticino river before the wastewater treatment plant) to 3·106 (activated 
sludge of the wastewater treatment plant in Giubiasco) CFU in 100 mL. The Fecal Coliforms 
concentration reached 2.07·106 CFU/100 mL in the Bellinzona Hospital wastewaters, whereas 
they were 3 CFU/100 mL in the Lake Cadagno. The ratio between the two bacterial groups 
was higher in the Lake Cadagno (about 1283), while it was under the unit (0.7005) in the 
wastewaters of Bellinzona Hospital where the Fecal Coliforms are predominant.  
We isolated a total of 231 Aeromonas strains and 250 Fecal Coliforms which were identified 
by MALDI-TOF MS. The most prevalent Aeromonas species were A. hydrophila, A. media, 
A. caviae, and A. salmonicida (Table 4.1.2). In the Bellinzona Hospital sampling, A. 
hydrophila represented the 84.78% of the identified species, while in the Ticino River before 
and after the wastewater treatment plant the species A. media counted for the 57.14% and 
45.65%, respectively; this species was predominant also in the Giubiasco waste water 
treatment plant representing the 51.22% of the Aeromonas species. On the other hand, the 
principal specie collected in Lake Cadagno was A. salmonicida (87.76%). 
The most representative species belonging to the Fecal Coliforms group was Escherichia coli, 
which was highly present at each sampling site (Table 4.1.3). The recovery of Klebsiella 
pneumoniae and Enterobacter cloacae was also significant in the waste water treatment plant 
(34% and 20% respectively). K. pneumoniae represented the 22% of the species isolated from 
the Ticino river after the treatment plant of Giubiasco. 
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Table 4.1.1: Concentrations of Aeromonas spp. and Fecal Coliforms, expressed in CFU/100 mL (Colony 
Forming Units in 100 mL), and their relative ratios in the five sampling areas. The colored squares refer to the 
sampling areas indicated on the map shown in “Material and Methods”. WW.T.P, wastewater treatment plant. 
Ratio (Aer/FC)
TICINO  RIVER BEFORE THE WW.T.P 12.1212
BELLINZONA  HOSPITAL 0.7005
WW.T.P.  GIUBIASCO 4.2553
TICINO RIVER  AFTER  WW.T.P. 2.2699
LAKE  CADAGNO 1283.34
1.45*10^6 2.07*10^6
3*10^6 7.05*10^5
3.7*10^4 1.63*10^4
3.85*10^3 3
CFU/100mL
Aeromonas Fecal Coliforms
2*10^3 1.65*10^2
 
 
 
Table 4.1.2: Aeromonas spp. identified in the five sampling areas. 
SPECIES Percentage Percentage Percentage Percentage Percentage
A.bestiarum 10.20 0.00 0.00 2.17 0.00
A.caviae 12.24 2.17 17.07 32.61 0.00
A.hydrophila 6.12 84.78 29.27 17.39 0.00
A.media 57.14 4.35 51.22 45.65 4.08
A.salmonicida 4.08 6.52 2.44 0.00 87.76
A.sobria 10.20 0.00 0.00 0.00 0.00
A.veronii 0.00 2.17 0.00 2.17 0.00
A.eucrenophila 0.00 0.00 0.00 0.00 6.12
A.popoffii 0.00 0.00 0.00 0.00 2.04
AEROMONAS
TICINO RIVER 
before WW.T.P.
BELLINZONA        
HWW
WW.T.P 
GIUBIASCO
TICINO RIVER 
after WW.T.P.
CADAGNO 
LAKE
 
 
 
Table 4.1.3: Fecal Coliforms identified in the five sampling areas. 
SPECIES Percentage Percentage Percentage Percentage Percentage
E.coli 80.00 90.00 34.00 64.00 90.00
E.cloacae 2.00 2.00 20.00 2.00 4.00
C.freundii 4.00 2.00 8.00 12.00 2.00
E.hermannii 2.00 0.00 0.00 0.00 0.00
K.pneumoniae 10.00 6.00 34.00 22.00 0.00
K.oxytoca 2.00 0.00 4.00 0.00 0.00
P.shigelloides 0.00 0.00 0.00 0.00 4.00
FECAL COLIFORMS
TICINO RIVER 
before WW.T.P.
BELLINZONA        
HWW
WW.T.P 
GIUBIASCO
TICINO RIVER 
after WW.T.P.
CADAGNO 
LAKE
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4.2 Plasmid profiles 
Plasmids were extracted from 231 Aeromonas spp. and 250 Fecal Coliforms. The plasmid 
profiles were compared using the BioNumerics software (Applied Maths, NV), that allowed 
to identify six major groups based on their complexity (Figure 4.2.1). The blue group clusters 
the plasmid profiles showing the higher number of bands (1 to 300 kbp), whereas bacteria 
without plasmids belong to the light blue group (61 strains). The others groups shown 
different intermediate range of complexity as plasmids with predominantly high molecular 
weight (over 23 kbp, red group), plasmids with molecular weight ranging from 1 to 170 kbp 
(yellow group), one or two plasmids with an intermediate molecular weight (approx. 23 kbp, 
purple group), and plasmids with predominantly medium/low molecular weight (1 to 23 kbp, 
green group). 
Some bacteria, belonging to different genera and species, shared similar or identical profiles 
(see e.g. Figure 4.2.2). The distribution (in percentages) of the Aeromonas and Fecal 
Coliforms strains in the different plasmid complexity groups is reported in Table 4.2.1. The 
origin of the strains was related to the complexity of the plasmid profiles. Aeromonas strains 
isolated from the Ticino River before the treatment plant outlet belonged mostly to the blue 
and green groups (30.61% and 26.53%, respectively), whereas those isolated from the same 
river but after the treatment plant belonged to the blue group (58,70%). Most of the 
Aeromonas spp. isolated from the Bellinzona Hospital wastewater clustered in the yellow 
group (63.04%); the majority of those from the wastewater treatment plant ended in the blue 
and green groups (39.02% and 26.83%); Aeromonas strains from the Lake Cadagno belonged 
to the purple group(73.47%). The Fecal Coliforms of the two river samplings were distributed 
in the groups blue (26,00% and 30,00%) and green (28.00% of the strains isolated before the 
WWTP); in the yellow group were clustered 26.00% of the Fecal Coliforms isolated from the 
river before the WWTP but only the 12,00% of those isolated after the WWTP. The Fecal 
Coliforms of the Bellinzona Hospital wastewater were mainly present in the yellow group 
(28.00%). The Fecal Coliforms isolated from the wastewater treatment plant clustered in the 
blue (38.00%) and those of the Lake Cadagno in the green (56.00%) groups. 
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Figure 4.2.2: example of similar or identical plasmidic profiles. 
Red lines indicated common profiles 
 
Figure 4.2.1: Aeromonas and Fecal Coliforms plasmid profiles. The Blue group includes the most complex 
plasmid profiles; the Yellow and Green groups comprise intermediate complex profiles; the Purple and Red 
groups include strains with only one or two bands, respectively; the Light blue group comprises the strains 
without visible bands on gel. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4.2.1: Distribution of Aeromonas spp. and Fecal Coliforms in the six groups of plasmid complexity. 
In the Table are indicated the percentage of the strains per group, the total number of bacteria per group, and the 
six colored squares, representing the groups of plasmidic complexity. 
Aer F.C. Aer F.C. Aer F.C. Aer F.C. Aer F.C.
Strains 49 50 46 50 41 50 46 50 49 50
120 30.61 26.00 4.35 18.00 39.02 38.00 58.70 30.00 0.00 8.00
40 10.20 8.00 2.17 12.00 4.88 14.00 4.35 14.00 4.08 8.00
89 12.24 26.00 63.04 28.00 12.20 8.00 2.17 12.00 2.04 20.00
61 2.04 6.00 2.17 12.00 4.88 10.00 2.17 12.00 73.47 0.00
110 26.53 28.00 13.04 12.00 26.83 14.00 21.74 12.00 18.37 56.00
61 18.37 6.00 15.22 18.00 12.20 16.00 10.87 20.00 2.04 8.00
LAKE  CADAGNO
Percentage (%) Percentage (%) Percentage (%) Percentage (%) Percentage (%)
TICINO RIVER  
BEFORE  WW.T.P. BELLINZONA  HWW WW.T.P.  GIUBIASCO
TICINO RIVER  AFTER  
WW.T.P.
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4.3 Resistance phenotypes 
The resistance phenotypes were established by the Kirby-Bauer method for all the Aeromonas 
spp. and Fecal Coliforms. The antibiograms conducted on the 481 strains were based on 20 
antibiotics (Table 4.3.1). The majority of the resistances observed were Cefazolin (66.11%), 
Streptomycin (31.81%), Nalidixic Acid (30.98%), Sulfamethoxazole (25.57%), and Cefoxitin 
(21.41%). As genus Aeromonas are constitutively resistant to Ampicillin, this antibiotic was 
tested only on the Fecal Coliforms: the 16.22% (78 out of 481) of the strains were resistant. 
However, all the Aeromonas strains were sensitive to the Amikacin while the Fecal Coliforms 
were not tested for this antibiotic. 
The resistant phenotypes of the strains according to the six groups of plasmid complexity, are 
listed in the Table 4.3.2. 
Of the 481 strains tested, 198 (namely the 41.16%) presented three or more antibiotic 
resistances; 189 (namely the 39.29%) had one or two resistances, and 94 (19.54%) were 
sensitive to all the antibiotics tested. Most of the strains with three or more resistances were 
included in the blue group (58.33%), while the majority of the strains with one or two 
resistances were comprised in the purple group (67.21%). Strains without any antibiotic 
resistances were spread along the six groups with different percentages: from the 25.00% in 
the red group to the 13.11% in the purple one. The distribution of the strains according to the 
number of antibiotic resistances is shown in Table 4.3.3. 
In Table 4.3.4 are reported the percentages of Aeromonas spp. and Fecal Coliforms carrying 
plasmids. In the five sampling areas the percentages of Aeromonas spp. carrying plasmids 
were comprised between the 81.63% of the Ticino River before the wastewater treatment 
plant and the 97.96% of the Cadagno Lake. For the Fecal Coliforms, the strains with plasmids 
ranged from 80.00% to 96.00% of the river after and before the treatment plant. In the Lake 
Cadagno the 92.00% of the strains carried plasmids. 
Only a portion of the strains with plasmids shown three or more antibiotic resistances, as 
reported in Table 4.3.5. The strains carrying plasmids and showing three or more antibiotic 
resistances were particularly abundant in the wastewater treatment plant in Giubiasco 
(87.80% and 40.00% for Aeromonas spp. and Fecal Coliforms, respectively), while they were 
rarely isolated in the Lake Cadagno (2.04% and 18.00% for Aeromonas spp. and Fecal 
Coliforms, respectively). 
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Table 4.3.1: Number of resistant strains to each antibiotic, and relative percentages.. CZ, Cefazolin; CXM, 
Cefuroxime; CRO, Ceftriaxone; FOX, Cefoxitin; GM, Gentamycin; SXT, Bactrim; CIP, Ciprofloxacin; MEM, 
Meropenem; PB, Polymyxin B; C, Chloramphenicol; NA, Nalidixic Acid; AN, Amikacin; AMP, Ampicillin; 
RL, Sulfamethoxazole; Te, Tetracycline; S, Streptomycin; TMP, Trimethoprim; ATM, Aztreonam; NN, 
Tobramycin; K, Kanamycin; NET, Netilmicin. 
CZ CXM CRO FOX GM SXT CIP MEM PB C NA
Strains 318 23 21 103 7 24 46 0 2 12 149
Percentages 66,11 4,78 4,37 21,41 1,46 4,99 9,56 0,00 0,42 2,49 30,98
AN AMP RL Te S TMP ATM NN K NET
Strains 0 78 123 32 153 29 11 17 1 5
Percentages 0,00 16,22 25,57 6,65 31,81 6,03 2,29 3,53 0,21 1,04
 
 
 
Table 4.3.2: Aeromonas spp. and Fecal Coliforms resistant phenotypes. The names, the sampling areas, and 
the specie of the Aeromonas spp. and Fecal Coliforms are listed and divided in the six group of plasmid 
complexity (colored ribbons). The resistances to the antibiotics are indicated by the black squares. The gray 
squares represent the antibiotics not tested. 
Groups Key Origins Species
C
Z
C
X
M
C
R
O
FO
X
G
M
SX
T
C
IP
M
EM
PB C N
A
A
N
A
M
P
R
L
Te S TM
P
A
TM
N
N
K N
ET
190FDD-CF TR-a-WWTP K.pneumoniae
24FT-CF TR-b-WWTP K.pneumoniae
129DG-CF WWTP K.pneumoniae
104DG-CF WWTP K.pneumoniae
130DG-CF WWTP E.coli
199FDD-CF TR-a-WWTP E.coli
53SG-CF HWW K.pneumoniae
169FDD-CF TR-a-WWTP K.pneumoniae
182FDD-CF TR-a-WWTP K.pneumoniae
233LC-CF CL E.coli
105DG-CF WWTP K.pneumoniae
154FDD-CF TR-a-WWTP K.pneumoniae
163FDD-CF TR-a-WWTP E.coli
111DG-CF WWTP E.coli
134DG-CF WWTP K.pneumoniae
165FDD-CF TR-a-WWTP E.coli
132DG-CF WWTP K.pneumoniae
148DG-CF WWTP K.pneumoniae
146DG-CF WWTP K.pneumoniae
171FDD-CF TR-a-WWTP E.coli
128DG-CF WWTP E.coli
22FT-CF TR-b-WWTP E.coli
73SG-CF HWW E.coli
80SG-CF HWW E.coli
45FT-CF TR-b-WWTP E.coli
88SG-CF HWW E.coli
138DG-CF WWTP K.pneumoniae
139DG-CF WWTP K.pneumoniae
16FT-Aer TR-b-WWTP A.media
109DG-Aer WWTP A.eucrenophila
77SG-Aer HWW A.hydrophila
Resistances
 
continued… 
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85SG-CF HWW E.coli
179FDD-Aer TR-a-WWTP A.caviae
23FT-CF TR-b-WWTP E.coli
11FT-CF TR-b-WWTP K.pneumoniae
195FDD-CF TR-a-WWTP K.pneumoniae
137DG-CF WWTP K.pneumoniae
120DG-CF WWTP E.cloacae
161FDD-CF TR-a-WWTP E.coli
32FT-CF TR-b-WWTP E.coli
101DG-CF WWTP K.pneumoniae
32FT-Aer TR-b-WWTP A.bestiarum
8FT-Aer TR-b-WWTP A.media
7FT-Aer TR-b-WWTP A.sobria
86SG-CF HWW E.coli
105DG-Aer WWTP A.caviae
39FT-Aer TR-b-WWTP A.media
153FDD-Aer TR-a-WWTP A.media
155FDD-Aer TR-a-WWTP A.media
195FDD-Aer TR-a-WWTP A.veronii
231LC-CF CL E.coli
180FDD-Aer TR-a-WWTP A.hydrophila
44FT-Aer TR-b-WWTP A.caviae
5FT-CF TR-b-WWTP E.coli
42FT-Aer TR-b-WWTP A.media
1FT-Aer TR-b-WWTP A.media
6FT-Aer TR-b-WWTP A.media
181FDD-Aer TR-a-WWTP A.media
117DG-Aer WWTP A.media
101DG-Aer WWTP A.caviae
133DG-Aer WWTP A.hydrophila
5FT-Aer TR-b-WWTP A.hydrophila
97SG-Aer HWW A.media
151FDD-CF TR-a-WWTP E.coli
218LC-CF CL E.coli
151FDD-Aer TR-a-WWTP A.caviae
180FDD-CF TR-a-WWTP K.pneumoniae
199FDD-Aer TR-a-WWTP A.hydrophila
123DG-CF WWTP E.cloacae
102DG-CF WWTP K.pneumoniae
14FT-Aer TR-b-WWTP A.hydrophila
192FDD-Aer TR-a-WWTP A.caviae
25FT-CF TR-b-WWTP E.hermannii
102DG-Aer WWTP A.media
171FDD-Aer TR-a-WWTP A.media
135DG-Aer WWTP A.media
50FT-CF TR-b-WWTP E.coli
139DG-Aer WWTP A.hydrophila
143DG-Aer WWTP A.hydrophila
3FT-CF TR-b-WWTP K.pneumoniae
43FT-CF TR-b-WWTP E.coli
38FT-Aer TR-b-WWTP A.media
131DG-Aer WWTP A.media
192FDD-CF TR-a-WWTP E.coli
28FT-Aer TR-b-WWTP A.media
12FT-Aer TR-b-WWTP A.media
59SG-CF HWW E.coli
16FT-CF TR-b-WWTP K.pneumoniae
198FDD-Aer TR-a-WWTP A.media
10FT-Aer TR-b-WWTP A.media
150DG-Aer WWTP A.caviae
 
continued… 
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169FDD-Aer TR-a-WWTP A.media
184FDD-Aer TR-a-WWTP A.media
163FDD-Aer TR-a-WWTP A.media
165FDD-Aer TR-a-WWTP A.caviae
173FDD-Aer TR-a-WWTP A.media
200FDD-Aer TR-a-WWTP A.media
152FDD-Aer TR-a-WWTP A.caviae
193FDD-Aer TR-a-WWTP A.media
188FDD-Aer TR-a-WWTP A.caviae
189FDD-Aer TR-a-WWTP A.punctata
177FDD-CF TR-a-WWTP E.coli
197FDD-Aer TR-a-WWTP A.hydrophila
129DG-Aer WWTP A.media
191FDD-Aer TR-a-WWTP A.caviae
116DG-CF WWTP K.pneumoniae
56SG-CF HWW E.coli
122DG-CF WWTP K.pneumoniae
158FDD-Aer TR-a-WWTP A.caviae
158FDD-CF TR-a-WWTP K.pneumoniae
113DG-Aer WWTP A.caviae
115DG-Aer WWTP A.media
118DG-Aer WWTP A.media
141DG-Aer WWTP A.hydrophila
186FDD-Aer TR-a-WWTP A.caviae
187FDD-Aer TR-a-WWTP A.caviae
160FDD-Aer TR-a-WWTP A.caviae
227LC-CF CL E.coli
58SG-CF HWW E.coli
12FT-CF TR-b-WWTP E.coli
17FT-Aer TR-b-WWTP A.salmonicida
41FT-Aer TR-b-WWTP A.media
100SG-CF HWW E.coli
104DG-Aer WWTP A.media
10FT-CF TR-b-WWTP E.coli
118DG-CF WWTP E.coli
119DG-CF WWTP E.coli
11FT-Aer TR-b-WWTP A.salmonicida
127DG-CF WWTP E.coli
142DG-CF WWTP E.coli
147DG-Aer WWTP A.hydrophila
150DG-CF WWTP K.oxytoka
155FDD-CF TR-a-WWTP E.coli
156FDD-CF TR-a-WWTP E.coli
160FDD-CF TR-a-WWTP E.coli
166FDD-Aer TR-a-WWTP A.media
174FDD-CF TR-a-WWTP E.coli
18FT-CF TR-b-WWTP K.oxytoka
196FDD-Aer TR-a-WWTP A.media
202LC-CF CL E.coli
206LC-CF CL E.cloacae
209LC-Aer CL A.salmonicida
213LC-CF CL E.coli
216LC-Aer CL A.salmonicida
225LC-CF CL E.coli
23FT-Aer TR-b-WWTP A.media
29FT-Aer TR-b-WWTP A.media
33FT-CF TR-b-WWTP E.coli
52SG-CF HWW E.coli
92SG-Aer HWW A.veronii
94SG-CF HWW E.coli
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97SG-CF HWW E.coli
98SG-CF HWW E.coli
99SG-CF HWW E.coli
125DG-CF WWTP E.cloacae
191FDD-CF TR-a-WWTP E.coli
136DG-CF WWTP K.oxytoka
187FDD-CF TR-a-WWTP E.coli
189FDD-CF TR-a-WWTP E.coli
26FT-CF TR-b-WWTP E.coli
78SG-Aer HWW A.hydrophila
80SG-Aer HWW A.hydrophila
133DG-CF WWTP E.coli
98SG-Aer HWW A.hydrophila
135DG-CF WWTP E.coli
143DG-CF WWTP E.cloacae
166FDD-CF TR-a-WWTP E.coli
168FDD-CF TR-a-WWTP E.coli
173FDD-CF TR-a-WWTP E.coli
203LC-Aer CL A.salmonicida
209LC-CF CL E.coli
60SG-Aer HWW A.hydrophila
61SG-Aer HWW A.hydrophila
70SG-CF HWW E.coli
72SG-Aer HWW A.hydrophila
73SG-Aer HWW A.salmonicida
79SG-Aer HWW A.hydrophila
81SG-Aer HWW A.salmonicida
86SG-Aer HWW A.hydrophila
88SG-Aer HWW A.hydrophila
94SG-Aer HWW A.hydrophila
95SG-Aer HWW A.hydrophila
96SG-Aer HWW A.hydrophila
106DG-Aer WWTP A.media
110DG-Aer WWTP A.hydrophila
112DG-Aer WWTP A.caviae
119DG-Aer WWTP A.hydrophila
137DG-Aer WWTP A.hydrophila
157FDD-CF TR-a-WWTP E.cloacae
178FDD-CF TR-a-WWTP E.coli
184FDD-CF TR-a-WWTP K.pneumoniae
203LC-CF CL E.coli
204LC-CF CL E.coli
210LC-CF CL E.coli
212LC-CF CL E.coli
217LC-CF CL E.coli
222LC-CF CL E.coli
226LC-CF CL E.coli
232LC-CF CL E.coli
234LC-CF CL E.coli
28FT-CF TR-b-WWTP E.coli
30FT-CF TR-b-WWTP E.coli
35FT-CF TR-b-WWTP E.coli
38FT-CF TR-b-WWTP E.coli
40FT-CF TR-b-WWTP E.coli
46FT-Aer TR-b-WWTP A.bestiarum
51SG-CF HWW E.coli
57SG-CF HWW E.coli
61SG-CF HWW E.coli
63SG-CF HWW E.coli
64SG-CF HWW E.coli
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69SG-CF HWW E.coli
71SG-CF HWW E.coli
74SG-CF HWW E.coli
83SG-Aer HWW A.hydrophila
84SG-Aer HWW A.hydrophila
85SG-Aer HWW A.hydrophila
161FDD-Aer TR-a-WWTP A.caviae
19FT-Aer TR-b-WWTP A.caviae
19FT-CF TR-b-WWTP E.coli
20FT-CF TR-b-WWTP E.coli
21FT-CF TR-b-WWTP E.coli
24FT-Aer TR-b-WWTP A.caviae
26FT-Aer TR-b-WWTP A.caviae
42FT-CF TR-b-WWTP E.coli
6FT-CF TR-b-WWTP E.coli
75SG-CF HWW E.coli
76SG-CF HWW E.coli
93SG-CF HWW E.coli
49FT-CF TR-b-WWTP E.coli
79SG-CF HWW E.coli
48FT-CF TR-b-WWTP K.pneumoniae
34FT-CF TR-b-WWTP E.coli
82SG-CF HWW E.coli
51SG-Aer HWW A.hydrophila
52SG-Aer HWW A.hydrophila
54SG-Aer HWW A.hydrophila
55SG-Aer HWW A.hydrophila
62SG-Aer HWW A.hydrophila
63SG-Aer HWW A.hydrophila
64SG-Aer HWW A.salmonicida
65SG-Aer HWW A.hydrophila
69SG-Aer HWW A.hydrophila
145DG-CF WWTP E.coli
59SG-Aer HWW A.hydrophila
67SG-Aer HWW A.hydrophila
13FT-Aer TR-b-WWTP A.bestiarum
30FT-Aer TR-b-WWTP A.bestiarum
57SG-Aer HWW A.hydrophila
14FT-CF TR-b-WWTP E.coli
96SG-CF HWW E.coli
65SG-CF HWW E.coli
123DG-Aer WWTP A.media
71SG-Aer HWW A.hydrophila
154FDD-Aer TR-a-WWTP A.media
68SG-CF HWW E.coli
130DG-Aer WWTP A.media
170FDD-CF TR-a-WWTP E.coli
172FDD-CF TR-a-WWTP E.coli
107DG-CF WWTP K.pneumoniae
167FDD-CF TR-a-WWTP K.pneumoniae
144DG-CF WWTP E.coli
229LC-Aer CL A.salmonicida
131DG-CF WWTP E.coli
141DG-CF WWTP E.cloacae
34FT-Aer TR-b-WWTP A.media
140DG-CF WWTP E.coli
81SG-CF HWW E.coli
164FDD-CF TR-a-WWTP E.coli
72SG-CF HWW E.coli
27FT-CF TR-b-WWTP E.coli
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31FT-CF TR-b-WWTP E.coli
238LC-Aer CL A.salmonicida
215LC-Aer CL A.salmonicida
210LC-Aer CL A.salmonicida
214LC-Aer CL A.salmonicida
220LC-Aer CL A.salmonicida
227LC-Aer CL A.salmonicida
235LC-Aer CL A.salmonicida
236LC-Aer CL A.salmonicida
237LC-Aer CL A.salmonicida
240LC-Aer CL A.eucrenophila
211LC-Aer CL A.salmonicida
247LC-Aer CL A.salmonicida
208LC-Aer CL A.salmonicida
217LC-Aer CL A.salmonicida
218LC-Aer CL A.salmonicida
224LC-Aer CL A.salmonicida
226LC-Aer CL A.salmonicida
228LC-Aer CL A.salmonicida
239LC-Aer CL A.salmonicida
245LC-Aer CL A.salmonicida
249LC-Aer CL A.salmonicida
231LC-Aer CL A.salmonicida
233LC-Aer CL A.salmonicida
243LC-Aer CL A.salmonicida
222LC-Aer CL A.salmonicida
225LC-Aer CL A.salmonicida
244LC-Aer CL A.eucrenophila
213LC-Aer CL A.salmonicida
230LC-Aer CL A.salmonicida
223LC-Aer CL A.salmonicida
242LC-Aer CL A.salmonicida
202LC-Aer CL A.salmonicida
207LC-Aer CL A.salmonicida
212LC-Aer CL A.salmonicida
221LC-Aer CL A.salmonicida
159FDD-CF TR-a-WWTP E.coli
179FDD-CF TR-a-WWTP E.coli
95SG-CF HWW K.pneumoniae
228LC-CF CL E.coli
99SG-Aer HWW A.hydrophila
58SG-Aer HWW A.hydrophila
221LC-CF CL E.coli
47FT-CF TR-b-WWTP E.coli
201LC-CF CL E.coli
216LC-CF CL E.coli
114DG-CF WWTP E.coli
136DG-Aer WWTP A.media
13FT-CF TR-b-WWTP E.coli
2FT-CF TR-b-WWTP E.coli
41FT-CF TR-b-WWTP E.coli
46FT-CF TR-b-WWTP E.coli
4FT-CF TR-b-WWTP E.coli
9FT-CF TR-b-WWTP E.coli
230LC-CF CL E.coli
152FDD-CF TR-a-WWTP E.coli
236LC-CF CL E.coli
205LC-CF CL E.coli
219LC-Aer CL A.salmonicida
220LC-CF CL E.coli
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223LC-CF CL E.coli
208LC-CF CL E.coli
17FT-CF TR-b-WWTP E.coli
29FT-CF TR-b-WWTP E.coli
67SG-CF HWW E.cloacae
78SG-CF HWW E.coli
211LC-CF CL E.coli
219LC-CF CL E.coli
60SG-CF HWW E.coli
175FDD-CF TR-a-WWTP E.coli
37FT-CF TR-b-WWTP E.coli
39FT-CF TR-b-WWTP E.coli
44FT-CF TR-b-WWTP E.coli
7FT-CF TR-b-WWTP E.coli
229LC-CF CL E.coli
181FDD-CF TR-a-WWTP K.pneumoniae
185FDD-CF TR-a-WWTP C.freundii
121DG-CF WWTP E.coli
145DG-Aer WWTP A.hydrophila
117DG-CF WWTP E.cloacae
149DG-CF WWTP E.cloacae
124DG-CF WWTP E.cloacae
176FDD-CF TR-a-WWTP E.coli
3FT-Aer TR-b-WWTP A.caviae
9FT-Aer TR-b-WWTP A.media
148DG-Aer WWTP A.media
40FT-Aer TR-b-WWTP A.media
120DG-Aer WWTP A.bestiarum
15FT-CF TR-b-WWTP E.cloacae
214LC-CF CL P.shigelloides
215LC-CF CL P.shigelloides
204LC-Aer CL A.media
206LC-Aer CL A.media
234LC-Aer CL A.salmonicida
246LC-Aer CL A.salmonicida
201LC-Aer CL A.popoffii
205LC-Aer CL A.salmonicida
175FDD-Aer TR-a-WWTP A.media
232LC-Aer CL A.salmonicida
250LC-Aer CL A.salmonicida
68SG-Aer HWW A.hydrophila
54SG-CF HWW K.pneumoniae
91SG-Aer HWW A.media
188FDD-CF TR-a-WWTP E.coli
167FDD-Aer TR-a-WWTP A.media
244LC-CF CL E.coli
247LC-CF CL E.coli
164FDD-Aer TR-a-WWTP A.hydrophila
55SG-CF HWW E.coli
239LC-CF CL E.coli
248LC-CF CL E.cloacae
241LC-CF CL E.coli
243LC-CF CL E.coli
245LC-CF CL E.coli
240LC-CF CL E.coli
238LC-CF CL E.coli
246LC-CF CL E.coli
172FDD-Aer TR-a-WWTP A.caviae
237LC-CF CL E.coli
127DG-Aer WWTP A.media
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27FT-Aer TR-b-WWTP A.sobria
128DG-Aer-A WWTP A.media
92SG-CF HWW E.coli
144DG-Aer WWTP A.media
25FT-Aer TR-b-WWTP A.media
4FT-Aer TR-b-WWTP A.media
2FT-Aer TR-b-WWTP A.media
156FDD-Aer TR-a-WWTP A.hydrophila
183FDD-Aer TR-a-WWTP A.media
235LC-CF CL E.coli
43FT-Aer TR-b-WWTP A.media
114DG-Aer WWTP A.hydrophila
140DG-Aer WWTP A.media
66SG-Aer HWW A.hydrophila
90SG-Aer HWW A.hydrophila
112DG-CF WWTP K.pneumoniae
224LC-CF CL E.coli
157FDD-Aer TR-a-WWTP A.hydrophila
47FT-Aer TR-b-WWTP A.media
45FT-Aer TR-b-WWTP A.media
50FT-Aer TR-b-WWTP A.media
48FT-Aer TR-b-WWTP A.media
36FT-Aer TR-b-WWTP A.media
110DG-CF WWTP E.coli
128DG-Aer-B WWTP A.caviae
159FDD-Aer TR-a-WWTP A.hydrophila
121DG-Aer WWTP A.media
176FDD-Aer TR-a-WWTP A.media
178FDD-Aer TR-a-WWTP A.caviae
103DG-CF WWTP K.pneumoniae
106DG-CF WWTP C.freundii
107DG-Aer WWTP A.media
108DG-CF WWTP C.freundii
109DG-CF WWTP E.cloacae
111DG-Aer WWTP A.media
113DG-CF WWTP E.coli
115DG-CF WWTP E.cloacae
116DG-Aer WWTP A.media
122DG-Aer WWTP A.hydrophila
126DG-Aer WWTP A.salmonicida
126DG-CF WWTP C.freundii
147DG-CF WWTP C.freundii
153FDD-CF TR-a-WWTP E.coli
15FT-Aer TR-b-WWTP A.sobria
162FDD-CF TR-a-WWTP C.freundii
168FDD-Aer TR-a-WWTP A.hydrophila
174FDD-Aer TR-a-WWTP A.media
177FDD-Aer TR-a-WWTP A.bestiarum
182FDD-Aer TR-a-WWTP A.media
183FDD-CF TR-a-WWTP C.freundii
186FDD-CF TR-a-WWTP E.coli
18FT-Aer TR-b-WWTP A.caviae
190FDD-Aer TR-a-WWTP A.media
193FDD-CF TR-a-WWTP E.coli
194FDD-CF TR-a-WWTP K.pneumoniae
196FDD-CF TR-a-WWTP C.freundii
197FDD-CF TR-a-WWTP C.freundii
198FDD-CF TR-a-WWTP C.freundii
1FT-CF TR-b-WWTP C.freundii
200FDD-CF TR-a-WWTP E.coli
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207LC-CF CL E.coli
20FT-Aer TR-b-WWTP A.bestiarum
21FT-Aer TR-b-WWTP A.media
22FT-Aer TR-b-WWTP A.sobria
242LC-CF CL C.freundii
248LC-Aer CL A.eucrenophila
249LC-CF CL E.coli
250LC-CF CL E.coli
31FT-Aer TR-b-WWTP A.media
33FT-Aer TR-b-WWTP A.sobria
36FT-CF TR-b-WWTP E.coli
37FT-Aer TR-b-WWTP A.hydrophila
49FT-Aer TR-b-WWTP A.media
53SG-Aer HWW A.hydrophila
56SG-Aer HWW A.hydrophila
62SG-CF HWW E.coli
66SG-CF HWW C.freundii
75SG-Aer HWW A.hydrophila
76SG-Aer HWW A.hydrophila
77SG-CF HWW E.coli
82SG-Aer HWW A.caviae
83SG-CF HWW E.coli
84SG-CF HWW E.coli
87SG-Aer HWW A.hydrophila
87SG-CF HWW E.coli
89SG-Aer HWW A.hydrophila
89SG-CF HWW E.coli
8FT-CF TR-b-WWTP C.freundii
90SG-CF HWW E.coli
91SG-CF HWW E.coli
 
 
 
Table 4.3.3: Distribution of the resistances within the six groups of plasmid complexity. The number and 
the percentage of the strains with three or more resistances, one or two resistances and no antibiotic resistances 
in the groups are reported. 
> 3 2 - 1 0 > 3 2 - 1 0
70 28 22 58,33 23,33 18,33
13 17 10 32,50 42,50 25,00
33 37 19 37,08 41,57 21,35
12 41 8 19,67 67,21 13,11
43 47 20 39,09 42,73 18,18
27 19 15 44,26 31,15 24,59
198 189 94
Strains with resistaces Percentage with resistaces (%)
Total Total
41,16 39,29 19,54
481
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Table 4.3.4: Percentages of Aeromonas spp. and Fecal Coliforms carrying plasmids. 
TICINO  RIVER BEFORE WW.T.P.
BELLINZONA  HWW
WW.T.P.  GIUBIASCO
TICINO RIVER  AFTER  WW.T.P.
LAKE  CADAGNO
82.61% 82.00%
90.24% 84.00%
91.30% 80.00%
97.96% 92.00%
Percentage of strains carrying plasmids
Aeromonas  spp. Fecal Coliforms
81.63% 96.00%
 
 
 
Table 4.3.5: Percentages of Aeromonas spp. and Fecal Coliforms carrying plasmids with three or more 
antibiotic resistances. 
TICINO  RIVER BEFORE WW.T.P.
BELLINZONA  HOSPITAL
WW.T.P.  GIUBIASCO
TICINO RIVER  AFTER  WW.T.P.
LAKE  CADAGNO
Percentage of strains with 3 or more resistances
69.39%
60.87%
87.80%
Aeromonas  spp Fecal Coliforms
73.91%
22.00%
28.00%
40.00%
22.00%
2.04% 18.00%
 
 
 
4.4 Extended spectrum β-lactamases 
The research of the extended spectrum β-lactamases production was carried out on 
presumptive positive strains. 
Of the 231 Aeromonas spp., 13 strains were resistant to the Cephalosporins (first to third 
generation) and were further investigated for the synergy of PM/PML (Cefepime/Cefepime + 
Clavulanic Acid). The strain 77 SG-Aer, isolated from the Bellinzona Hospital wastewater, 
showed the rounded “phantom” in the PM/PML E-Test®. 
36 over 250 Fecal Coliforms, resistant to the Cephalosporins (first to third generation) and 
growing on the chromogenic selective plates for ESBL producers (chromID ESBL, 
BioMérieux), were further investigated for the detection of the ESBL phenotype. Strains 55 
SG-CF (HWW) and 172 FDD-CF (TR-a-WWTP) presented the typical rounded “phantom”, 
due to the synergy between the two antibiotics CTX and AMC. The CT/CTL E-Test® 
confirmed the ESBL phenotype for the strains 56 SG-CF (HWW) and 85 SG-CF (HWW) 
(Table 4.4.1). 
The five phenotypical ESBL strains were screened by PCR for the plasmidic bla genes; 
sequencing of the amplicons showed the presence of the genes blaSHV-12, blaOXA-1 in the 
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Aeromonas 77 SG-Aer strain as well as in the Fecal Coliforms 56 SG-CF and 85 SG-CF, 
blaSHV-12 in the strain 55 SG-CF, and blaCTX-M27 in the strain 172 FDD-CF. 
 
 
Table 4.4.1: Fecal Coliforms tested for the ESBL phenotypes. The colored rows indicated the ESBL 
phenotype of the four strains. The gray rows indicated the strains with a clear synergy (rounded “phantom”) 
between CTX and AMC. The orange rows indicated the CT/CTL E-Test® positive strains. (---) sensitive strains 
to the antibiotics tested. 
Source Species Strains Resistace phenotypes Source Species Strains Resistace phenotypes
HWW E.coli 55SG-CF AM,CPD,CRO,AMC,CTX,ATM,FEP(I) WWTP C.freundii 126 DG-CF CXM,CPD,CRO,AMC,CTX,ATM
HWW E.coli 56SG-CF AM, FOX,CXM,CPD,CTX,ATM,FEP(I) WWTP E.coli 130 DG-CF ---
HWW E.coli 58SG-CF AMC WWTP E.coli 133 DG-CF ---
HWW C.freundii 66SG-CF AM,CXM,CPD,CRO,AMC,CTX,ATM WWTP E.coli 135 DG-CF ---
HWW E.cloacae 67SG-CF CPD,CRO,AMC,CTX,ATM, WWTP K.oxytoca 136 DG-CF ---
HWW E.coli 72SG-CF --- WWTP E.cloacae 141 DG-CF CXM,CPD,CRO,AMC,CTX,ATM
HWW E.coli 80SG-CF CPD,AMC,CTX,ATM,FOX WWTP E.cloacae 143 DG-CF CXM,CPD,CRO,AMC,CTX,ATM
HWW E.coli 85SG-CF CPD,CTX,ATM WWTP C.freundii 147 DG-CF CXM,CPD,CRO,AMC,CTX,ATM
WWTP C.freundii 106 DG-CF AM,CXM,CPD,CRO,AMC,CTX,ATM WWTP K.oxytoca 150 DG-CF ---
WWTP C.freundii 108 DG-CF AM,CXM,CPD,CRO,AMC,CTX,ATM TR-a-WWTP E.cloacae 157 FDD-CF CXM,CPD,CRO,AMC,CTX,ATM
WWTP E.cloacae 109 DG-CF CXM,CPD,AMC,CTX,ATM TR-a-WWTP C.freundii 162 FDD-CF CXM,CPD,CRO,AMC,CTX,ATM,FEP(i)
WWTP E.coli 110 DG-CF --- TR-a-WWTP E.coli 172 FDD-CF AM,CXM,CPD,CRO,AMC,CTX,ATM,FEP
WWTP E.cloacae 115 DG-CF CXM,CPD,CRO,AMC,CTX,ATM TR-a-WWTP C.freundii 183 FDD-CF CXM,CPD,CRO,AMC,CTX,ATM
WWTP E.cloacae 117 DG-CF CXM,CPD,CRO,AMC,CTX,ATM TR-a-WWTP C.freundii 185 FDD-CF CXM,CPD,CRO,AMC,CTX,ATM
WWTP E.cloacae 120 DG-CF CXM,CPD,CRO,AMC,CTX,ATM TR-a-WWTP E.coli 189 FDD-CF ---
WWTP E.cloacae 123 DG-CF CXM,CPD,CRO,AMC,CTX,ATM,FEP(i) TR-a-WWTP C.freundii 197 FDD-CF CXM,CPD,CRO,AMC,CTX,ATM
WWTP E.cloacae 124 DG-CF CXM,CPD,CRO,AMC,CTX,ATM CL E.coli 213 LC-CF ---
WWTP E.cloacae 125 DG-CF CXM,CPD,CRO,AMC,CTX,ATM CL E.cloacae 248 LC-CF CXM,CPD,CRO,AMC,CTX,ATM
 
 
 
4.5 Nalidixic acid and Ciprofloxacin resistances 
29/231 Aeromonas spp. and 10/250 Fecal Coliforms carrying the phenotypical resistance to 
Ciprofloxacin, as well as 6 Aeromonas spp. resistant to Nalidixic Acid were screened by PCR 
in order to investigate the specific Gyrase A gene (GyrA) resistance mutation. Results showed 
the existence of mutations localized near the active site of the enzyme in all the Aeromonas 
spp. tested. In particular, mutations were found in the amino acid Ser83→Ile or Ser83→Arg 
of the GyrA enzyme. The mutation Ser83→Phe was found in one Aeromonas caviae strain 
resistant only to Nalidixic acid. In addition, three Aeromonas media showed a second 
mutation Asp87→Asn, and one A. caviae in Asp87→Ala. On the other hand, the Fecal 
Coliform 85 SG-CF (HWW) was found wild-type, showing the sequence expected for the two 
controls sensitive to Ciprofloxacin (Aeromonas 195 FDD-Aer and Fecal coliform 235 LC-CF 
(CL)). The other nine strains presented the mutation in the position Ser83→Val. 7 of the 9 
resistant Fecal Coliform showed also a second mutation in Asp87→Asn.  
The single and/or double mutation, and the wild type strains are reported in Figure 4.5.1. 
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Figure 4.5.1: Mutations in the Gyrase A enzyme. The figure resumes the Aeromonas and Fecal Coliforms 
strains carrying the mutation in the amino acid 83 (the Serine can be substituted with Isoleucine, Arginine, 
Phenylalanine or Leucine) or in the amino acid 87 (Aspartic acid substituted with Asparagine). The amino-acid 
83 is indicated with the black harrow, while the amino acid 87 with red harrow. The sequences of the reference 
strains (ATCC) were retrieved from NCBI. S, Serine; I, Isoleucine; R, Arginine; A, Alanine; D, Aspartic acid; N, 
Asparagine; L, Leucine. 
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4.6 Mobilization and incompatibility groups 
The MOB sub-families screening carried out by Dot-blot of the Aeromonas spp. plasmids 
(205 strains) has shown that the 31.7% of the Aeromonas strains had mobilizable and 
potentially transferable plasmids belonging to the MOBP13, and MOBP14 subfamilies. 
Approximately 69% of the Fecal Coliforms (149 out of 216 strains) had mobilizable and 
potentially transferable plasmids belonging to the MOBF12, MOBP12, and MOBH11 (Table 
4.6.1). The MOBP13, one of the largest subfamily in Aeromonas plasmids, was observed in the 
2.08% of the Lake Cadagno isolates and the 17.07% of the strains isolated from the Giubiasco 
wastewater treatment plant. Plasmids of the MOBP14 were distributed in the 2.17% of the 
Bellinzona Hospital strains and in the 46.34% of the wastewater treatment plant isolates. The 
Aeromonas plasmids from Lake Cadagno were hardly characterizable by the MOB screening.  
The MOB sub-families identified in the Fecal Coliforms were: the MOBF12, detected in 
16.00% of strains from wastewater treatment plant and in 72.00% of those from Lake 
Cadagno; the MOBP12, identified in 12.50% and 28.00% of the strains from the Ticino River 
after and before the wastewater treatment plant, respectively. Finally, the MOBH11 was 
distributed in the 8.00% of the Ticino River after the treatment plant and Bellinzona Hospital 
strains, and in the 14.00% of those isolated from the Giubiasco wastewater treatment plant.  
The MOB sub-families identified in the plasmid extracts of the Aeromonas spp. and Fecal 
Coliforms strains are listed in Table 4.6.2.  
Table 4.6.1 reports the distribution of the MOB sub-families as well as the Dot-Blot based 
screening results for the incompatibility group U (Inc U) performed on the plasmid extracts. 
All the other BHR groups, namely Inc A/C, Inc N, Inc P, and Inc W, which were screened by 
PCR, resulted negative. In Aeromonas spp., four strains (139 DG-Aer, 145 DG-Aer, 114 DG-
Aer and160 FDD-Aer isolated from WWTP and after the WWTP in the river Ticino) were 
positives for the presence of plasmids belonging to the incompatibility group U, whereas in 
Fecal Coliforms, only one strain (133 DG-CF isolated from WWTP) was found positive. 
The majority of the mobilizable plasmids identified belonged to the MOBP13 (17 strains), and 
MOBP14 (37 strains), for the Aeromonas spp., and to the MOBF12 (79 strains), MOBP12 (42 
strains), and MOBH11 (21 strains), for the Fecal Coliforms.  
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Table 4.6.1: Mobilizable and transferable plasmids in Aeromonas spp. and Fecal Coliforms strains.  
Incompatibility 
group
H121 F12 P12 P13 P14 H11 IncU
Aeromonas  spp. TR-b-WWTP - - - 4.08% 8.16% - -
HWW 2.17% 2.17% 2.17% 2.17% 2.17% - -
WWTP 2.44% - 4.88% 17.07% 46.34% 7.32% 7.32%
TR-a-WWTP - - 4.65% 13.95% 34.88% - 2.33%
CL - - - 2.08% - - -
Fecal Coliforms TR-b-WWTP 4.00% 26.00% 28.00% - - 12.00% -
HWW 6.00% 26.00% 14.00% - - 8.00% -
WWTP - 16.00% 16.00% 2.00% 2.00% 14.00% 2.00%
TR-a-WWTP - 18.00% 12.50% - - 8.00% -
CL - 72.00% 16.00% - - - -
MOB subfamilies
 
 
 
 
Table 4.6.2: MOB sub-families in Aeromonas spp. and Fecal Coliforms. 231 Aeromonas spp. and 250 Fecal 
Coliforms are listed and divided by sampling areas. The black squares indicate the positive plasmids for the 
MOB sub-families; colored squares indicated the groups of plasmidic complexity. 
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1FT-Aer TR-b-WWTP A.media 1FT-CF TR-b-WWTP C.freundii
2FT-Aer TR-b-WWTP A.media 2FT-CF TR-b-WWTP E.coli
3FT-Aer TR-b-WWTP A.caviae 3FT-CF TR-b-WWTP K.pneumoniae
4FT-Aer TR-b-WWTP A.media 4FT-CF TR-b-WWTP E.coli
5FT-Aer TR-b-WWTP A.hydrophila 5FT-CF TR-b-WWTP E.coli
6FT-Aer TR-b-WWTP A.media 6FT-CF TR-b-WWTP E.coli
7FT-Aer TR-b-WWTP A.sobria 7FT-CF TR-b-WWTP E.coli
8FT-Aer TR-b-WWTP A.media 8FT-CF TR-b-WWTP C.freundii
9FT-Aer TR-b-WWTP A.media 9FT-CF TR-b-WWTP E.coli
10FT-Aer TR-b-WWTP A.media 10FT-CF TR-b-WWTP E.coli
11FT-Aer TR-b-WWTP A.salmonicida 11FT-CF TR-b-WWTP K.pneumoniae
12FT-Aer TR-b-WWTP A.media 12FT-CF TR-b-WWTP E.coli
13FT-Aer TR-b-WWTP A.bestiarum 13FT-CF TR-b-WWTP E.coli
14FT-Aer TR-b-WWTP A.hydrophila 14FT-CF TR-b-WWTP E.coli
15FT-Aer TR-b-WWTP A.sobria 15FT-CF TR-b-WWTP E.cloacae
16FT-Aer TR-b-WWTP A.media 16FT-CF TR-b-WWTP K.pneumoniae
17FT-Aer TR-b-WWTP A.salmonicida 17FT-CF TR-b-WWTP E.coli
18FT-Aer TR-b-WWTP A.caviae 18FT-CF TR-b-WWTP K.oxytoka
19FT-Aer TR-b-WWTP A.caviae 19FT-CF TR-b-WWTP E.coli
20FT-Aer TR-b-WWTP A.bestiarum 20FT-CF TR-b-WWTP E.coli
21FT-Aer TR-b-WWTP A.media 21FT-CF TR-b-WWTP E.coli
22FT-Aer TR-b-WWTP A.sobria 22FT-CF TR-b-WWTP E.coli
23FT-Aer TR-b-WWTP A.media 23FT-CF TR-b-WWTP E.coli
24FT-Aer TR-b-WWTP A.caviae 24FT-CF TR-b-WWTP K.pneumoniae
25FT-Aer TR-b-WWTP A.media 25FT-CF TR-b-WWTP E.hermannii
26FT-Aer TR-b-WWTP A.caviae 26FT-CF TR-b-WWTP E.coli
27FT-Aer TR-b-WWTP A.sobria 27FT-CF TR-b-WWTP E.coli
28FT-Aer TR-b-WWTP A.media 28FT-CF TR-b-WWTP E.coli
29FT-Aer TR-b-WWTP A.media 29FT-CF TR-b-WWTP E.coli
30FT-Aer TR-b-WWTP A.bestiarum 30FT-CF TR-b-WWTP E.coli
31FT-Aer TR-b-WWTP A.media 31FT-CF TR-b-WWTP E.coli
32FT-Aer TR-b-WWTP A.bestiarum 32FT-CF TR-b-WWTP E.coli
33FT-Aer TR-b-WWTP A.sobria 33FT-CF TR-b-WWTP E.coli
34FT-Aer TR-b-WWTP A.media 34FT-CF TR-b-WWTP E.coli
36FT-Aer TR-b-WWTP A.media 35FT-CF TR-b-WWTP E.coli
MOB Subfamilies MOB Subfamilies
Aeromonas spp. Fecal Coliforms
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37FT-Aer TR-b-WWTP A.hydrophila 36FT-CF TR-b-WWTP E.coli
38FT-Aer TR-b-WWTP A.media 37FT-CF TR-b-WWTP E.coli
39FT-Aer TR-b-WWTP A.media 38FT-CF TR-b-WWTP E.coli
40FT-Aer TR-b-WWTP A.media 39FT-CF TR-b-WWTP E.coli
41FT-Aer TR-b-WWTP A.media 40FT-CF TR-b-WWTP E.coli
42FT-Aer TR-b-WWTP A.media 41FT-CF TR-b-WWTP E.coli
43FT-Aer TR-b-WWTP A.media 42FT-CF TR-b-WWTP E.coli
44FT-Aer TR-b-WWTP A.caviae 43FT-CF TR-b-WWTP E.coli
45FT-Aer TR-b-WWTP A.media 44FT-CF TR-b-WWTP E.coli
46FT-Aer TR-b-WWTP A.bestiarum 45FT-CF TR-b-WWTP E.coli
47FT-Aer TR-b-WWTP A.media 46FT-CF TR-b-WWTP E.coli
48FT-Aer TR-b-WWTP A.media 47FT-CF TR-b-WWTP E.coli
49FT-Aer TR-b-WWTP A.media 48FT-CF TR-b-WWTP K.pneumoniae
50FT-Aer TR-b-WWTP A.media 49FT-CF TR-b-WWTP E.coli
51SG-Aer HWW A.hydrophila 50FT-CF TR-b-WWTP E.coli
52SG-Aer HWW A.hydrophila 51SG-CF HWW E.coli
53SG-Aer HWW A.hydrophila 52SG-CF HWW E.coli
54SG-Aer HWW A.hydrophila 53SG-CF HWW K.pneumoniae
55SG-Aer HWW A.hydrophila 54SG-CF HWW K.pneumoniae
56SG-Aer HWW A.hydrophila 55SG-CF HWW E.coli
57SG-Aer HWW A.hydrophila 56SG-CF HWW E.coli
58SG-Aer HWW A.hydrophila 57SG-CF HWW E.coli
59SG-Aer HWW A.hydrophila 58SG-CF HWW E.coli
60SG-Aer HWW A.hydrophila 59SG-CF HWW E.coli
61SG-Aer HWW A.hydrophila 60SG-CF HWW E.coli
62SG-Aer HWW A.hydrophila 61SG-CF HWW E.coli
63SG-Aer HWW A.hydrophila 62SG-CF HWW E.coli
64SG-Aer HWW A.salmonicida 63SG-CF HWW E.coli
65SG-Aer HWW A.hydrophila 64SG-CF HWW E.coli
66SG-Aer HWW A.hydrophila 65SG-CF HWW E.coli
67SG-Aer HWW A.hydrophila 66SG-CF HWW C.freundii
68SG-Aer HWW A.hydrophila 67SG-CF HWW E.cloacae
69SG-Aer HWW A.hydrophila 68SG-CF HWW E.coli
71SG-Aer HWW A.hydrophila 69SG-CF HWW E.coli
72SG-Aer HWW A.hydrophila 70SG-CF HWW E.coli
73SG-Aer HWW A.salmonicida 71SG-CF HWW E.coli
75SG-Aer HWW A.hydrophila 72SG-CF HWW E.coli
76SG-Aer HWW A.hydrophila 73SG-CF HWW E.coli
77SG-Aer HWW A.hydrophila 74SG-CF HWW E.coli
78SG-Aer HWW A.hydrophila 75SG-CF HWW E.coliE.coli
79SG-Aer HWW A.hydrophila 76SG-CF HWW E.coli
80SG-Aer HWW A.hydrophila 77SG-CF HWW E.coli
81SG-Aer HWW A.salmonicida 78SG-CF HWW E.coli
82SG-Aer HWW A.caviae 79SG-CF HWW E.coli
83SG-Aer HWW A.hydrophila 80SG-CF HWW E.coli
84SG-Aer HWW A.hydrophila 81SG-CF HWW E.coli
85SG-Aer HWW A.hydrophila 82SG-CF HWW E.coli
86SG-Aer HWW A.hydrophila 83SG-CF HWW E.coli
87SG-Aer HWW A.hydrophila 84SG-CF HWW E.coli
88SG-Aer HWW A.hydrophila 85SG-CF HWW E.coli
89SG-Aer HWW A.hydrophila 86SG-CF HWW E.coli
90SG-Aer HWW A.hydrophila 87SG-CF HWW E.coli
91SG-Aer HWW A.media 88SG-CF HWW E.coli
92SG-Aer HWW A.veronii 89SG-CF HWW E.coli
94SG-Aer HWW A.hydrophila 90SG-CF HWW E.coli
95SG-Aer HWW A.hydrophila 91SG-CF HWW E.coli
96SG-Aer HWW A.hydrophila 92SG-CF HWW E.coli
97SG-Aer HWW A.media 93SG-CF HWW E.coli
98SG-Aer HWW A.hydrophila 94SG-CF HWW E.coli
99SG-Aer HWW A.hydrophila 95SG-CF HWW K.pneumoniae
101DG-Aer WWTP A.caviae 96SG-CF HWW E.coli
102DG-Aer WWTP A.media 97SG-CF HWW E.coli
104DG-Aer WWTP A.media 98SG-CF HWW E.coli
105DG-Aer WWTP A.caviae 99SG-CF HWW E.coli
106DG-Aer WWTP A.media 100SG-CF HWW E.coli
107DG-Aer WWTP A.media 101DG-CF WWTP K.pneumoniae
109DG-Aer WWTP A.eucrenophila 102DG-CF WWTP K.pneumoniae
110DG-Aer WWTP A.hydrophila 103DG-CF WWTP K.pneumoniae
111DG-Aer WWTP A.media 104DG-CF WWTP K.pneumoniae
112DG-Aer WWTP A.caviae 105DG-CF WWTP K.pneumoniae
113DG-Aer WWTP A.caviae 106DG-CF WWTP C.freundii
114DG-Aer WWTP A.hydrophila 107DG-CF WWTP K.pneumoniae
115DG-Aer WWTP A.media 108DG-CF WWTP C.freundii
116DG-Aer WWTP A.media 109DG-CF WWTP E.cloacae
117DG-Aer WWTP A.media 110DG-CF WWTP E.coli
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118DG-Aer WWTP A.media 111DG-CF WWTP E.coli
119DG-Aer WWTP A.hydrophila 112DG-CF WWTP K.pneumoniae
120DG-Aer WWTP A.bestiarum 113DG-CF WWTP E.coli
121DG-Aer WWTP A.media 114DG-CF WWTP E.coli
122DG-Aer WWTP A.hydrophila 115DG-CF WWTP E.cloacae
123DG-Aer WWTP A.media 116DG-CF WWTP K.pneumoniae
126DG-Aer WWTP A.salmonicida 117DG-CF WWTP E.cloacae
127DG-Aer WWTP A.media 118DG-CF WWTP E.coli
128DG-Aer-A WWTP A.media 119DG-CF WWTP E.coli
128DG-Aer-B WWTP A.caviae 120DG-CF WWTP E.cloacae
129DG-Aer WWTP A.media 121DG-CF WWTP E.coli
130DG-Aer WWTP A.media 122DG-CF WWTP K.pneumoniae
131DG-Aer WWTP A.media 123DG-CF WWTP E.cloacae
133DG-Aer WWTP A.hydrophila 124DG-CF WWTP E.cloacae
135DG-Aer WWTP A.media 125DG-CF WWTP E.cloacae
136DG-Aer WWTP A.media 126DG-CF WWTP C.freundii
137DG-Aer WWTP A.hydrophila 127DG-CF WWTP E.coli
139DG-Aer WWTP A.hydrophila 128DG-CF WWTP E.coli
140DG-Aer WWTP A.media 129DG-CF WWTP K.pneumoniae
141DG-Aer WWTP A.hydrophila 130DG-CF WWTP E.coli
143DG-Aer WWTP A.hydrophila 131DG-CF WWTP E.coli
144DG-Aer WWTP A.media 132DG-CF WWTP K.pneumoniae
145DG-Aer WWTP A.hydrophila 133DG-CF WWTP E.coli
147DG-Aer WWTP A.hydrophila 134DG-CF WWTP K.pneumoniae
148DG-Aer WWTP A.media 135DG-CF WWTP E.coli
150DG-Aer WWTP A.caviae 136DG-CF WWTP K.oxytoka
151FDD-Aer TR-a-WWTP A.caviae 137DG-CF WWTP K.pneumoniae
152FDD-Aer TR-a-WWTP A.caviae 138DG-CF WWTP K.pneumoniae
153FDD-Aer TR-a-WWTP A.media 139DG-CF WWTP K.pneumoniae
154FDD-Aer TR-a-WWTP A.media 140DG-CF WWTP E.coli
155FDD-Aer TR-a-WWTP A.media 141DG-CF WWTP E.cloacae
156FDD-Aer TR-a-WWTP A.hydrophila 142DG-CF WWTP E.coli
157FDD-Aer TR-a-WWTP A.hydrophila 143DG-CF WWTP E.cloacae
158FDD-Aer TR-a-WWTP A.caviae 144DG-CF WWTP E.coli
159FDD-Aer TR-a-WWTP A.hydrophila 145DG-CF WWTP E.coli
160FDD-Aer TR-a-WWTP A.caviae 146DG-CF WWTP K.pneumoniae
161FDD-Aer TR-a-WWTP A.caviae 147DG-CF WWTP C.freundii
163FDD-Aer TR-a-WWTP A.media 148DG-CF WWTP K.pneumoniae
164FDD-Aer TR-a-WWTP A.hydrophila 149DG-CF WWTP E.cloacae
165FDD-Aer TR-a-WWTP A.caviae 150DG-CF WWTP K.oxytoka
166FDD-Aer TR-a-WWTP A.media 151FDD-CF TR-a-WWTP E.coli
167FDD-Aer TR-a-WWTP A.media 152FDD-CF TR-a-WWTP E.coli
168FDD-Aer TR-a-WWTP A.hydrophila 153FDD-CF TR-a-WWTP E.coli
169FDD-Aer TR-a-WWTP A.media 154FDD-CF TR-a-WWTP K.pneumoniae
171FDD-Aer TR-a-WWTP A.media 155FDD-CF TR-a-WWTP E.coli
172FDD-Aer TR-a-WWTP A.caviae 156FDD-CF TR-a-WWTP E.coli
173FDD-Aer TR-a-WWTP A.media 157FDD-CF TR-a-WWTP E.cloacae
174FDD-Aer TR-a-WWTP A.media 158FDD-CF TR-a-WWTP K.pneumoniae
175FDD-Aer TR-a-WWTP A.media 159FDD-CF TR-a-WWTP E.coli
176FDD-Aer TR-a-WWTP A.media 160FDD-CF TR-a-WWTP E.coli
177FDD-Aer TR-a-WWTP A.bestiarum 161FDD-CF TR-a-WWTP E.coli
178FDD-Aer TR-a-WWTP A.caviae 162FDD-CF TR-a-WWTP C.freundii
179FDD-Aer TR-a-WWTP A.caviae 163FDD-CF TR-a-WWTP E.coli
180FDD-Aer TR-a-WWTP A.hydrophila 164FDD-CF TR-a-WWTP E.coli
181FDD-Aer TR-a-WWTP A.media 165FDD-CF TR-a-WWTP E.coli
182FDD-Aer TR-a-WWTP A.media 166FDD-CF TR-a-WWTP E.coli
183FDD-Aer TR-a-WWTP A.media 167FDD-CF TR-a-WWTP K.pneumoniae
184FDD-Aer TR-a-WWTP A.media 168FDD-CF TR-a-WWTP E.coli
186FDD-Aer TR-a-WWTP A.caviae 169FDD-CF TR-a-WWTP K.pneumoniae
187FDD-Aer TR-a-WWTP A.caviae 170FDD-CF TR-a-WWTP E.coli
188FDD-Aer TR-a-WWTP A.caviae 171FDD-CF TR-a-WWTP E.coli
189FDD-Aer TR-a-WWTP A.punctata 172FDD-CF TR-a-WWTP E.coli
190FDD-Aer TR-a-WWTP A.media 173FDD-CF TR-a-WWTP E.coli
191FDD-Aer TR-a-WWTP A.caviae 174FDD-CF TR-a-WWTP E.coli
192FDD-Aer TR-a-WWTP A.caviae 175FDD-CF TR-a-WWTP E.coli
193FDD-Aer TR-a-WWTP A.media 176FDD-CF TR-a-WWTP E.coli
195FDD-Aer TR-a-WWTP A.veronii 177FDD-CF TR-a-WWTP E.coli
196FDD-Aer TR-a-WWTP A.media 178FDD-CF TR-a-WWTP E.coli
197FDD-Aer TR-a-WWTP A.hydrophila 179FDD-CF TR-a-WWTP E.coli
198FDD-Aer TR-a-WWTP A.media 180FDD-CF TR-a-WWTP K.pneumoniae
199FDD-Aer TR-a-WWTP A.hydrophila 181FDD-CF TR-a-WWTP K.pneumoniae
200FDD-Aer TR-a-WWTP A.media 182FDD-CF TR-a-WWTP K.pneumoniae
201LC-Aer CL A.popoffii 183FDD-CF TR-a-WWTP C.freundii
202LC-Aer CL A.salmonicida 184FDD-CF TR-a-WWTP K.pneumoniae
203LC-Aer CL A.salmonicida 185FDD-CF TR-a-WWTP C.freundii
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204LC-Aer CL A.media 186FDD-CF TR-a-WWTP E.coli
205LC-Aer CL A.salmonicida 187FDD-CF TR-a-WWTP E.coli
206LC-Aer CL A.media 188FDD-CF TR-a-WWTP E.coli
207LC-Aer CL A.salmonicida 189FDD-CF TR-a-WWTP E.coli
208LC-Aer CL A.salmonicida 190FDD-CF TR-a-WWTP K.pneumoniae
209LC-Aer CL A.salmonicida 191FDD-CF TR-a-WWTP E.coli
210LC-Aer CL A.salmonicida 192FDD-CF TR-a-WWTP E.coli
211LC-Aer CL A.salmonicida 193FDD-CF TR-a-WWTP E.coli
212LC-Aer CL A.salmonicida 194FDD-CF TR-a-WWTP K.pneumoniae
213LC-Aer CL A.salmonicida 195FDD-CF TR-a-WWTP K.pneumoniae
214LC-Aer CL A.salmonicida 196FDD-CF TR-a-WWTP C.freundii
215LC-Aer CL A.salmonicida 197FDD-CF TR-a-WWTP C.freundii
216LC-Aer CL A.salmonicida 198FDD-CF TR-a-WWTP C.freundii
217LC-Aer CL A.salmonicida 199FDD-CF TR-a-WWTP E.coli
218LC-Aer CL A.salmonicida 200FDD-CF TR-a-WWTP E.coli
219LC-Aer CL A.salmonicida 201LC-CF CL E.coli
220LC-Aer CL A.salmonicida 202LC-CF CL E.coli
221LC-Aer CL A.salmonicida 203LC-CF CL E.coli
222LC-Aer CL A.salmonicida 204LC-CF CL E.coli
223LC-Aer CL A.salmonicida 205LC-CF CL E.coli
224LC-Aer CL A.salmonicida 206LC-CF CL E.cloacae
225LC-Aer CL A.salmonicida 207LC-CF CL E.coli
226LC-Aer CL A.salmonicida 208LC-CF CL E.coli
227LC-Aer CL A.salmonicida 209LC-CF CL E.coli
228LC-Aer CL A.salmonicida 210LC-CF CL E.coli
229LC-Aer CL A.salmonicida 211LC-CF CL E.coli
230LC-Aer CL A.salmonicida 212LC-CF CL E.coli
231LC-Aer CL A.salmonicida 213LC-CF CL E.coli
232LC-Aer CL A.salmonicida 214LC-CF CL P.shigelloides
233LC-Aer CL A.salmonicida 215LC-CF CL P.shigelloides
234LC-Aer CL A.salmonicida 216LC-CF CL E.coli
235LC-Aer CL A.salmonicida 217LC-CF CL E.coli
236LC-Aer CL A.salmonicida 218LC-CF CL E.coli
237LC-Aer CL A.salmonicida 219LC-CF CL E.coli
238LC-Aer CL A.salmonicida 220LC-CF CL E.coli
239LC-Aer CL A.salmonicida 221LC-CF CL E.coli
240LC-Aer CL A.eucrenophila 222LC-CF CL E.coli
242LC-Aer CL A.salmonicida 223LC-CF CL E.coli
243LC-Aer CL A.salmonicida 224LC-CF CL E.coli
244LC-Aer CL A.eucrenophila 225LC-CF CL E.coli
245LC-Aer CL A.salmonicida 226LC-CF CL E.coli
246LC-Aer CL A.salmonicida 227LC-CF CL E.coli
247LC-Aer CL A.salmonicida 228LC-CF CL E.coli
248LC-Aer CL A.eucrenophila 229LC-CF CL E.coli
249LC-Aer CL A.salmonicida 230LC-CF CL E.coli
250LC-Aer CL A.salmonicida 231LC-CF CL E.coli
232LC-CF CL E.coli
233LC-CF CL E.coli
234LC-CF CL E.coli
235LC-CF CL E.coli
236LC-CF CL E.coli
237LC-CF CL E.coli
238LC-CF CL E.coli
239LC-CF CL E.coli
240LC-CF CL E.coli
241LC-CF CL E.coli
242LC-CF CL C.freundii
243LC-CF CL E.coli
244LC-CF CL E.coli
245LC-CF CL E.coli
246LC-CF CL E.coli
247LC-CF CL E.coli
248LC-CF CL E.cloacae
249LC-CF CL E.coli
250LC-CF CL E.coli
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Strains Percentages Strains Percentages
TR-b-WWTP 49 22.45% 50 16.00%
HWW 46 8.70% 50 18.00%
WWTP 41 60.98% 50 2.00%
TR-a-WWTP 43 55.81% 50 12.00%
CL 48 - 50 2.00%
Aeromonas  spp. Fecal Coliforms
Integrase I
4.7 Class 1 integrons 
The Integrase I (IntI1) gene has been investigated by Dot-blot on the total DNA extracts of 
231 Aeromonas spp. and 250 Fecal Coliforms (Table 4.7.1). The IntI1 gene was detected in 
the 60.98% of the Aeromonas strains collected from the wastewater treatment plant, and in the 
55.81% of those sampled in the Ticino river after the treatment plant. In the Bellinzona 
Hospital wastewater only the 8.70% of the strains resulted positive for the IntI1 gene, while in 
the river before the wastewater treatment plant the frequency was 22.45%. The strains of the 
Lake Cadagno did not have any Integrase 1 gene. The IntI1 gene was present in the 2.00% of 
the Fecal Coliforms isolated from the wastewater treatment plant and from the Lake Cadagno, 
and in the 18.00% of those isolated from the Hospital wastewater. 
All the strains which tested positive for the genomic presence of the IntI1 gene were further 
investigated through the amplification and sequencing of the variable regions of the class 1 
integrons performed on the plasmid extracts. Class 1 integrons had a plasmid localization in 
all the Fecal Coliforms harboring the IntI1 gene except for the strains from the Ticino river 
after the wastewater treatment plant, in which integrons were located on plasmids in only the 
50% of the strains. In Aeromonas spp., class 1 integrons were plasmid located in the 45.45% 
and 12.50% of the strains isolated from the Ticino river before and after the wastewater 
treatment plant, respectively, in the 16.00% of those from the Giubiasco wastewater treatment 
plant, and in all strains originated from the Bellinzona Hospital wastewaters.  
The most common gene cassettes (Table 4.7.2) within the class 1 integrons found in the 
Aeromonas strains were aadA1 (62.5%), CatB8 (37.5%), and CatB3 (25%); in the Fecal 
Coliforms the most common gene cassettes were aadA1 (63.6%), CatB2 (36.4%) and dfrA14 
(22.7%). 
 
 Table 4.7.1: Percentage of Integrase 1 gene positive strains from the total DNA extracts. 
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Table 4.7.2: Plasmidic class 1 Integrons in Aeromonas spp. and Fecal Coliforms. The variable regions of the 
class 1 Integrons were amplified between the PantF and the qacE∆1 genes. The gene cassettes colored in red 
showed incomplete sequences or portions of hypothetical proteins. 
Source Species Strains PantF-qacE∆1 Source Species Strains PantF-qacE∆1
TR-b-WWTP A.sobria 7FT-Aer dfrB1-aadA1b-CatB2 TR-b-WWTP E.coli 6FT-CF dfrA14-aadA1-CatB2
A.media 16FT-Aer OXA10-aadA1 E.coli 21FT-CF dfrA14-aadA1-CatB2
A.sobria 27FT-Aer Empty E.coli 22FT-CF dfrA17-aadA5
A.media 39FT-Aer dfr22 K.pneumoniae 24FT-CF aadA4a-hypotetical protein
A.media 42FT-Aer CatB3- aadA1 E.coli 30FT-CF dfrA14-aadA1-catB2
E.coli 34FT-CF dfrA14-aadA1-CatB2
HWW A.hydrophila 52SG-Aer CatB8-aadA1 E.coli 35FT-CF dfrA14-aadA1-CatB2
A.hydrophila 57SG-Aer CatB8-aadA1 K.pneumoniae 48FT-CF aadA2
A.hydrophila 77SG-Aer aacA4cr-OXA1-CatB3-aar3
A.hydrophila 96SG-Aer CatB8-aadA1 HWW E.coli 55SG-CF aacA4-aadA1-CatB2
E.coli 56SG-CF aacA4-aadA1-CatB2
WWTP A.caviae 105 DG-Aer CatB8-Transposase E.coli 58SG-CF dhfrA1-aadA1
A.media 130 DG-Aer dfr?-aadA1 E.coli 65SG-CF dfrA1-aadA1
A.media 135 DG-Aer aadA2 E.coli 72SG-CF EstX putative esterase/hydrolase
A.hydrophila 137 DG-Aer CatB3-aadA1 E.coli 80SG-CF dfrA17-aadA5
E.coli 81SG-CF dfrA12-OrfF-?
TR-a-WWTP A.caviae 161 FDD-Aer CatB8-aadA1 E.coli 85SG-CF aacA4-aadA1-CatB2
A.media 167 FDD-Aer CatB8-aadA1 E.coli 96SG-CF dfrA1-aadA1
A.media 171 FDD-Aer aacA3-OXA21-CatB3-aadA16
WWTP E.coli 110 DG-CF dfrA1-aadA1
TR-a-WWTP K.pneumoniae 169 FDD-CF Empty
E.coli 172 FDD-CF dfrA17-aadA5
E.coli 189 FDD-CF dfrB4
CL E.coli 235 LC-CF aadA1
Aeromonas  spp Fecal Coliforms
Plasmidic Class I Integron
 
 
 
4.8 Plasmid curing 
205 of 231 Aeromonas spp. strains harbored plasmids. All the strains with these accessory 
DNA molecules were grown in presence of SDS 10%, but most of them (62.44%) were not 
able to replicate in these conditions. Of the remaining strains (Table 4.8.1), only two strains (5 
FT-Aer and 91 SG-Aer) showed the loss of plasmids. The antibiotic resistance phenotype 
(resistance to Nalidixic Acid) was lost only for the strain 91 SG-Aer (Table 4.8.2). 
In 13.17% of the strains no variations of the resistance phenotype were observed, whereas the 
chemical curing caused some other changes in a number of Aeromonas strains such as a 
decrease of resistance (0.98%), an increase of resistance in approx. 21% of the strains, and a 
mixed effect of increased resistance for some antibiotics and decreased for others (1.46%) 
(Table 4.8.1). 
The antibiotic resistance phenotype before and after SDS 10% curing of six strains, used as 
example to summarize the possible resistance and plasmidic variations of the Aeromonas spp. 
strains, are shown in Table 4.8.2. 
The strains unable to grow in presence of SDS 10% and the strain 91 SG-Aer were submitted 
to the plate curing by the culture transfer on solid agar medium. Plasmids were again cured 
only from the strain 91 SG-Aer (Figure 4.8.1). All the other attempts of curing plasmids 
(culture transfer in liquid minimal medium, culture transfer in water or curing using acridine 
 - 76 - 
orange) failed. No strain tested showed loss of plasmids, but some developed an increased 
resistance to one of the fallowing antibacterial compounds: Cefoxitin, Gentamicin, Bactrim 
and Ciprofloxacin (data not shown). 
 
 
Table 4.8.1: Percentages of each variation in Aeromonas spp. strains following the curing with SDS 10%. 
 
 
 
 
 
 
 
 
 
Table 4.8.2: Summary of the changes observed after the chemical curing (SDS 10%). The red rectangles 
indicate the phenotype “antibiotic resistant”; the green rectangles indicate the phenotype “antibiotic susceptible”. 
The numbers in the color rectangles indicate the diameters of inhibition. In the bottom of the Table are indicated 
the types of variations. 
wild type Curing wild type Curing wild type Curing wild type Curing wild type Curing wild type Curing
Cefazolin CZ 11 16 8 8 7 6 9 6 6 6 6 6
Cefuroxime CXM 6 31
Ceftriaxone CRO 11 36
Cefoxitin FOX 17 18 18 20 20 15 6 16 6 6
Ciprofloxacin CIP 25 19
Polymyxin PB 17 9
Nalidixic Acid NA 6 23 8 6 6 6 6 6 11 6
123 DG-Aer
Antibiotics
5 FT-Aer91 SG-Aer 119 DG-Aer 60 SG-Aer 19 FT-Aer
Any variations No variationsLost of plasmidsNo variations
Lost of plasmids
Decrease of resistances Decrease of resistances Increase of resistances
 
 
 
  
 
 
 
 
 
 
 
Figure 4.8.1: Agarose gel of the total plasmid extracts of the strain 91 SG-Aer 
before and after the SDS 10% and plate curing. The black harrow indicates the loss 
of one plasmid. 
 
Lost of plasmids 0.98%
Decrease of resistances 0.98%
Increase of resistances 20.98%
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4.9 Bacterial conjugations 
The results of conjugations on solid supports or in liquid media performed between 
Aeromonas spp. and Fecal Coliforms are listed in Table 4.9.1. Strains of both groups were 
used alternatively as donors and recipients. On the 55 solid and 33 liquid conjugation, only 
the 7.27% of the first group gave a positive conjugation. A positive transfer of plasmids, and 
of the related antibiotic resistance phenotype, was obtained with four Aeromonas strains used 
as donors in conjugations performed on solid support. In liquid media the same strains were 
not able to transfer their plasmids by conjugation. 
The resistance profiles of the transconjugants obtained by conjugation between the four 
Aeromonas spp. strains (2 FT-Aer, 19 FT-Aer, 156 FDD-Aer, and 183 FDD-Aer) used as 
donors, and the Fecal Coliforms (66 SG-CF) used as recipient, are listed in Table 4.9.2. The 
double selection was performed using Ciprofloxacin (chromosomal resistance) and 
Ceftriaxone, antibiotics for whom the donor and the recipient were sensitive, respectively. 
The resistance phenotype of the transconjugants confirms the transfer of the resistance to 
Ceftriaxone. 
The plasmid profile of the donors and the transconjugants were visualized by electrophoresis 
on an agarose gel. The gel reported in Figure 4.9.1 shows the transfer of one plasmid from the 
donors to the recipient bacteria. 
 
Table 4.9.1: Conjugations experiments on solid supports or in liquid media. 
Conjugation 
type Strain Species Source Resistances Strain Species Source Resistances
Double 
Selection
Concentration 
(µg/mL)
Solid 121 DG-Aer A.media WWTP CZ, FOX, C, RL 126 DG-Aer A.salmonicida WWTP CZ, NA, S(I), RL(I) C, NA 16, 32
190 FDD-Aer A.media TR-a-WWTP CZ, FOX, NA
66SG-CF C.freundii HWW CZ, FOX, NA, AM, CXM, CPD, CRO, AMC, CTX, ATM
Solid 138 DG-Aer Alcaligenes faecalis WWTP CZ, GM 126 DG-Aer A.salmonicida WWTP CZ, NA, S(I), RL(I) GM, NA 32, 32
190 FDD-Aer A.media TR-a-WWTP CZ, FOX, NA
66SG-CF C.freundii HWW CZ, FOX, NA, AM, CXM, CPD, CRO, AMC, CTX, ATM
Solid 2FT-Aer A.media TR-b-WWTP CZ, CXM, CRO, FOX, NA, S, TMP 66SG-CF C.freundii HWW CZ, FOX, NA, AM, CXM, CPD, CRO, AMC, CTX, ATM CRO, CIP 4, 4
19FT-Aer A. caviae TR-b-WWTP CZ, CXM, CRO, FOX, NA, S
156 FDD-Aer A.hydrophila TR-a-WWTP CZ, CXM, CRO, FOX, NA
183 FDD-Aer A.media TR-a-WWTP CZ, CXM, CRO, FOX, NA(I)
Solid 119 DG-CF E.coli WWTP SXT, S, TMP, RL(I) J53 E.coli Ref. strain C, NA, Rif, NaN3 SXT, C 4, 8
29FT-Aer A.media TR-b-WWTP CZ, CXM, FOX, NA, Te(I),S, RL, CRO(I),SXT(I),CIP(I)
Solid, Liquid 173 FDD-Aer A.media TR-a-WWTP CZ, NA, CIP(I), S(I) J53 E.coli Ref. strain C, NA, Rif, NaN3 CIP, C 1, 8
184 FDD-Aer A.media TR-a-WWTP CZ, NA, CIP(I), S(I), RL(I) 29FT-Aer A.media TR-b-WWTP CZ, CXM, FOX, NA, Te(I), S, RL, CRO(I) ,SXT(I) ,CIP(I) CIP, SXT 1, 4
186 FDD-Aer A.caviae TR-a-WWTP CZ, CIP, NA, S(I)
187 FDD-Aer A.caviae TR-a-WWTP CZ, CIP, NA
188 FDD-Aer A.caviae TR-a-WWTP CZ, CIP, NA, S(I)
189 FDD-Aer A.punctata TR-a-WWTP CZ, CIP, NA, S(I)
191 FDD-Aer A.caviae TR-a-WWTP CZ, NA, CIP(I), RL(I)
192 FDD-Aer A.caviae TR-a-WWTP CIP, NA, CZ(I)
193 FDD-Aer A.media TR-a-WWTP CZ, CIP, NA, S(I), RL(I)
200 FDD-Aer A.media TR-a-WWTP CZ, CIP, NA, S(I)
Donor Recipient
 
 
continued… 
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1  2    3  4   5  6  7  8 
2 FT-Aer 66 SG-CF 66/2 19 FT-Aer 66 SG-CF 66/19
Antibiotics
CZ 6 14 6 6 14 6
CXM 6 23 6 6 23 6
CRO 6 28 11 11 28 9
FOX 6 6 6 6 6 6
GM 21 19 20 22 19 20
SXT 24 26 25 29 26 25
CIP 22 17 15 35 17 14
MEM 32 32 30 32 32 30
PB 16 17 17 17 17 17
C 28 22 16 33 22 17
NA 6 6 6 11 6 6
AM 16 6 16 6
156 FDD-Aer 66 SG-CF 66/156 183 FDD-Aer 66 SG-CF 66/183
Antibiotics
CZ 6 14 6 6 14 6
CXM 6 23 6 6 23 6
CRO 14 28 9 16 28 10
FOX 6 6 6 6 6 6
GM 23 19 20 26 19 20
SXT 29 26 24 31 26 24
CIP 29 17 16 31 17 16
MEM 35 32 30 38 32 30
PB 17 17 16 19 17 16
C 35 22 16 37 22 16
NA 13 6 6 15 6 6
AM 16 6 16 6
Strains Strains
StrainsStrains
Table 4.9.2: Resistant phenotypes of Donors, Recipient 
and Transconjugants strains. The red rectangles indicate 
the phenotype “antibiotic resistant”; the green rectangles 
indicate the phenotype “antibiotic susceptible”. The numbers 
indicate the diameters of inhibition. 
Figure 4.9.1: Plasmid profiles of 
Transconjugants (T) and Donor (D) 
strains. The recipient strain (66SG-
CG) was not included in the picture 
because it didn’t have any plasmid. 
Lane 1, 66/2 (T); lane 2, 2FT-Aer (D); 
lane 3, 66/19 (T); Lane 4, 19FT-Aer 
(D); lane 5, 66/156 (T); lane 6, 
Solid, Liquid 1FT-Aer A.media TR-b-WWTP CZ, CXM, FOX, NA, CIP(I) J53 E.coli Ref. strain C, NA, Rif, NaN3 CIP, C 1, 8
6FT-Aer A.media TR-b-WWTP CZ, CXM, CRO, FOX, NA, CIP(I) 29FT-Aer A.media TR-b-WWTP CZ, CXM, FOX, NA, Te(I), S, RL, CRO(I) ,SXT(I) ,CIP(I) CIP, SXT 1, 4
8FT-Aer A.media TR-b-WWTP CZ, CXM, CRO, FOX, CIP, NA, S(I),RL(I)
10FT-Aer A.media TR-b-WWTP CZ, CXM, CRO, FOX, NA, CIP(I), RL(I)
12FT-Aer A.media TR-b-WWTP CZ, FOX,CIP,NA, S(I)
43FT-Aer A.media TR-b-WWTP CZ, FOX, NA, NN, CRO(I), CIP(I), S(I)
77SG-Aer A.hydrophila HWW CZ, CXM, CRO, GM, CIP, NAS, RL, ATM, NN, NET
105 DG-Aer A.caviae WWTP NA, S, RL, CIP(I)
113 DG-Aer A.caviae WWTP CZ, CIP, NA, S(I)
127 DG-Aer A.media WWTP CZ, NA, CIP(I)
131 DG-Aer A.media WWTP CZ, CXM, CRO, FOX, NA, S(I), CIP(I)
137 DG-Aer A.hydrophila WWTP CZ, (FOX), CIP, NA, SXT(I)
151 FDD-Aer A.caviae TR-a-WWTP CZ, CIP, NA, S(I)
153 FDD-Aer A.media TR-a-WWTP CZ, FOX, NA, CIP(I)
155 FDD-Aer A.media TR-a-WWTP CZ, FOX, NA, CIP(I)
158 FDD-Aer A.caviae TR-a-WWTP CZ, CIP, NA, S(I)
163 FDD-Aer A.media TR-a-WWTP CZ, CIP, NA, S(I)
165 FDD-Aer A.caviae TR-a-WWTP CZ, NA, CIP(I), RL(I)
167 FDD-Aer A.media TR-a-WWTP CZ, NA, CIP(I), RL(I), S(I)
169 FDD-Aer A.media TR-a-WWTP CZ,FOX,CIP,NA, S(I)
Solid, Liquid 42FT-Aer A.media TR-b-WWTP CZ, FOX, CIP, C, NA, S(I), RL, NN 29FT-Aer A.media TR-b-WWTP CZ, CXM, FOX, NA, Te(I),S, RL, CRO(I) ,SXT(I), CIP(I) CIP, SXT 1, 4
127 DG-Aer A.media WWTP CZ, NA, CIP(I)
167 FDD-Aer A.media TR-a-WWTP CZ, NA, CIP(I), S(I), RL
Solid 1FT-Aer A.media TR-b-WWTP CZ, CXM, FOX, NA, CIP(I) J53 E.coli Ref. strain C, NA, Rif, NaN3 CIP, NaN3 1, 100
12FT-Aer A.media TR-b-WWTP CZ,FOX,CIP,NA, S(I)
105 DG-Aer A.caviae WWTP NA, S, RL, CIP(I)
127 DG-Aer A.media WWTP CZ,, NA, CIP(I)
137 DG-Aer A.hydrophila WWTP CZ, (FOX), CIP, NA, SXT(I)
153 FDD-Aer A.media TR-a-WWTP CZ, FOX, NA, CIP(I)
155 FDD-Aer A.media TR-a-WWTP CZ, FOX, NA, CIP(I)
167 FDD-Aer A.media TR-a-WWTP CZ, NA, CIP(I), RL(I), S(I)
Solid 2FT-Aer A.media TR-b-WWTP CZ, CXM, CRO, FOX, NA, S, TMP J53 E.coli Ref. strain C, NA, Rif, NaN3 CRO, NaN3 2, 100
19FT-Aer A. caviae TR-b-WWTP CZ, CXM, CRO, FOX, NA, S
38FT-Aer A.media TR-b-WWTP CZ, CXM, FOX, SXT, NA, CRO(I), S(I)
156 FDD-Aer A.hydrophila TR-a-WWTP CZ, CXM, CRO, FOX, NA
166 FDD-Aer A.media TR-a-WWTP CZ, CXM, CRO, FOX, NA, S(I), RL(I)
183 FDD-Aer A.media TR-a-WWTP CZ, CXM, CRO, FOX, NA(I)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 - 79 - 
4.10 Bacterial transformations 
Plasmids from Aeromonas spp. and Fecal Coliforms (listed in Table 4.10.1) were used in the 
transformation experiments. In the 36 transformations performed with the competent bacteria 
E. coli DH5α, and in the 5 with the E. coli BL21, the uptake of the exogenous DNA was not 
successful, and no colonies grew after 24-48 hours of incubation in selective agar culture 
media. 
 
Table 4.10.1: Transformation of competent bacteria with plasmids extracted from Aeromonas spp. and 
Fecal Coliforms. 
Competent 
Bacteria Stranis Species Source Resistances
Concentration 
(ng/transformation) Selection
Concentration 
(µg/mL)
DH5α 6FT-Aer A.media TR-b-WWTP CZ, CXM, CRO, FOX, NA, CIP(I ) 100 CIP, CRO 1, 4
8FT-Aer A.media TR-b-WWTP CZ, CXM, CRO, FOX, CIP, NA, S(I ),RL(I )
10FT-Aer A.media TR-b-WWTP CZ, CXM, CRO, FOX, NA, CIP(I ), RL(I )
29FT-Aer A.media TR-b-WWTP CZ, CXM, FOX, NA, Te(I ),S, RL, CRO(I ),SXT(I ),CIP(I )
43FT-Aer A.media TR-b-WWTP CZ, FOX, NA, NN, CRO(I ), CIP(I ), S(I)
77SG-Aer A.hydrophila HWW CZ, CXM, CRO, GM, CIP, NAS, RL, ATM, NN, NET
131 DG-Aer A.media WWTP CZ, CXM, CRO, FOX, NA, S(I ), CIP(I )
DH5α 1FT-Aer A.media TR-b-WWTP CZ, CXM, FOX, NA, CIP(I ) 100 CIP 1
12FT-Aer A.media TR-b-WWTP CZ, FOX,CIP,NA, S(I )
105 DG-Aer A.caviae WWTP NA, S, RL, CIP(I )
113 DG-Aer A.caviae WWTP CZ, CIP, NA, S(I )
151 FDD-Aer A.caviae TR-a-WWTP CZ, CIP, NA, S(I )
153 FDD-Aer A.media TR-a-WWTP CZ, FOX, NA, CIP(I )
155 FDD-Aer A.media TR-a-WWTP CZ, FOX, NA, CIP(I )
158 FDD-Aer A.caviae TR-a-WWTP CZ, CIP, NA, S(I )
163 FDD-Aer A.media TR-a-WWTP CZ, CIP, NA, S(I )
165 FDD-Aer A.caviae TR-a-WWTP CZ, NA, CIP(I ), RL(I )
167 FDD-Aer A.media TR-a-WWTP CZ, NA, CIP(I ), RL(I ), S(I )
169 FDD-Aer A.media TR-a-WWTP CZ,FOX,CIP,NA, S(I )
173 FDD-Aer A.media TR-a-WWTP CZ, NA, CIP(I ), S(I )
184 FDD-Aer A.media TR-a-WWTP CZ, NA, CIP(I ), S(I ), RL(I )
186 FDD-Aer A.caviae TR-a-WWTP CZ, CIP, NA, S(I )
187 FDD-Aer A.caviae TR-a-WWTP CZ, CIP, NA
188 FDD-Aer A.caviae TR-a-WWTP CZ, CIP, NA, S(I )
189 FDD-Aer A.caviae TR-a-WWTP CZ, CIP, NA, S(I )
191 FDD-Aer A.caviae TR-a-WWTP CZ, NA, CIP(I ), RL(I )
192 FDD-Aer A.caviae TR-a-WWTP CIP, NA, CZ(I )
200 FDD-Aer A.media TR-a-WWTP CZ, CIP, NA, S(I )
DH5α 2FT-Aer A.media TR-b-WWTP CZ, CXM, CRO, FOX, NA, S, TMP 100 CRO 4
19FT-Aer A. caviae TR-b-WWTP CZ, CXM, CRO, FOX, NA, S
166 FDD-Aer A.media TR-a-WWTP CZ, CXM, CRO, FOX, NA, S(I ), RL(I )
DH5α 55SG-CF E.coli HWW CZ, CXM, CRO, SXT, CIP, C, NA, AM, Te, S, TMP, RL, ATM, NN(I ), K 100 CIP, CRO 1, 4
56SG-CF E.coli HWW CZ, CXM, CRO, FOX, CIP, NA, AM, S(I ), RL, ATM
85SG-CF E.coli HWW CZ, CXM, CRO, AM, CIP(I), NA(I ), S(I ), RL, ATM 
172 FDD-CF E.coli TR-a-WWTP CZ, CXM, CRO, SXT, CIP, NA, AM, Te, S, TMP, RL, ATM
DH5α 161 FDD-Aer A.caviae TR-a-WWTP CZ, FOX, NA, SXT(I ), S(I ), RL 100 SXT 4
BL21 29FT-Aer A.media TR-b-WWTP CZ, CXM, FOX, NA, Te(I ),S, RL, CRO(I ),SXT(I ),CIP(I ) 100 SXT+C 4, 8
38FT-Aer A.media TR-b-WWTP CZ, CXM, FOX, SXT, NA, CRO(I ), S(I)
137 DG-Aer A.hydrophila WWTP CZ, (FOX), CIP, NA, SXT(I )
BL21 127 DG-Aer A.media WWTP CZ, NA, CIP(I ) 100 CIP+C 1, 8
193 FDD-Aer A.media TR-a-WWTP CZ, CIP, NA, S(I ), RL(I )
Plasmids Antibiotics
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5 DISCUSSION 
 
 
The concentrations of Aeromonas in the surface water, the wastewater and the water before 
and after the wastewater treatment plant ranged from 2·103 CFU/100 mL into the Ticino river 
before the treatment plant to 3·106 CFU/100 mL in the Giubiasco wastewater treatment plant, 
and were similar to those reported by Figueira et al. (2011).  
The concentrations of Fecal Coliforms in the sampling areas followed the trend expected. In 
fact in presence of high amount of organic matter of fecal origin, the number of these bacteria 
was particularly high, such as in the Bellinzona Hospital wastewater (2.07·106 CFU/100 mL) 
and in the wastewater treatment plant (7.05·105 CFU/100 mL). In the Ticino river the 
sampling collected in the vicinity of the exhaust duct of the sewage plant showed a 
concentration of 1.63·104 CFU/100 mL, which was higher than the one from the same river 
but before the outlet (1.65·102 CFU/100 mL). Therefore it clearly appears that the wastewater 
treatment plant has an impact on the microbiology of the river even if the wastewater 
treatment plants are generally able to reduce about the 99% of the bacteria present in the input 
waters. On the other hand, the presence of Fecal Coliforms at low concentrations (3 CFU/100 
mL) in the alpine lake may be due to the leaching from the pastures that surround it.  
 
The identification of the bacterial species was performed by MALDI-TOF MS, which is a 
useful and very rapid method able to identify both Aeromonas and Fecal Coliforms (Benagli, 
et al., 2012; Thevenon et al., 2012). The most common mesophilic and psychrophilic species 
of Aeromonas were: A. hydrophila (up to 84.78%), A. caviae (up to 36.61%), A. media (up to 
57.14%) and A. salmonicida (up to 87.76%). The distribution of the species reflected what 
expected to find in different types of surface water (Janda et al., 2010) that had, in addition, 
different temperatures from each other. It is not surprising that the major part of the A. 
salmonicida, the mesophilic species of the genus, were found in the Lake Cadagno (1921 
m.a.s.l.). 
Among the Fecal Coliforms the species Escherichia coli was the most frequently identified 
(representing up to the 90% of the strains). In the sample of the wastewater treatment plant, E. 
cloacae (20%) and K. pneumoniae (34%) were also present in large amounts. It is known that 
the presence and concentration of Fecal Coliforms in environmental waters are not closely 
related to the kind of water, the temperature or the season (Byappanahalli et al., 2006), but 
rather to the fecal contamination of the environment. 
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The complexity of the extrachromosomal genomes of the Aeromonas spp. and Fecal 
Coliforms isolates was visualized by total plasmid extracts electrophoresis (plasmid profile).  
We decided to make a comparison of the plasmid profiles as such even if the bands on the 
gels may be due to different topological forms of the same plasmid. In fact, the common 
topological forms of plasmids comprises the covalently close circular (CCC), the open 
circular (OC), the open linear (OL), and the positive and negative supercoiled forms (Barth et 
al., 2009). All the profiles shared a band of approx. 23kbp. In other works (Kado and Liu, 
1981; Anderson and McKay, 1983; Takahashi and Nagano, 1984; Pedraza and Ricci, 
2002), the same band was described to be composed by chromosomal DNA. The restriction  
analysis (using EcoRI, SmaI, and SalI) of this single band taken from the gels of some 
Aeromonas spp., Fecal Coliforms, and Flavobacterium psychrophilum (a fish pathogen) 
plasmid extracts, has shown that the band corresponded to a combination of the plasmids 
contained in each single bacterial strain (data not shown). 
 
The plasmid profiles presented from few to many bands. The comparison of the plasmid 
profiles obtained from 231 Aeromonas strains and 250 Fecal Coliforms, has permitted to 
create six groups of profiles based on their complexity: 120 plasmidic profiles were clustered 
in the group of higher complexity (blue), 40 in the red group (low complexity with 2 or 3 
bands per profile), 89 in the yellow group (moderately complex profiles with bands from 1 to 
170 kbp), 61 plasmid profiles were placed in the purple group (with only one band of 23 kbp), 
and 110 in the green group (moderately complex profiles with bands from 1 to 23 kbp). The 
last group (light blue) includes 61 strains (27 Aeromonas spp. and 34 Fecal Coliforms) with 
no visible plasmids.  
 
About 60% of the profiles of the Aeromonas strains isolated from the river before the 
wastewater treatment plant clustered in the blue and green groups. In these groups clustered 
also approx. the 80% of the profiles of the Aeromonas isolated from the river after the plant. 
Therefore, there was a substantial difference between the two sampling areas, which may be 
due to the input in the river of the strains coming from the wastewater treatment plant. In fact, 
65% of the strains isolated in the plant presented plasmid profiles belonging to the blue and 
green groups. 
The 63% of the Aeromonas plasmid profiles isolated from the Bellinzona hospital wastewater 
were assigned to the yellow group, while the 73% of those isolated from the Lake Cadagno 
were included in the purple group. As this last complexity group clustered profiles with only 
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one band, we may thus speculate on the reduced need to have accessory genetic material for 
the strains living in this low polluted environment.  
The biggest part (80%) of the Fecal Coliforms plasmid profiles isolated from the Ticino river 
before the treatment plant were distributed in the blue, yellow and green groups, i.e. the 
groups showing an elevated complexity. This may be due to the presence of pollutants and/or 
of peculiar strains in the water collected, probably linked in part to the rain fall in the period 
in which the sampling was made. In fact, it has already been reported (Kim et al., 2010) that 
antibiotics and resistant bacteria can be transported into surface waters from soils by surface 
runoff or leaching after rainfall events. The Fecal Coliforms isolated from the hospital 
wastewater showed plasmid profiles clustered mainly in the yellow group (28%), while there 
has been a shift toward the blue group (38%) for those isolated from the wastewater treatment 
plant. These findings could be explained by differences of the environmental conditions 
resulting in different selective pressures. In the wastewater treatment plant the distribution of 
the plasmid profiles into the groups ranged between the 8% in the yellow group and the 38% 
in the blue group. Similar results were obtained in the river after the treatment plant, probably 
because of the partial mixing of the water leaving the plant with that of the river. Even if the 
changes observed in the plasmid profiles of the Fecal Coliforms were not as evident as those 
observed for Aeromonas, we can conclude that the outlet of the wastewater treatment plant 
affects the microbial flora of the receiving waters at least regarding the gene pool.  
More than the fifty percent of the stains isolated from the Lake Cadagno were included in the 
green group (moderately complex profiles). The presence of Fecal Coliforms with an elevated 
diversity of extrachromosomal elements may indicate the need for these bacteria to adapt to 
an hostile environment (oligotrophic waters and low temperature). Moreover, the selection of 
antibiotic resistant strains can not be excluded, given the presence on the neighboring land of 
a large herd of cows.  
 
The 481 strains showed resistance to Cefazolin (66.11%), Streptomycin (31.81%), Nalidixic 
acid (30.98%), Sulfamethoxazole (25.57%), Cefoxitin (21.41%), Ampicillin (16.22% of the 
Fecal coliforms), and Ciprofloxacin (9.56%) among the 20 antibiotics tested. Previous works 
carried out on Aeromonas strains isolated from two wastewater treatment plants (Igbinosa 
and Okoh, 2012), and from fishes, shellfishes and waters (Borrego et al., 1991) showed 
Aeromonas to be resistant to Ampicillin, Chloramphenicol, Gentamicin, Kanamycin, 
Nalidixic acid, Streptomycin, Tetracycline, Tobramycin, and Sulfamethoxazole. These 
resistances were related to the presence of small to large plasmids. Similar results have been 
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reported for Fecal Coliforms isolated in four hospitals (Gu et al., 2008) and in a 
slaughterhouse wastewater treatment plant (Moura et al., 2007). These antibiotic resistances 
seem therefore to be commonly present in various environments and bacteria.  
 The 80.5% of the 481 Aeromonas spp. and Fecal Coliforms analyzed was resistant to at least 
one antibiotic. Only 9.5% of the strains with one or more resistances belonged to the group 
without plasmids. On the contrary, more than the 50% of the strains resistant to one or more 
antibiotics, were included in the groups with the higher plasmid complexity, namely the blue 
(20.37%), the yellow (14.55%) and the green (18.71%) groups.  
Among the Aeromonas strains carrying plasmids isolated from the Ticino river before the 
wastewater treatment plant, approx. the 69% had three or more resistances. Among those 
isolated from the Bellinzona hospital wastewater, the strains resistant to three or more 
antibiotics represented the 60.87%, from the Giubiasco wastewater treatment plant the 
percentage was 87.80%, whereas from the Ticino river after the treatment plant, it was 
73.91%. The 97.96% of the Aeromonas strains isolated from the Lake Cadagno had plasmids 
but only 2% were resistant to three or more antibiotics.  
Fecal Coliforms harbouring plasmids and being resistant to at least three antibiotics, 
represented the 22% of the strains isolated from the river before and after the treatment plant, 
the 28% of the strains from the hospital wastewater, the 40% of the strains isolated from the 
wastewater treatment plant, and the 18% of the alpine Lake Cadagno strains. These results 
indicate a relation between the plasmid carriage and the resistance phenotype. In the 
environments where selective pressure of any type is expected, both the plasmid complexity 
and the number of resistances increased.  
 
During the characterization of the extended spectrum β-lactamases associated with plasmids, 
one A. hydrophila (77 SG-Aer, blaSHV-12, blaOXA-1) and four E. coli (55 SG-CF, blaSHV-12; 56 
SG-CF, blaSHV-12, blaOXA-1; 85 SG-CF, blaSHV-12, blaOXA-1; 172 FDD-CF, blaCTX-M27) were 
identified. Four of these strains (one Aeromonas and three E. coli) were isolated from the 
Bellinzona hospital wastewater, while one E. coli from the Ticino river after the treatment 
plant. The strains carried on their plasmids the ESBL genes blaOXA-1, blaCTX-M27, and blaSHV-12 
which are resistant determinants often encountered in clinical isolates all over the world 
(Yano et al., 2013; Carattoli A., 2009). Furthermore, the blaOXA-1 has been found also in 
animals, in addition to human samples (Shaheen et al., 2011). The finding of ESBL strains in 
the wastewater of a hospital is therefore not unexpected. On the contrary, it may be of concern 
the isolation of such strains from the river after the outlet of the wastewater treatment plant. In 
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fact, this result demonstrate the possibility for this worrisome resistance to disseminate into 
the natural environment through environmental, aquatic bacteria such as Aeromonas strains. 
 
About 12.6% of the Aeromonas spp. and 4% of the Fecal Coliforms were Ciprofloxacin 
resistant. Usually, the resistance to this antibiotic is due to the presence of genes, such as 
those of the qnr family, located on the chromosome or on plasmids. The resistance gene 
qnrS2 has been reported in an A. hydrophila isolated from an infected fish (Majumdar et al., 
2011), a qnrS1 gene in an E.coli isolated from cattle (Kirchner et al., 2011), and qnrA1, 
qnrS1, and qnrB19 genes were found in E.coli and K. pneumoniae, in a collection of 232 
Ciprofloxacin resistant or ESBL-producing isolates (Richter et al., 2010). Another study 
conducted on Aeromonas strains recovered from a Swiss lake identified the presence of the 
qnrS2 gene and of a class 1 integron, containing the acc(6’)-Ib-cr cassette, in an A. 
allosaccharophila (Picão et al., 2008). 
On the contrary, the resistance to Ciprofloxacin found in our strains was due to mutations in 
the Gyrase A protein (encoded by GyrA), the target of the quinolones and fluoroquinolones 
antibiotics. Among the 29 Aeromonas spp. resistant to Ciprofloxacin and the six resistant to 
Nalidixic Acid, 29 strains (seven from the Ticino river before and 16 after the WW.T.P outlet) 
were resistant due to a single mutation in position 83 of the gyrA gene, leading to the 
substitution Ser83→Ile in the protein, and one strain (A. caviae) to the mutation Ser83→Arg. 
These results were in agreement with those reported by other authors (Goñi-Urriza et al., 
2002), who found that the substitution of the Serine 83 in Isoleucine was more frequent than 
that in Arginine in A. caviae, A. hydrophila and A. sobria isolates from European rivers. One 
of our strains, A. media isolated from the river before the treatment plant, showed a different 
mutation Ser83→Phe. To our knowledge, this mutation was never reported in Aeromonas spp. 
In fact, this substitution has been described previously only in E. coli isolated from 
outpatients (Minarini et al., 2008), and in S. typhimurium isolated from clinical specimens 
(Reyna et al., 1995). This unusual mutation seems related to the Nalidixic acid and 
Ciprofloxacin resistances but not to other fluoroquinolones, since these last showed milder 
increases of the MIC (Minimal Inhibitory Concentration) (Reyna et al., 1995). Another 
substitution that confers resistance to quinolones, already described in Aeromonas isolates 
from feces (Alcaide et al., 2010) but not present in our strains, was the Ser83→Val. In three 
A. media and one A. caviae the resistance was a result of a double substitution. In two A. 
media resistant to Ciprofloxacin and in the one resistant to Nalidixic acid, we showed the 
substitutions Ser83→Ile and Asp87→Asn. The A. caviae, which was resistant to Nalidixic 
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acid and Ciprofloxacin, had the double substitution Ser83→Ile and Asp87→Ala. These 
double mutations are not described in the scientific literature, and do not seem to be directly 
related to the phenotype of resistance to fluoroquinolones and quinolones. Actually, other 
strains presented the same resistance profile but harbored only the single mutation Ser83→Ile. 
However, we would have to check any change of the MIC regarding these antibiotics. 
The single substitution Ser83→Leu was found in two E.coli, isolated from the wastewater of 
the Bellinzona Hospital and from the river after the treatment plant in Giubiasco. These 
mutations were already reported in E.coli and K. pneumoniae (Fu et al., 2013). The double 
mutation Ser83→Leu and Asp87→Asn was detected in seven E. coli isolated from the same 
sampling areas (three from the hospital wastewater and two strains from the river after the 
WWTP) and in two strains isolated from the wastewater treatment plant in Giubiasco. The E. 
coli 85 SG-CF, isolated from the hospital wastewater, showed a wild-type sequence of the 
GyrA gene. Its resistance might therefore be due to the presence of a resistance determinant, 
such as the qnr or the aac(6’)-Ib-cr genes, conferring resistance to quinolones. These genes 
may be carried on plasmids, rare in E. coli (Richter et al., 2010), or on the chromosome 
(Ruiz et al. 2012). 
 
In order to verify the presence of a relationship between the phenotypic resistances and the 
genotype of our strains, we investigated the distribution of Class 1 integrons and of their 
associated gene cassettes. The integrase I gene (IntI1) was detected in the 18.5% of the strains 
analyzed; in details, about the 28% (64 out of 231) of the Aeromonas spp. and the 10% (25 
out of 250) of the Fecal Coliforms had this gene. In a study carried out in a slaughterhouse 
wastewater treatment plant the IntI1-carrying bacteria (Aeromonas spp. and 
Enterobacteriaceae) were the 30.7% (Moura et al., 2007). Our findings were in agreement 
with those reported by these authors since we found that 28.5% of the strains isolated from 
the wastewater treatment plant of Giubiasco were IntI1 positive. The rate of Aeromonas 
strains carrying Class I integrons was found to be 65% in a set of 40 A. salmonicida isolated 
during a clinical outbreak of furunculosis (Schmidt et al., 2001), and 10% of the 133 
Aeromonas strains arising from samples suspected of a foodborne outbreak (Chang et al., 
2007). 221 out of 1832 (12.1%) Enterobacteriaceae isolated from a wastewater treatment 
plant in a municipal area in Poland  were IntI1 positive (Mockraka et al., 2012). Considering 
only the species  E. coli, K. pneumoniae, K. oxytoca, C. freundii, and E. cloacae, i.e. those we 
also found in the sampling done in the wastewater treatment plant of Giubiasco, the 
percentage of positive IntI1 isolates drops to 7.5%, a rate very close to our percentage. In 
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another study conducted in Kenya during a 19-year period, the authors analyzed E. coli strains 
isolated from hospitalized and non-hospitalized patients, and found that the 35% (464 out of 
1327) of the strains were positive for the Class 1 integrons (Kiiru et al., 2013). In our study 
the percentage of IntI1 positive E. coli strains, considering only those isolated from the 
Bellinzona hospital wastewater, was of 20% (9 out of 45). These different rates, are probably 
due to their different origin and degree of pathogenicity. 
The 25% (16 out of 64) of the Aeromonas strains and the 88% (22 out of 25) of the Fecal 
Coliform carried the IntI1 gene on plasmids. The sequencing of the gene cassettes within the 
Class 1 integrons was performed exclusively in the total plasmid extracts of the positive IntI1 
strains, in order to investigate only the resistance determinants associated to plasmids. 
The IntI1 gene located on plasmids was detected in the 43.75% of the A. media, in the 31.25% 
of the A. hydrophila, and in the 12.5% of the A. caviae and A. sobria. In the Fecal Coliforms 
the percentage of the plasmidic IntI1 genes was 88% (22 out of 25); the majority of strains, 
about the 86% (19 out of 22) were E. coli. 
In a work conducted on 267 Aeromonas strains from human origin isolated in Taiwan, the 
IntI1 gene was present in the 13.8% of the isolates, but only nine of them carried plasmids;  
therefore, merely the 0.75% of the strains carried IntI1 on plasmids (Lee et al., 2008). Similar 
results were obtained in strains of E. coli isolated from animal samples: the IntI1 gene was 
present in the 27% of the bacteria but only in about the 3.7% of the strains the gene was 
plasmid located (Shaheen et al., 2010). Our results differ from those reported above since the 
values we found are substantially higher, but it should be considered that the strains had a 
different origin. It is likely that our set of environmental strains was submitted to a significant 
selective pressure in the water ecosystems we studied, that favored the selection of  more 
versatile strains, possessing an elevated ability to survive in these hostile environments thanks 
to a large availability of extrachromosomal material. The presence of Class 1 integrons 
indicates that our environmental strains are able to store, to use and to eventually mobilize 
some of their genes when needed. 
 
In the Class 1 integrons of our Aeromonas spp. and Fecal Coliforms, we identified genes that 
confers resistance to aminoglycosides (aadA- and aacA-like gene), carbapenems  (blaOXA-
like gene), trimethoprim (dfrA-, dfrB-, dfr- like gene), and chloramphenicol (catB-like gene). 
In Aeromonas, the most common plasmid integrons contained the gene cassettes catB8-
aadA1. aadA1 was included in the 62.5% of the integrons, CatB8 in the 37.5%, CatB3 in the 
25%, and dfr- in the 18.75%. These rates are in agreement with the results reported by Chang 
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and colleagues (2007). Only one strain shown an empty Class 1 integron. Usually, the first 
cassette resistance gene in the variable part of the Class 1 integrons confers a phenotypic 
resistance, while the other genes positioned from the second position onwards confers low 
resistances or do not affects the phenotype. In the 50% of the integrons detected in the 
Aeromonas strains, the first cassette, represented by the genes CatB8 or CatB3, did not confer 
the resistance to Chloramphenicol. A similar observation was reported by Moura and 
colleagues (2007) regarding the aadA1 gene cassette. This is probably due to the presence of 
weak promoters that cause the absence or the low expression of the gene cassette. In some 
cases, as in the strain 42 FT-Aer (A. media) showing the CatB3-aadA1 gene cassettes, the 
resistances to Chloramphenicol, Streptomycin, and Tobramycin were phenotypically 
detectable. In Fecal Coliforms the most common gene cassettes were dfrA14-aadA1-catB2, 
aacA4-aadA1-catB2, and dfrA1-aadA1. aadA1 was detected in 59.1% of the integrons, CatB2 
in the 36.4%, and DfrA14 in the 22.7%. Consequently, the resistances to the aminoglycosides 
and to the trimethoprim were the most common resistances found in the Class 1 integron as 
reported by other studies (Shaheen et al., 2010; Kiiru et al., 2013). As found in Aeromonas, 
the presence of the gene cassette CatB2 was not related to the Chloramphenicol resistance, but 
it has to be noted that the gene was always present in the third position. The only exception 
was represented by the strain 55 SG-CF (E. coli) that was Chloramphenicol resistant despite 
the position of CatB2. In few strains, we noted the presence of genes with no clear functions 
in resistance. In one E. coli  the ExtX (putative Esterase/Hydrolase) sequence was integrated 
in the variable part of the integron.  This genetic construct was also reported  by Mokracka 
and colleagues (2012), but its function remains unexplained. We were not able to complete 
the sequence of the integron gene cassettes DfrA12-OrfF-? of an E. coli strain despite many 
attempts.  Gestal and colleagues (2005) reported a variable region of a Class 1 integron 
composed by the genes DfrA12-OrfF-aadA8b  that conferred resistance to 
Streptomycin/Spectinomycin; the gene aadA8b is probably an hybrid cassette that results 
from the recombination of the aadA2 and the aadA1 genes. Our strain was phenotypically 
resistant to Trimethoprim/Sulfamethoxazole, Trimethoprim, and Streptomycin, making 
plausible the presence of the aadA8b cassette. 
All the Aeromonas spp. and the Fecal Coliforms that possessed integrons were resistant to 
Sulfamethoxazole; this resistance is normally due to the presence of the sul gene in all the 
Class 1 integron. As already stated by Moura and colleagues (2007), the other antibiotic 
resistances detected by phenotypical methods in our strains reflected the presence of genes or 
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mechanisms of resistance located on the chromosome  or on plasmids, but not associated with 
integrons.  
 
Approximately the 32% of the Aeromonas spp. and the 69% of the Fecal Coliforms had 
mobilizable plasmids belonging to the subfamilies MOBH121, MOBH11, MOBF12, MOBP12, 
MOBP13, and MOBP14. The MOBP subfamily was the most frequent in Aeromonas spp. 
(25.54%), while in the Fecal Coliforms the 31.6% of the strains harbored plasmids belonging 
to the MOBF. Plasmids characterized by a MOB family were more frequent in the strains with 
complex plasmid profiles, i.e. belonging to the Blue, the Yellow and the Green groups.  
According to a previous study carried out on Gammaproteobacteria (Garcillàn-Barcia et al., 
2011), the MOBP, MOBH. and MOBF families are characteristic of  plasmids of large size. 
Contrary to the finding reported, the MOBF were found solely in Aeromonas showing 
plasmids with medium/low size. The MOBP was the family most frequently found in 
environmental bacteria (Smillie et al., 2010) as in the Aeromonas spp. we analyzed.  
 
Plasmid extracts were investigated in order to identify the presence of sequences permitting 
the transfer of plasmids by conjugation. The search for the incompatibility groups Inc A/C, 
Inc P, Inc W, Inc N, or Inc Q by PCR was, in our experience, unsuccessful: whereas this 
failure may be explained for the Aeromonas extracts by the use of primers designed on the 
Enterobacteriaceae (Carattoli et al., 2005; Cattoir et al., 2008; Götz et al., 1996), other 
reasons have to be at the base of this negative result in the Fecal Coliforms. 
Dot-Blot was performed only for the screening of the incompatibility group U allowing the 
detection of some positive plasmid extracts. Plasmids belonging to the IncU group and 
carrying resistance determinants have already been described in Aeromonas strains (Picão et 
al., 2008; Rhodes et al., 2004; Sørum et al., 2003). This incompatibility group was identified 
in the plasmid extract of Aeromonas spp. isolated from the wastewater treatment plant of 
Giubiasco (three strains) and from the river after the treatment plant (one strain), and in a 
Fecal Coliforms isolated from the wastewater treatment plant. Since the annealing of the Dot-
Blot probes are less specific than those of the primers, the finding of some positive extracts 
only by Dot-Blot is conceivable. The incompatibility groups Inc N, Inc P, Inc W, and Inc U, 
were found in 29 of 32 plasmids tested by Coutourier and colleagues (1988).  The 
percentage of positivity was therefore about 91%, and for the Inc U alone the rate was 25%. 
This result was in contrast with the present study where only few representatives of the Inc U 
group were found at the very low rate of 1.19%.   
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Treating E. coli K-12 strains with 10% SDS, Inuzuka and colleagues (1969) obtained the 
loss of plasmids without reducing the growth. In our case, the use of the same protocol has led 
the inability to survive in approx. 63% of the Aeromonas strains. The loss of plasmids was 
obtained in two strains, and only in one (91 SG-Aer), it was coupled to the loss of the 
resistance to Nalidixic Acid. Other attempts of plasmid curing based on minimal medium, 
water and plate curing or using the DNA-intercalating acridine orange were carried out. In 
particular, the DNA-intercalating acridine orange proved to be effective in Pseudomonas 
aeruginosa in which  the 66% of the isolate lost concomitantly plasmids and resistances such 
as those for Amikacin, Tetracycline, and Chloramphenicol (Shahid et al., 2003). Since none 
of the curing procedures tested was effective, we concluded that plasmids are stably 
maintained in Aeromonas. On the other hand, it has to be noted that the stress induced to the 
Aeromonas strains has led to the development of adaptations, which were expressed in the 
23% of the strains through changes in the profiles of resistance. These variations in the 
resistance profiles may be a signal of changes in pathways used by Aeromonas to survive in 
polluted aquatic environments. 
 
To investigate the ability of the Aeromonas spp. to horizontally transfer the resistance genes, 
some strains were used as donors in conjugation experiments, while Fecal Coliforms were 
employed as the recipients. No conjugations were successful when performed in liquid media, 
whereas it was possible to obtain transconjugants when the conjugation was performed in a 
solid medium. The efficiency of conjugation in liquid or solid media is linked to the 
morphology of the sexual pili (Bradley et al., 1980): with rigid pili, as those expressed by the 
IncM, IncN, IncP and IncW plasmids, the efficiency is higher in solid media, whereas the 
flexible pili expressed by the incompatibility groups IncH1, IncH2 or IncT, are more efficient 
in conjugation experiments carried out in liquid media. A. media, A. caviae, and A. hydrophila 
were able to transfer one of their plasmids to a Citrobacter freundii, isolated from the 
wastewater of the Bellinzona Hospital that became resistant to Ceftriaxone, the antibiotic used 
as selection for the donors. It was therefore possible to transfer horizontally a conjugative 
plasmid to an environmental bacterium. This result reinforces the role Aeromonas can play in 
the diffusion of resistances in the aquatic environment. It has already been demonstrated that 
Aeromonas are able to transfer their resistances to other bacteria, but the recipients were 
generally laboratory strains such as E. coli J53, E. coli K12 14R525, and P. putida KT2442-
GFP (Moura et al., 2012a; Cattoir et al., 2008; Lee et al., 2008; Schmidt et al., 2001; 
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Mokracka et al., 2012). It is therefore not surprising that the efficiency of the conjugations 
found in those experiments was higher compared to our experiments.  
We were unable to determine the MOB subfamilies of the plasmids present in the strains used 
in the conjugation experiments, except for the plasmid extract of the strain 19 FT-Aer, that  
was positive for the MOBP14. This MOB subfamily is related to the incompatibility groups 
IncQ2 and IncP6. Given that this strain was able to conjugate on a solid support, we can thus 
assume that the strain 19 FT-Aer harbors and is able to transfer a plasmid belonging to the 
incompatibility group P. Furthermore, it is possible that all the strains that conjugated 
possessed rigid sexual pili because they were able to transfer their resistance plasmids 
exclusively on solid supports.  
 
The few attempts of transformation we carried out gave negative results, perhaps because the 
excessive size or number of the plasmids used. Generally, the bacterial transformation is 
performed through electroporation to facilitate the entry of the plasmids into the recipient 
strain, using naturally competent bacteria, and plasmids of limited size, i.e. max. 13-14 kbp 
(Sota et al., 2010; Demanèche et al., 2002).  In order to confirm the ability of Aeromonas 
strains to acquire exogenous DNA from the aquatic environment further experiments of 
transformation should be carried out using: plasmids in the CCC form (Covalently Closed 
Circular) to eliminate any topological obstacle, electroporation, and/or naturally competent 
bacteria.    
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6 CONCLUSIONS 
 
The hypothesis of this PhD thesis was that bacteria of the genus Aeromonas could play a 
substantial role in the diffusion of resistant genes in aquatic environments. Since these 
bacteria are natural inhabitants of hydric ecosystems but can also be find as pathogens in 
humans, we assumed that they could be considered not only a “reservoir” of antibiotic 
resistance genes but possibly also a “vector” in the aquatic environment for the spread of 
these genes  to bacteria of clinical relevance, such as the Fecal Coliforms.  
The experimental planning has permitted to isolate and to identify Aeromonas spp. and Fecal 
Coliforms from five sampling areas, representing five different aquatic ecosystems, and to 
characterize their plasmid content and their antibiotic resistances. 
The rationale behind this study is the growing awareness of the existence of a pool of 
resistance genes, which are selected by the presence in the environment of increasing amounts 
of micro-pollutants, such as antibiotics (Campagnolo et al., 2002). These resistance genes 
can be transferred horizontally to pathogenic bacteria, thereby increasing the risk of infections 
caused by resistant germs. 
Several studies (Shaheen et al., 2010; van Hoek et al., 2011) have shown that the use of 
antimicrobial compounds in aquaculture, in veterinary and in clinical settings, can lead to the 
selection of resistant bacteria, and, even more important, to the selection of mobile genetic 
elements containing resistance determinants that can be transmitted among bacteria (Nardelli 
et al., 2012; Shaheen et al., 2011). 
Pollutants and resistant and/or virulent bacteria can reach the water environment through the 
sewage waters but also through the rainfall or watering of the fields which drain the soils 
(Cabello et al., 2013; Kim et al, 2010). On the other hand, the waterborne infections are well 
known pathologies not only in developing countries. (Puthucheary et  al., 2012; Majumdar 
et al., 2011; Cremonesini and Thomson, 2008).  
 
In this study we demonstrated that several antibiotic resistances found in the analyzed 
Aeromonas were located on Class 1 integrons associated to plasmids. Other resistance genes 
were located on plasmids outside integrons or in the chromosomal DNA, both in Class 1 
integrons and in other regions. As found in a study looking for presence of ESBL resistance 
genes on plasmids in the Seine river (Girlich et al., 2011), we were able to isolate from the 
hospital wastewater an Aeromonas strain producing extended spectrum beta-lactamases thank 
to genes located on a plasmid.  These findings confer to these bacteria a more important 
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contribution for the spread of resistance determinants in the aquatic environment. It should be 
emphasized that Aeromonas are aquatic bacteria that can reach significant high 
concentrations; considering the proportion that we obtained in our analysis of one ESBL 
producing Aeromonas each 250 strains, the number of Aeromonas ESBL positive that could 
be found in the analyzed waters could range from 2*1012 to 2*1015 CFU/day.  
The number and type of resistance genes identified so far on Aeromonas spp.  plasmids allows 
to support the hypothesis of considering these bacteria an environmental "reservoir" of 
plasmid resistance genes. 
 
In presence of variable stress conditions, the totality of the Aeromonas strains was able to 
adapt and grow, highlighting the capacity of this bacterial genus to persist under adverse 
conditions. The strains maintained their plasmids even under extreme stress conditions, such 
as growing in 10% SDS. We observed some phenotypic changes regarding the antibiotic 
resistance, which might be due to nonspecific mechanisms of resistance as those induced by 
chemical compounds or heavy metals (Yilmaz et al., 2013; Aktan et al., 2013). Furthermore, 
the stability of the plasmids contained in Aeromonas promotes their role as environmental 
“reservoirs” of antibiotic resistance genes. 
 
The presence in Aeromonas strains of mobilizable (MOBP) and potentially transferable 
plasmids endorses the assumptions of a plausible role of these bacteria in the horizontal gene 
transfer mediated by plasmids in the aquatic environment. We verified in a preliminary study 
that Aeromonas were able to transfer their resistant plasmids to other Aeromonas strains, as 
also reported by Bello-Lòpez and colleagues (2011). In our study, four strains of Aeromonas 
transferred one or more plasmids and the respective resistances to a C. freundii strain. The 
horizontal transfer of resistance genes from Aeromonas spp. strains to a strain of fecal origin, 
allowed to demonstrate the ability of Aeromonas spp. to relocate the resistance plasmids to 
other bacterial genera, thus leading to the formation of transconjugants potentially resistant to 
a given pharmacological treatment. In the aquatic environment that we studied here, these 
exchanges of genetic material through conjugation might involve a huge number of 
Aeromonas strains, in the order of 4.5*1012 to 1014 CFU/day. The ability of Aeromonas strains 
to transfer their resistance plasmids at inter-species and inter-genera levels, confirms also its 
role as a "vector" of genetic resistance determinants possibly to the human intestinal flora or 
to pathogenic bacteria. 
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Given the significant number of resistant and conjugative Aeromonas strains in the various 
aquatic environments, the role that Aeromonas hold in the spread of resistant genes seems to 
be very important. However, further analysis will be needed in order to characterize unknown 
MOB or BHR groups of plasmids and therefore to better understand the horizontal transfer of 
resistance determinants among Aeromonas strains and other potentially pathogenic bacteria. 
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